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1.1. General introduction 
The eukaryotic cell is a highly compartmentalized structure, each compartment 
differing in composition and function. Best known are the membrane-surrounded 
compartments, like the mitochondria that provide the cell with energy, the 
nucleus containing the genetic material, and the elaborate system of discrete 
organelles and vesicles that make up the endocytotic/secretory system. This 
latter system is comprised of early and late endosomes, lysosomes, secretory 
vesicles, the Golgi apparatus and the endoplasmic reticulum (ER). Organelles of 
this network are interconnected with each other by a mechanism of vesicular 
or tubulovesicular transport in which four discrete steps can be discerned: (A) 
Budding of a vesicle from a donor membrane, followed by (B) transport along 
the cytoskeleton and finally, (C) tethering to, and (D, E) fusion with the acceptor 
membrane (summarized in Figure 1). Not to end in chaos these different steps 
need to be under a tight spatial and temporal control. This control is achieved 
by the action of several proteins. First, budding of vesicles from their donor 
membrane occurs, in a reaction cascade that is mainly orchestrated by small 
GTPases of the Arf-family (for review: Takai et al., 2001). Until now 6 different 
Arf-isoforms have been recognized. After budding, vesicles translocate along the 
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Figure 1: Different 
membrane transport 
steps summarized. 
Budding and fission 
of a vesicle from the 
donor membrane (A) is 
followed by kinesin or  
dynein/dynactin-medi-
ated transport along the 
microtubule cytoskel-
eton (B) or myosin-me-
diated transport along 
the actin cytoskeleton 
(B’). After transport the 
vesicle is tethered to 
the acceptor membrane 
(C), followed by the 
assembly of the SNARE 
complex (D). This results 
in fusion with the accep-
tor membrane (E).
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cytoskeleton towards their acceptor membrane where tethering is achieved with 
the aid of tethering proteins. The subsequent fusion of donor and acceptor mem-
branes is mediated by SNAREs (Soluble N-ethylmaleimide sensitive factor attach-
ment protein receptor; for review see Jahn et al., 2006). Given the complexity 
of the endocytotic/secretory system, the coordination and specificity of all steps 
described clearly requires the action of regulatory proteins. The small GTPases 
of the Rab-family (Ypt-proteins in yeast) are the key players that orchestrate 
the different transport steps described above. These proteins constantly cycle 
between an active GTP-bound conformation at the membrane and an inactive 
GDP-bound state in the cytoplasm. In their active membrane-associated confor-
mation these proteins are selectively able to interact with a multitude of other 
proteins, so called effector proteins, making larger protein complexes, which 
finally govern the regulation and specificity of vesicular transport. 
1.2 The Rab family of small GTPases
Small GTPases can be divided into several groups depending on their structure 
and function, such as the Rho-family members Rac and Cdc42 which regulate 
gene expression and cytoskeletal rearrangements, the Ran protein which regu-
lates transport between the cytoplasm and nucleus, the Sar1 and Arf family of 
proteins, which as mentioned above are important in vesicle budding, and the 
Ras superfamily of proteins, which are involved in signal transduction and regu-
lation of gene expression. To this latter family of small GTPases also belong Ral 
(RalA and RalB) and Rab proteins both involved in regulating membrane transport 
(for review: (Takai et al., 2001). Rab proteins form the largest branch of the Ras 
superfamily of small GTPases. The first Rab protein identified was yeast protein-
2 (YP-2) in bakers yeast (Saccharomyces cerevisiae), later named Ypt1 (Gallwitz 
and Donath et al. 1983). First data implying a crucial role for these proteins in 
membrane trafficking came from the study of a protein very similar to Ypt1, 
named Sec4. Mutations in the Sec4 gene resulted in the accumulation of post 
Golgi vesicles, thereby blocking the transport to the plasma membrane (Salminen 
and Novick et al., 1987; Goud et al., 1988). The mammalian counterparts of Ypt1 
and Sec4 were named Rab (Ras-related in brain) as they were first identified in 
brain (Touchot et al., 1987). To date, 11 Rab proteins (including Ypt proteins and 
Sec4) have been identified in yeast and more than 60 in mammalian cells (Sten-
mark and Olkkonen 2001; Sivars and Aivazian 2003). The high number of different 
Rab proteins in mammalian cells compared to yeast reflects the complexity and 
functional diversity of membrane transport in higher eukaryotes. Figure 2 pres-
ents an overview of several Rab proteins and the membrane trafficking pathways 
in which they are involved. 
Rab proteins specify motorized vesicle transport
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Figure 2: Rab-regulated protein transport. 
A few examples of Rab-regulated transport pathways in the endocytotic/secretory system. ER (endo-
plasmic reticulum), ERGIC (ER Golgi intermediate compartment), EE (early endosome), RE (recycling 
endosome), LE (late endosome), LS (lysosomes), TGN (trans Golgi network), SV (secretory vesicle), 
MS (melanosome). Figure adapted from Zerial and McBride, 2001.
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Rab protein structure
Like other members of the Ras superfamily of small GTPases, Rab proteins 
contain highly conserved domains, including the motifs involved in guanine 
nucleotide binding (G1-G3) and Mg2+/phosphate binding (PM1-PM3) (Valencia et 
al., 1991). Rab proteins can be distinguished from other members of the Ras 
superfamily by five small stretches of conserved amino acids, named RabF1 to 
RabF5. Differences between Rab subfamily members can be discerned in other 
specific conserved stretches called RabSF1 to RabSF4 (Pereira-Leal et al., 2001). 
Furthermore, Rab proteins contain two switch regions (switch-I and switch-II). 
These regions change in conformation upon GTP binding and hydrolysis and effect 
activity and binding to effector proteins. A schematic drawing of the Rab protein 
structure showing the relative position of the PM, G, switch regions, hypervari-
able C-terminal domain, RabF and the RabSF domains, is given in figure 3.
Membrane association of Rab proteins
To ensure specificity in trafficking, it is essential that Rab proteins are associated 
with membranes. To enable the association, all newly synthesised Rab proteins 
are post-translationally modified by the addition of one, but usually two, geranyl-
geranyl groups to their C-terminal cysteine residues. These cysteine motifs vary 
between the different members i.e. they appear as -nnCnC, -nnnCC, -nnCCn, 
-nCCnn, -nCCnnn or in some cases –nCnnn motifs, where C is a cysteine residue 
and n any amino acid  (Kinsella et al., 1991; Farnsworth et al., 1994; Pereira-Leal 
et al., 2000). Important factors in the irreversible addition of this lipid moiety 
are Rab Escort Proteins (of which two isoforms are known: REP-I (Andres et al., 
1993) and REP-II (Cremers et al., 1994)) and Rab-geranylgeranyltransferase type 
II (RabGGTaseII, Seabra et al., 1992). Newly synthesized Rab proteins form a 
complex with REP and are subsequently recognized by RabGGTaseII, which then 
transfers the phosphoisoprenoid geranylgeranylpyrophosphate (GGpp) to the Rab. 
Rab proteins specify motorized vesicle transport
Figure 3: Schematic representation of Rab protein structure.
Conserved domains involved in guanine nucleotide binding (G1-G3) are boxed in grey and Mg2+/phos-
phate binding (PM1-PM2) are boxed in black. Rab specific sequences (F1-F5) are boxed in grey as is 
the C-terminal cysteine motif (CC). The two switch regions, the hypervariable C-terminal domain 
and regions determining Rab subfamily differences (SF1-SF4) are  highlighted. Figure adapted from 
Ali et al., 2004.
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After this transfer the RabGGTaseII dissociates from the complex and the Rab 
protein is delivered to its target membrane, where it also disassociates from REP 
(for review Goody 2005, Leung et al., 2006). Besides REP also Rab GDP disassocia-
tion inhibitor (RabGDI) can deliver Rab proteins to their target membranes (first 
identified by Takai et al., 1993). Whereas REP delivers newly synthesised Rab 
proteins, RabGDI delivers recycled Rab proteins back to their target membrane. 
Both REP and RabGDI are closely related in sequence and function, with one ma-
jor difference: As recycled Rab proteins are already geranylgeranylated, RabGDI, 
in contrast to REP, is not involved in the modification of Rab proteins.
The Rab Cycle 
As outlined above, Rab proteins constantly cycle between a membrane-associ-
ated guanosine triphosphate (GTP) bound ‘active’ and guanosine diposphate 
(GDP) bound ‘inactive’ state. This constant cycling between GTP- and GDP-bound 
states leads to subsequent association and disassociation from the membrane 
and enables both a tight spatial and temporal regulation of Rab activity which is 
further coordinated by several factors (shown in figure 4). The first step in the 
cycle involves the delivery of cytosolic Rab proteins to the proper target mem-
brane. The transition from cytosolic Rab proteins (either bound to REP or RabGDI) 
to the association with their target membrane is catalysed by GDI displacement 
factors (GDF), integral membrane proteins first identified by Dirac-Svejstrup et 
al., 1997. One other example of a GDF is the well characterized Yip3/PRA1 which 
catalyses the dissociation of Rab5, Rab7 and Rab9 from RabGDI and promotes the 
association of these Rabs onto membranes (Sivars et al. 2003). Once associated 
with their target membrane the Rab protein must be stabilized and activated by 
replacing the GDP for GTP. This exchange of nucleotides is catalysed by Guanine 
exchange factors (GEFs). Until now several Rab specific GEFs have been identi-
fied. Examples are Rabex-5 and GAP6, which both function as GEFs for Rab5 
(Horiuchi et al., 1997, Hunker et al., 2006) and Rabin8, which is a GEF for Rab8 
(Hattula et al., 2002). Once activated, Rab proteins can recruit a multitude of 
effector proteins (see below). When Rab proteins have fulfilled their function 
GTPase activating proteins (GAPs) catalyse the intrinsic GTPase activity of Rab 
proteins and convert them back to their ‘inactive’ GDP bound state. Examples of 
GAPs or proteins with a characteristic GAP domain are the centrosome associated 
GAPCenA, a GAP with activity towards Rab4, Rab11, Rab14 (Fuchs et al., 2007) 
and Rab6 (Cuif et al., 1999), the p85 subunit of phosphatidylinositol 3’-kinase 
which displays GAP-activity towards Rab4 and Rab5 (Chamberlain et al., 2004), 
and RN-Tre a GAP for Rab5 (Lanzetti et al., 2000). Finally the membrane-associ-
ated and GDP-bound Rab proteins are “extracted” from the membrane by RabGDI 
and become ready to be recycled back to their target membrane.
General introduction
 13
Rab interacting proteins
Rab-interacting proteins can be divided into two different groups, comprising 
regulatory proteins or effector proteins. Regulatory proteins bind to and affect 
the intrinsic properties of Rab proteins either catalyzing the intrinsic GTPase 
activity, such as the GAPs discussed above, or inhibiting it. Next to the GAPs the 
Rab proteins specify motorized vesicle transport
Figure 4: Rab cycle. 
Newly synthesized Rab proteins associate with REP (Rab escort protein) (A) or recycled Rab proteins 
associated with GDI (GDP dissociation inhibitor) (B) are transported to the membrane. Binding to REP 
or GDI is lost by the action of GDF (GDI displacement factor) and anchoring of the Rab protein into 
the membrane occurs (C). Next,  the GDP is replaced for GTP by GEF (GDP exchange factor) (D). In 
the GTP-bound active conformation Rab proteins can engage in binding to a wide variety of different 
protein complexes (E). The intrinsic GTPase activity of Rab proteins is catalysed by a GAP (GTPase 
activating protein) (F) and inorganic phosphate is released (G). Finally the Rab protein is extracted 
from the membrane by GDI (H) and is again recycled (figure adapted from Martinez and Goud, 1998).
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GEFs can also be considered to be part of this group. Other regulatory proteins 
bind specifically to Rab proteins in their GTP-bound conformation and inhibit the 
intrinsic GTPase activity. Thereby, they keep the Rab protein for a longer period 
in this active conformation. One such example is Rabaptin4, which binds to Rab4 
on early endosomes and inhibits the intrinsic GTPase activity of this small GTPase 
(Nagelkerken et al., 2000). 
 Unlike the regulatory proteins, effector proteins do not affect the in-
trinsic GTPase properties. They predominantly bind to Rab-proteins in their GTP 
bound conformation and are most of the time part of an even bigger protein 
complex. These protein complexes are in charge of regulating the different steps 
of membrane trafficking (Grosshans et al., 2006). For example, the Golgi-local-
ized GM130/GRASP65 protein complex, a Rab1 effector, is involved in tethering 
ER derived vesicles. Although GM130 is bound to the membrane independently 
of Rab1, the presence of this small GTPase aids in the assembly of the complex 
(Sztul et al., 2006). Next, SNAREs initiate the tethering and fusion of endosomal 
membranes. The Rab5 effector EEA1 is a large coiled-coil protein responsible for 
this process. This protein interacts with the tSNARE syntaxin13, thereby coordi-
nating the clustering and subsequent homotypic fusion of endosomes (Sztul et 
al., 2006). The Rab27/Granuphilin interaction facilitates binding with the vSNARE 
syntaxin1a (Torii et al., 2002). Furthermore the Rabphilin protein mediates bind-
ing of Rab3 and Rab27 with the vSNARE SNAP-25 (Tsuboi et al., 2005), providing 
yet another example of Rab involved membrane fusion. 
 Although most effector proteins bind only to one or a couple of closely 
related Rab proteins, there is one example of an effector protein binding to more 
than one Rab. This effector protein is Rabenosyn5, which interacts with both 
Rab4 and Rab5 and aids in the homotypic fusion of early endosomes (de Renzis et 
al., 2002). These so-called divalent Rab effector proteins allow fine-tuning of the 
action of different Rab proteins functioning in the same pathway. Finally, it is of 
note that Rab effector protein complexes are not only involved in the generation 
and fusion of vesicles. Rab proteins and their effectors are also found in motor 
protein complexes associated with the cytoskeleton, as is for example the case 
for Rab6. Since this role in transport is the particular topic of this thesis, this 
function and the type of interactions involved, will be discussed in more detail on 
page 17. 
Targeting of Rab proteins
How is the specific localization and activation of Rab proteins at their donor 
membranes achieved? As both RabGDI and GDF are not specific for one Rab 
protein these factors are probably not sufficient for proper targeting and merely 
contribute to Rab delivery. Initial targeting of newly synthesized Rabs seems to 
General introduction
 15
depend on their prenylation as monogeranylated Rab5 and Rab27 are mistargeted 
and non-functional (Gomes et al., 2003). It has long been thought that the C-
terminal hypervariable domain is essential in the targeting of Rab proteins. Early 
studies, where the C-terminal parts of Rab5 and Rab6 were interchanged sug-
gested the importance of these domains in correct localization (Stenmark et al., 
1994). However more recent studies, where the hypervariable domain of Rab5 
was replaced with that of Rab1, Rab2 or Rab7 did not alter the endosomal lo-
calization of Rab5. Instead, specific sequences upstream of the C-terminus were 
found to play a key role in the targeting of these Rab proteins (Ali et al., 2004). 
Chimeras between Rab9 and Rab5 or Rab9 and Rab1 revealed the importance of 
effector proteins in Rab localization. Both chimeras were still able to bind their 
specific effector proteins, however, in the presence of a high concentration of 
the Rab9 effector TIP47 the Rab1 chimera relocalized to the Rab9 compartment, 
i.e. late endosomes (Aivazian et al., 2006). Taken together, this demonstrates 
that a multitude of mechanisms play a role in the correct targeting of Rabs. 
Perhaps exact targeting is not even necessary. Instead Rabs are delivered to their 
proper membrane where they first diffuse freely through the membrane before 
encountering specific effector complexes that help to further stabilize the pro-
tein assembly (Pfeffer and Aivazian, 2004). 
Rab membrane domains and Rab maturation
More than one specific Rab protein can reside on a given membrane. Further-
more, the distribution of Rab proteins on a single organelle is not uniform. 
Instead, they seem to be organized in domains. The best-characterized system is 
the endocytotic system, where the early endosomes consist of different domains 
containing Rab4 and Rab5 and the recycling endosomes contain both Rab4 and 
Rab11 (Sonnichsen et al., 2000).  As a consequence, the presence of these Rab- 
domains results also in the recruitment of different effector proteins to different 
parts of the organelle. This enables the segregation of cargo and may serve other 
functions as well. 
 Originally, organelles were considered static structures and cargo trans-
port was thought to occur via vesicular transport. However, accumulating evi-
dence points towards a mechanism referred to as organelle maturation. Accord-
ing to this model the organelle matures by changing its molecular determinants. 
Just lately, such a model was also proposed for the endocytotic pathway. In this 
pathway Rab5 is present on early endosomes and in time is rapidly replaced by 
Rab7, which is present on late endosomes and recycling endosomes. This process 
turned out to be dependent on the recruitment of the Rab7-GEF hVPS39/Vam6, 
present in the Rab7 interacting complex Vps/HOPS, which also interacts with 
Rab5 (Rink et al., 2005). This example of maturation by displacing Rab5 for Rab7 
Rab proteins specify motorized vesicle transport
16
is probably the first example of many. A similar mechanism could play a role, 
although this is still under debate, in Golgi maturation (Mironov et al., 2005).  
One example of such a process has now been identified in yeast, where Ypt31/
Ypt32, which play a role in budding of vesicles from the ER, recruit Sec2, a known 
GEF for Sec4, which is involved in ER to Golgi transport (Ortiz et al., 2002). This 
particular mechanism provides efficient activation of downstream Rab proteins in 
the same pathway. 
 In the future more and more Rabs and their divalent effector proteins 
will be identified that play a role in the maturation of organelles. Combined, 
the localization of Rab proteins in domains on organelles and the possibility of 
rapid “extraction” followed by the replacement with other Rab proteins gives an 
enormous dynamic and flexible nature to the process of regulation of membrane 
transport. Whether the newly identified process of membrane fusion-dependent 
compartment mixing (Yu and Bement, 2007) could affect Rab protein complex 
behavior and association with other cellular structures will remain matter for 
further study. 
1.3 Rab-regulated transport along the actin and microtubule 
cytoskeleton
Besides providing the cell with structural integrity the cytoskeleton also facili-
tates the transport of vesicles from their donor membrane towards the acceptor 
membrane or aids in the formation of tubulovesicular structures. The two major 
components of the cytoskeleton that are involved in vesicular transport are actin 
filaments and microtubules. Movement of vesicular cargo or the formation of tu-
bulo-vesicular structures along the cytoskeleton is driven by motor proteins (Vale 
et al., 2003) and shown in figure 1. 
Rab-regulated transport along the actin cytoskeleton
Actin filaments are polarized structures that have fast growing plus (barbed) 
ends and slow growing minus (pointed) ends. The motor proteins responsible for 
movement along actin filaments belong to the Myosin family. This family can be 
divided in two groups: conventional and unconventional Myosins. The convention-
al myosins (belonging to the Myosin II subfamily) are found at the cell cortex and 
cleavage furrow during cell division. Muscle-myosins also belongs to this group 
and are responsible for the contraction of muscles (Alberts, 1994). The other 
myosins are known as unconventional myosins. Of these, Myosin I, V, VI and VII 
are implicated in vesicle transport along actin filaments (Tuxworth et al., 2000). 
All Myosin based movement is towards the barbed end, with the exception of My-
osin-VI which moves towards the pointed end (Cramer 2000). Myosin movement 
is ATP-dependent. Rabs would be ideal candidates for regulating actin filament 
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based movement of cargo, since they can switch between active and inactive 
conformations enabling them to regulate and fine-tune this cytoskeleton based 
transport. Indeed Rab proteins turned out to be able to regulate this specific step 
of membrane trafficking. The first clue came from Deretic and co-workers who 
found Rab8 positive rhodopsin containing vesicles aligning along actin filaments 
(Deretic et al. 1995).
 The best-known example of Rab control of transport along the actin 
cytoskeleton is Rab27A regulating the transport of melanosomes in melanocytes. 
Transport of these organelles is achieved by binding of Rab27A via the mela-
nophillin adaptor protein to Mysosin Va (Wu et al., 2002). In epithelial cells of the 
retina Rab27A is known to bind another type of Myosin, Myosin VIIa, now using 
the Slac2c/MyRIP as adaptor protein (Kuroda et al., 2005). This complex is also 
found in b-cells of the pancreas where it is associated with insulin containing se-
cretory granules regulating insulin exocytosis (Waselle et al., 2003). These latter 
two processes are good examples of events where cell type specific Rab effector 
interactions are involved. 
 Another Rab protein implicated in melanosome movement along the actin 
cytoskeleton is Rab8 (Chabrillat et al., 2005). Via the accessory protein optineu-
rin Rab8 can recruit Myosin VI to the Golgi. This complex most likely regulates 
transport from the trans Golgi network (TGN) during exocytosis. Furthermore 
both Rab8 and Myosin VI are also present at secretory vesicles beneath the plas-
ma membrane and may be involved in tethering them to the plasma membrane 
(Sahlender et al., 2005). 
 Rab11 and its relative Rab25 can bind directly to Myosin Vb (Lapierre et 
al., 2005), or indirectly, via Rab11-FIP2, to Myosin Vb (Hales et al., 2002). This 
complex is reported to be involved in the internalisation and recycling of several 
receptors such as CXCR2 (Fan et al., 2004), glutamate (Lise et al., 2006) and 
muscarinic acetylcholine M4 receptor (Volpicelli et al., 2002). However, all these 
examples of Rab regulated myosin based transport are involved in short-ranged 
transport events.  Long-range transport involves the microtubule cytoskeleton 
and members of the kinesin and dynein family of motor proteins
Rab- regulated microtubule-based transport
Microtubules, like actin filaments, are polarized structures with a fast grow-
ing plus end and an unstable minus end. This minus end is often stabilized at a 
structure called the microtubule organizing centre (MTOC). The motor proteins 
which are attached to microtubules can be discerned into two distinct families: 
kinesins and dyneins. Although from a structural point of view kinesins, dyneins 
and myosins do resemble each other, for example in having a cytoskeleton bind-
ing motor domain with ATP-ase activity, these protein families are not related. 
Rab proteins specify motorized vesicle transport
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Kinesins move, with a few exceptions, cargo towards the plus end of the micro-
tubules. Already a large number of different kinesins have been identified, each 
having different properties (Miki et al., 2005). Cytoplasmic dynein is a minus-end 
directed motor protein complex, composed of two heavy chains, light intermedi-
ate chains and several different classes of light chains. Two forms of dynein have 
so far been identified, dynein 1 and dynein 2 (Mikami et al., 2002; Vallee et al., 
2004). Dynein 1 is the commonly known dynein (and as of now simply referred 
to as dynein in this text) and involved in a wide range of different functions, 
such as spindle pole organization, nuclear migration and positioning of different 
organelles (Pfister et al., 2006). Dynein 2 functions in intraflagellar transport and 
generation and maintenance of cilia (Cole, 2003; Mikami et al., 2002). The pro-
cessivity of dynein along the microtubules is enhanced by the accessory dynactin 
protein complex (King et al., 2000). As mentioned earlier, kinesin and dynein-me-
diated movement is dependent on ATP. 
 The first clue for Rab regulated transport along microtubules came a few 
years after the discovery of Rab regulated movement along the actin cytoskel-
eton, with the identification of Rabkinesin-6, a Rab6 effector belonging to the 
kinesin family (Echard et al., 1998). This interaction nicely fitted the proposed 
Rab6 regulated retrograde transport from Golgi to ER (Martinez et al., 1997). Lat-
er studies showed that Rabkinesin-6 functions in mitosis and its role in membrane 
transport in inter-phase cells is now being questioned (Fontijn et al., 2001).     
 Rab6 is also implicated in minus end directed dynein-mediated transport. 
This role became clear with the identification of Bicaudal-D1 and Bicaudal-D2, 
which via de p50dynamitin subunit of dynactin, were found to be complexed with 
dynein (Hoogenraad et al., 2001; Matanis et al., 2002). Around the same time 
p150glued was also identified as a Rab6 effector, providing a direct link of Rab6 
with the dynactin complex (Short et al., 2002). Another example of a Rab regu-
lated dynein-mediated transport is Rab7. Via its effector RILP Rab7 is able recruit 
the dynein/dynactin complex onto late endosomes and lysosomes. Overexpres-
sion of the C-terminal Rab7 binding part of RILP resulted in the relocalization 
of late endosomes and lysosomes towards the cell periphery (Cantalupo et al., 
2001; Jordens et al, 2001). However, no direct interaction of Rab7 or RILP with 
the dynein/dynactin complex was observed suggesting that other accessory pro-
teins are necessary to form the Rab7/RILP/Dynein/Dynactin complex (Johansson 
et al., 2007). 
 Whereas the association of Rab7 to the dynein/dynactin is indirect, Rab4 
is known to bind directly to LIC-1, one of the components of the dynein complex 
(Bielli et al. 2001). As Rab4 is localized to endosomes this interaction possibly 
regulates the retrograde movement of early endosomes. Rab4 is not only involved 
in dynein-mediated transport. Although Rab4 is not found to interact with KIFC2, 
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GTP hydrolysis of Rab4 results in the activation of this motor protein (Bananis 
et al., 2003). Rab4 further plays a role in translocation of the insulin-responsive 
glucose transporter GLUT4 containing vesicles along the microtubule cytoskel-
eton. In this process, Rab4 directly interacts with KIF3B, which is found on GLUT4 
vesicles (Imamura et al., 2003). After stimulation with insulin the association of 
Rab4 with KIF3B is enhanced. This event is dependent on PKC-l and PI3K activity. 
Activity of these two kinases also enhanced the binding of KIF3B to microtubules. 
Rab5 can be found on GLUT4 containing vesicles in complex with dynein (Huang 
et al., 2001). The stimulation of cells with insulin leads to decreased levels of 
active Rab5 resulting in reduced binding to dynein and inhibition of minus end di-
rected transport. Furthermore dynein binding to microtubules is also decreased. 
These processes are dependent on the activity of PI3K. Activation by insulin 
therefore insures the efficient delivery of GLUT4 to the plasma membrane by 
activating Rab4-KIF3 and inhibiting Rab5 dynein-mediated transport. 
 Rab5 is further involved in recruiting KIF16B, a Phox homology domain 
containing kinesin, to early endosomes. This recruitment is dependent on el-
evated levels of PI(3)P generated by the Rab5 effector hVPS34/P150, a phospha-
tidylinositol-3-OH kinase (Hoepfner et al., 2005). As PI3K turns out to be able 
to activate both minus and plus end directed movement the exact nature of 
the regulation is not clear yet. However, opposing motor activities could func-
tion in keeping the early endosome in close proximity to the plasma membrane 
for subsequent recycling of internalized cargo. Once binding is lost, endosomes 
leave the vicinity of the plasma membrane and are capable of forming endosomal 
carrier vesicles or maturing into late endosomes. To summarize the numerous 
interactions of Rab proteins with the cytoskeleton an overview is given in table 1.
1.4 Rab and Rab regulatory proteins in disease
Despite the large number and important functions, only a few Rab proteins have 
been shown to play a role in disease (Seabra et al., 2002). An explanation for this 
are the essential roles this class of proteins play in normal cellular function. Any 
dysfunctioning Rab will probably lead to death early in embryonic development. 
However there are a few exceptions. A mutation in the melanosome associated 
Rab27 encoding gene causes Griscelli syndrome which results in pigmentary dilu-
tion of the skin (Verhoeven  et al., 2003). Mouse models with mutations in Rab27 
(ashen), its effector protein melanophilin (leaden) or Myosin-Va (dilute) show the 
same phenotypes (Menasche at al., 2000; review: Grosshans et al., 2006). Pa-
tients with these mutations also have a defect in secreting lytic granules in cyto-
toxic T-lymphocytes, underlining the important role of Rab27 in granule secretion 
(Barral et al., 2002). 
 Mutations in the hypervariable C-terminal part of Rab7 cause Charcot-
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Marie-Tooth type 2B (CMT2B). This syndrome is characterized by marked distal 
muscle weakness and wasting and a high frequency of foot ulcers and infections, 
Table 1: Rab proteins and their associated motor proteins.
Rab Associated mo-
tor protein
via putative function reference
Rab4
Rab4
Rab5
Rab5
Rab6A/
Rab6B
Rab6
Rab6
Rab6
Rab7
Rab8
Rab11
Rab11
Rab25
Rab27A
Rab27A
Dynein
KIF3B
KIF16B
Dynein
Rabkinesin-6/
MKLP2A
Dynein/dynactin
Dynein/dynactin
Kinesin-1
Dynein
Myosin VI
Myosin Vb
Myosin Vb
Myosin Vb
Myosin Va
Myosin VIIa
LIC1
- direct -
- no interaction -
- unknown -
- direct -
p150glued
p50dynamitin via 
Bicaudal-D1
Bicaudal-D
RILP/unknown
Optineurin
- direct -
Rab11-FIP2
- direct -
Melanophillin
Slac2c/MyRIP
Endosome movement?
Movement of GLUT4
Endosome movement
Movement of GLUT4
Intra Golgi transport? 
Mitosis?
Intra Golgi transport? 
Mitosis?
Late endosome to Golgi, 
intra Golgi
Exocytosis
Movement of late endo-
somes/lysosome
Melanosme movement
Receptor internalisation/
recycling 
Receptor internalisation/
recycling 
Receptor internalisation/
recycling
Melanosome movement
Melanosome/insulin gran-
ule movement
Bielli et al., 2001
Imamura et al., 2003
Hoepfner et al.,2005
Huang et al., 2001
Echard et al., 1998
Short et al., 2002
Matanis et al., 2002; 
Wanschers et al.,
2007
Grigoriev et al., 
2007
Cantalupo et al., 
2001; Jordens et al., 
2001
Sahlender et al., 
2005
Lapierre et al., 2005
Hales et al., 2002
Lapierre et al., 2005
Wu et al., 2002
Kuroda et al., 2005
often leading to amputations of the toes because of recurrent problems (Cheng, 
Lahad et al. 2004). How a mutation in Rab7 is able to cause this disease remains 
unknown. Perhaps the interaction with one or more effector proteins is lost re-
sulting in aberrant lysosome function. Some Rab proteins are also upregulated in 
cancer cells, such as Rab20 in pancreatic cancer (Amillet et al., 2006) and Rab25 
in ovarian cancer. Rab25 is furthermore downregulated in a breast cancerline 
(Cheng et al., 2006). Most likely upregulation of these Rab proteins contributes 
to malignancy, possibly by affecting the internalisation, the subsequent trans-
port, the degradation or the recycling of growth factor receptors. This hypotheti-
cal scheme is supported by the observation that Rab20 is located at endosomal 
structures at the apical site of polarized epithelial cells (Lutcke et al., 1994) and 
by the fact that Rab25 is closely related to Rab11, the small GTPase involved in 
regulating trafficking at the recycling endosome (Goldenring et al., 2001). The 
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involvement of Rabs in cancer enables them to be used as diagnostic markers or 
potential future drug targets. 
 Also Rab regulatory proteins are implicated in disease. Mutations in for 
example GDIa were found in two patients with X-linked non-specific mental re-
tardation (D’Adamo et al., 1998). As this isoform is predominantly found in brain 
the recycling of brain specific Rabs (e.g Rab3A, Rab3C (Darchen et al., 1990; 
Fischer von Mollard et al., 1990) or Rab6B (Opdam et al., 2002)) could be af-
fected, but further study is necessary to support this model. Mutations in RabG-
GTase causes Hermansky–Pudlak syndrome (in mice called gunmetal phenotype) 
characterized by defects in lysosomal related organelles (Wei et al., 2006). Loss 
of function mutations in REP1 causes choroideremia. Patients with this X-linked 
disorder suffer from chorioretinal degeneration that is characterized by progres-
sive night blindness and loss of peripheral vision (Pereira-Leal et al., 2001).
1.5 Aim and outline of this thesis
Previous studies in our lab focused on the identification of Rab proteins expressed 
in polarized epithelial cells. Of the newly identified Rab proteins, two belong to 
the Rab6 subfamily: Rab6A’ (Echard et al., 2000) and Rab6B (Opdam et al., 2002). 
To gain more insight into the function of these small GTPases, we studied the 
characteristics and molecular environment of these proteins with special empha-
sis on Rab6B since this small GTPase is not as well characterized. 
 In chapter 2 we analysed the characteristics of Rab6B in further detail. 
As this protein is highly expressed in brain, we determined the relative protein 
levels and the distribution of this small GTPase in the different parts of the 
brain. SK-N-SH levels express high levels of Rab6B. This cell line was therefore 
used to study the localization at the ultrastructural level in more detail. Finally, 
with the aid of photoactivatable GFP tagged Rab6A and Rab6B we analysed the 
movement of these proteins in these cells. Combined, we show a role for Rab6B 
in anterograde post-Golgi transport. 
 In chapter 3 we examined a possible role for Rab6B in endocytosis. This 
was done using several different endocytosis markers such as transferrin, gold 
labeled BSA and alexa-ASSP and testing a possible effect of Rab6B on the inter-
nalisation of these proteins. This study reveals a possible role for Rab6B in the 
internalization of GPI-anchored proteins. 
 Another experimental approach to learn more about the function of the 
Rab6 isoforms is to characterize their molecular environment by identifying novel 
Rab6 effector proteins. Therefore we performed a yeast two hybrid screen with a 
human fetal cDNA library using Rab6 as bait. In chapter 4 we studied the interac-
tion of Rab6B with the large coiled-coil protein Bicaudal-D1, a known interactor 
of the p50dynamitin subunit of the dynactin complex. Especially in neurites of SK-N-
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SH this interaction could play a role in the retrograde transport of cargo. The in-
teraction with another component of the dynein/dynactin complex, DYNLRB1, is 
described in chapter 5 where we analyse a direct binding of Rab6 isoforms to the 
dynein complex via the specific interaction with the dynein light chain DYNLRB1. 
Both the interactions of Rab6 with Bicaudal-D1 and DYNLRB1 reveal an important 
role for this small GTPase in Dynein mediated transport.
 Finally the implications of our findings in the understanding of the role of 
Rab6 isoforms in membrane transport, with emphasis on microtubule motors, are 
discussed in chapter 6.   
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Abstract
Proteins of the Rab-family of small GTPases are key regulators of intracellular 
membrane transport. To date more than 60 members, including isoforms, have 
been identified.  The small subgroup of Rab6 proteins within this large family 
consists of three members, Rab6A and Rab6A’, which are ubiquitously expressed, 
and Rab6B, which has a more restricted distribution and is predominantly found 
in brain. The roles of both Rab6A and Rab6A’ are well characterized, whereas 
that of Rab6B still remains ill defined. To learn more about the biological signifi-
cance of Rab6B, we performed tissue and cell type distribution studies, and fol-
lowed the intracellular partitioning behavior of the protein in transfected SK-N-
SH cells using immunoelectron microcopy, and tagging with photoactivatable GFP 
for live cell imaging. Western blot analysis and immunohistochemistry revealed 
the presence of Rab6B across all brain regions and in different cell types such as 
neurons, pericytes and Purkinje cells.  Ultrastructually, Rab6B was mainly pres-
ent at the Golgi and in neurites, where trafficking of Rab6B-positive structures 
occurred in a bi-directional manner. Interestingly, Rab6B colocalized with tsVSVG-
EYFP-loaded vesicles en route from Golgi to the plasma membrane. This report is 
the first to suggest a role of Rab6B in post-Golgi anterograde trafficking.
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Introduction
The endocytotic-secretory system of eukaryotic cells is an elaborate and highly 
compartmentalized structure comprised of different organelles and vesicles. 
Communication between the compartments in this network can be achieved by 
vesicular or tubulovesicular transport.  Different steps in this transport, i.e. the 
fission of membranes, subsequent transport of loaded vesicles, and the tether-
ing and fusion with acceptor membranes of partner vesicles that act later in 
the transport pathway needs to be under a tight spatial and temporal control. 
Key regulators of these events are small GTPases of the Rab-family (Zerial and 
McBride 2001). Rabs constantly cycle between the active membrane-associ-
ated GTP-bound form, or the cytosolic-inactive GDP-bound form. In their active 
conformation Rab-proteins can interact with a wide variety of different classes 
of so-called effector proteins, forming larger Rab-effector complexes that are in 
charge of the actual regulation of membrane traffic (Grosshans et al., 2006). To 
date more than 60 different Rab-proteins, including isoforms, have been identi-
fied (Stenmark and Olkkonen 2001). The action of ubiquitously expressed Rab 
isoforms may, in light of possible different GTPase activity or effector protein 
binding, be complementary. Isoforms of which the expression is restricted to 
certain tissues or cell types most likely regulate a very specific transport step 
characteristic for that tissue or cell type.  
 In the past we have identified three isoforms of the Rab6 family: Rab6A, 
Rab6A’ and Rab6B. Both Rab6A (Goud et al., 1990) and Rab6A’ (Echard et al., 
2000) are ubiquitously expressed and have already been well characterized (Del-
Nery et al., 2006; Miserey-Lenkei et al., 2006). The role of Rab6B has been less 
well studied. In previous studies we have found that Rab6B is highly expressed 
in human brain, where it occurs in microglia, pericytes and Purkinje cells. The 
protein also occurs at high endogenous levels in the brain derived SK-N-SH cell 
line, where it  is localized to the Golgi and ER-Golgi intermediate compartment 
(ERGIC) (Opdam et al., 2000). Rab6B has a lower GTPase activity than its coun-
terpart Rab6A and its over-expression does not trigger the Golgi-to-ER relocaliza-
tion of Golgi-resident proteins seen with Rab6A (Opdam et al., 2000). 
 Here we present new data on the Rab6B protein. As the amino acid 
sequences of Rab6B are 100% identical between human and mouse, we used both 
human and mouse cells and tissues to study the protein’s cell-type distribution in 
tissues and intracellular localization. We found that Rab6B protein is evenly dis-
tributed across different brain regions and is present predominantly in neurons. 
In testis, Rab6B was found in Leydig cells. In SK-N-SH cells, a cell model, Rab6B 
was found predominantly at the Golgi apparatus and at transport vesicles in 
neurites that moved in anterograde and retrograde directions and at tsVSVG-EYFP 
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marked vesicles. We conclude that Rab6B may have a role in post-Golgi transport 
and speculate about the possible significance of this role in brain and testis. 
Material and methods
Rab6 Sequence comparison
Expressed sequences with homology to pre-existing Rab6A, Rab6A’ and Rab6B 
cDNA sequences were identified with BLAST searches and extracted from mam-
malian databases using the NCBI server. Sequences were aligned using ClustalW 
or Genedoc software. Phylogenetic analysis was performed with Phylip made 
available by the Biology Workbench (http://workbench.sdsc.edu/).
Construction of different Rab6 expression plasmids
Rab6A, Rab6A’ and Rab6B cDNA inserts with a full-length ORF were ligated in be-
tween the BamHI and XhoI restriction sites of the eukaryotic expression vectors 
pSG8-Myc or pEGFP-C1 (Clontech). The GTPase deficient and the constitutive GDP 
bound form of the different Rab6 isoforms were made by changing the glutamine 
residue at position 72 into leucine and the threonine at position 27 to an aspara-
gine, respectively using a site directed mutagenesis kit (Stratagene) according to 
the manufacturer’s specifications. To generate these mutants the following prim-
ers were used:  Rab6A Q72L forward: 5’-GGGACACAGCAGGTCTAGAGCGGTTCAGG-
3’, reversed: 5’-CCTGAACCGCTCTAGACCTGCTGTGTCCC-3’ 
Rab6A’ Q72L forward: 5’-GGGATACTGCGGGTCTGGAACGTTTCCGTAGC-3’, re-
versed:  5’-GCTACGGAAACGTTCCAGACCCGCAGTATCCC-3’
Rab6B forward: 5’-GGACACAGCTGGTCTGGAGAGGTTCCGC-3’, reversed: 5’-GCG-
GAACCTCTCCAGACCAGCTGTGTCC-3’
Rab6A/6A’ T27N forward: 5’-CCTGGGGGAGCAAAGCGTTGGAAAGAATTCTTTGAT-
CACC-3’, reversed: 5’-GGTGATCAAAGAATTCTTTCCAACGCTTTGCTCCCCCAGG-3’
Rab6B T27N forward: 5’-GGAGCAGAGCGTCGGGAAGAATTCTCTGATTACGAGG-3’, 
reversed: 5’-CCTCGTAATCAGAGAATTCTTCCCGACGCTCTGCTCC-3’.
Construction of photoactivatable GFP-tagged Rab6B was done by replacing the 
GFP moiety in pEGFP-C1-Rab6B for the photoactivatabe form (paGFP, Patterson 
et al., 2002, 2004) from paGFP-Rab6A (a kind gift from Dr. Franck Perez) using 
the AgeI and BsrGI restriction sites flanking the paGFP cDNA.
Isolation of GST-fusion proteins and anti-Rab6B antibody purification
For the isolation of GST alone or GST-Rab6A, GST-Rab6A’, GST-Rab6B fusion 
proteins 200 ml of Escherichia coli DH5a cultures expressing pGEX-Rab6A, -A’ or 
-6B were grown until an OD600 of about 0.7.  Cultures where then maintained for 
three hours at 30OC in the presence of 100 mM isopropyl β-D-thiogalactopyrano-
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side (IPTG) to induce the expression of the GST-fusion proteins. After induction 
the cultures were centrifuged and the pellets resuspended in phosphate buffered 
saline (PBS) supplemented with a mixture of protease inhibitors, 50 mM GTP, 0.1% 
Tween 20 and 1 mM DTT and incubated for 30 minutes at 4ºC in the presence of 1 
mg/ml lysozyme to release bacterial proteins. After sonification and centrifuga-
tion GST fusion proteins were isolated by adding 140 ml glutathione sepharose-4B 
beads (Amersham Biosciences AB, Uppsala, Sweden) and incubation under rota-
tion for 2 hours at 4ºC. 
 For the purification of Rab6B specific antibodies a total of 50 ml serum 
containing antibodies raised against GST-Rab6B (Opdam et al., 2000) were incu-
bated at 4OC in the presence of excess amounts of GST-Rab6A and GST-Rab6A’ fu-
sion proteins bound to glutathione sepharose-4B beads. To remove any GST-Rab6A 
or GST-Rab6A’ specific cross-reacting antibodies incubation was performed O/N in 
a total volume of 500 ml PBS with 1% BSA, and beads were removed by centrifu-
gation. Rab6B specific antibodies in the supernatant were further purified by af-
finity binding using recombinant GST-Rab6B coupled to a CNBr-sepharose column 
(Amersham Biosciences) and eluted with buffer containing 0.1M glycine pH 2.5, 
0.5 M NaCl and 0.05% NP-40. After elution the pH was normalized again with 1M 
Tris. The purified antibody was tested for specificity on Western blot before fur-
ther use.
Immunoblotting and immunohistochemistry
C57BL/6 mice were anaesthetized with hypnorm/dormicum and perfused trans-
cardially with 15 ml PBS. Subsequently the brain and peripheral organs were 
removed and snap frozen in liquid nitrogen and kept at –80OC until use. For 
Western blot analysis mouse tissue lysates were made by dounce homogenization 
in lysis buffer (100 mM Na2HPO4 pH 8.0, 1% Triton X-100, 2 mM EDTA) containing 
a protease inhibitor cocktail (Roche Diagnostics, GmbH, Mannheim, Germany). 
After homogenization, lysates were incubated for one hour on ice after which in-
soluble components were pelleted by centrifugation for 15 minutes at 14,000 rpm 
in a microcentrifuge. Protein concentration in the remaining supernatant was 
determined with the method described by Bradford (Bradford, 1976). For deter-
mining the relative amount of Rab6B protein in the mouse brain lysates a total of 
25 mg protein was taken up in 2x sample buffer (100 mM Tris-HCl pH 6.8, 200 mM 
dithiotreitol, 4% SDS, 0.2% bromophenol blue and 20% glycerol) and subjected to 
electrophoresis on 12.5% polyacrylamidegel. Resolved proteins were transferred 
to a PVDF-membrane (Immobilon-P from Millipore) by Western blotting. After 
blocking with 5% non-fat dry milk in 10 mM Tris-HCl pH 8.0, 150 mM NaCl and 
0.05% Tween-20 (TBST), the blot was incubated with affinity purified anti-Rab6B 
antibody (dilution 1:500), non-purified anti-Rab6B antibody (dilution 1:5000) or 
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anti-b-tubulin antibody E7 (dilution 1:5000; DHSB, university of Iowa, Iowa city) 
followed by secondary horse radish peroxidase-conjugated goat-anti mouse or 
anti-rabbit antibodies (dilution 1:20.000; Pierce). Incubation and subsequent 
washes were carried out in TBST at room temperature followed by a final rinse 
with TBS. Immunoreactive bands were visualized with freshly prepared chemilu-
minescent substrate (100 mM Tris-HCl pH 8.4, 1.25 mM r-coumaric acid, 0.2 mM 
luminol and 0.009% H2O2). Signals were revealed by exposure to Kodak X-omat 
autoradiography films.  
 For immunocytohistochemistry a similar protocol was used as described 
by Shi (Shi et al., 1993). Organs were embedded in paraffin, sectioned and 
mounted on glass slides. After O/N incubation at 37oC and one hour incubation 
at 50OC, a selection of sections were deparaffinated using ethanol. Next, an-
tigenic determinants were retrieved by boiling the slides for 10 minutes in 10 
mM sodiumcitrate pH 6.0. To block endogenous peroxidase activity, slides were 
incubated for 10 minutes in 3% H2O2. After a wash with PBS containing 20 mM gly-
cine and 0.05 % Tween-20 aspecific binding sites in the sections were blocked in 
0,1 M phosphate buffer containing 5% normal donkey serum, 0,5% cold water fish 
skin/gelatin (Sigma) and glycine. Slides were then incubated O/N at 4OC with af-
finity purified anti-Rab6B antibodies (dilution 1:50) followed by biotin-conjugated 
secondary donkey anti-rabbit antibody (dilution 1:250; Pierce). Immunoreactivity 
was visualized using the Vectastain protocol (Vector Laboratories, Burlingame, 
CA, USA) using 3-amino-9-ethyl-carbazole (AEC) as substrate. Sections were fi-
nally counterstained with haematoxylin for 3 minutes, dehydrated in ethanol and 
xylene, embedded in Eukitt (Electron Microscopy Science, Fort Washington, PA, 
USA) and examined with light microscopy.
Cell lines stably expressing paEGFP-Rab6B and live cell imaging
SK-N-SH (ATCC HTB-11) cells were transfected with a construct encoding paGFP-
RAB6B using Lipofectamine Plus reagent (Invitrogen Life Technologies) according 
the manufacturers specifications. Stable transfectants were selected by growth 
in Dulbecco’s modified Eagles Medium supplemented with 1% glutamate/pyruvate 
and containing neomycine (500 mg/ml). For live cell imaging cells were plated on 
35 mm glass bottom dishes (Wilco wells BV, Amsterdam, the Netherlands). Imag-
ing was performed on a Zeiss LSM510Meta microscope equipped with a tempera-
ture controlled stage and CO2 incubator.   
Immuno-electronmicroscopy
SK-N-SH cells stably expressing EGFP- or paGFP-Rab6B were fixed in 1% parafor-
maldehyde in 0.1 M PHEM buffer (60 mM PIPES, 25 mM HEPES, 10 mM EGTA, 2 mM 
MgCl2, pH 6.9). Cells were scraped from the plate, pelleted in 10% gelatin and 
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postfixed in 1% PFA for 24 hours. Ultrathin cryosectioning was done as described 
before (Fransen et al., 1985; Schweizer et al., 1988). Sections were incubated 
with anti-GFP antibody (1:5000; Cuppen et al., 1999) followed by protein A com-
plexed to 10 nm colloidal gold particles, and observed in a JEOL 1010 electron 
microscope operating at 80 kV.
tsVSVG-EYFP transport assay
HeLa cells (ATCC CCL-2) were grown in Dulbecco’s Modified Eagles Medium 
(DMEM) supplemented with 10% fetal calf serum (FCS) and 1% glutamate/pyru-
vate on glass coverslips in a 24 wells plate until 75% confluence. Next the cells 
were transfected with plasmids encoding EYFP-tagged VSVG from the ts045 strain 
of vesicular stomatitis virus (Presley et al., 1997) and Myc-tagged Rab6B WT, 
constitutive GDP-bound Rab6B T27N (Rab6-GDP) or GTPase deficient Rab6B Q72L 
(Rab6-GTP) using Lipofectamine Plus reagent. After transfection cells were put at 
the restrictive temperature of 40ºC to accumulate the tsVSVG-EYFP protein in the 
ER. After 16 hours, culture medium was replaced with medium of 32ºC containing 
10 mg/ml cyclohexemide to inhibit protein synthesis in order to achieve a pulse 
chase setting. Next, the cells were transferred to the permissive temperature 
of 32OC to release the tsVSVG-EYFP protein from the ER. After 0, 15, 30, and 60 
minutes cells were fixed and processed for immunofluorescence.
Immunofluorescence assay
Cells grown on cover slips were washed twice with PBS, fixed with 1% parafor-
maldehyde in 0.1 M phosphate buffer for 30 minutes at room temperature and 
permeabilized with 0.1% saponin/20mM glycine in PBS (PBSG/saponin). After per-
meabilization the cells were incubated with anti-Myc antibody 9E10 (diluted 1:10 
in PBSG/saponin; Kari et al., 1986) to visualize the Myc-Rab6B. For the character-
ization of the Myc-Rab6B positive tsVSVG-EYFP containing vesicles the following 
antibodies were used: anti-Sec13 antibody (1:50; Tang et al., 1997), anti-ERGIC53 
antibody (1:1000; Schindler et al., 1993), anti-bCOP antibody (1:100; Kuiper et 
al., 2001) and anti-TGN38 antibody (1:100; via Tanaka) diluted in PBSG/saponin. 
Specific labeling was detected by incubation with Alexa-conjugated second-
ary goat anti-mouse or goat anti-Rabbit IgG antibodies (dilution 1:600; Jackson 
ImmunoResearch laboratories Inc., West Grove, PA, USA) for one hour at room 
temperature. Finally glass coverslips were rinsed with PBSG/saponin, rinsed with 
water, dehydrated with methanol and mounted on glass slides by embedding in 
Mowiol (Sigma) containing 2,5% sodiumazide. Cells were studied with confocal 
laser scanning microscopy (Biorad MRC1024).
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Results
Evolutionary history of Rab6B
To elucidate the evolutionary history of Rab6B BLAST searches with the full 
length amino acid sequence of human Rab6B (Acc no. AAF61637) were per-
formed. Orthologous Rab6B sequences were identified in Mouse (Mus musculus 
acc. no P61294, which shows 100% similarity with human Rab6B), African clawed 
tooth frog (Xenopus laevis, Acc. no. Q6GM47 95% identical at the aminoacid 
level) and Zebrafish (Danio rerio Acc. no Q68EL1, 96% identical at the amino acid 
level). Until now no Rab6B sequences have been identified in invertebretes such 
as C. elegans. These sequences are, together with human Rab6A (acc. no), mouse 
Rab6A (acc no BAF02858) and Xenopus tropicalis Rab6A (acc. no Q6P304) aligned 
in Fig. 1A.  A Rab6B like protein was found in dog (Canis familiaris, acc. no. 
XP_853481). This protein is almost identical to Rab6B but has a smaller size and a 
different N-terminus, containing a proline rich region. It is unknown whether this 
Figure 1: Multiple alignment comparisons and phylogenetic analysis of Rab6B sequences. 
(A) Extent of identity between orthologous Rab6B amino acid sequences from Human (AAF61637), 
Mouse (P61294), Xenopus (Q6GM47) and Zebrafish (Q68EL1). Identical amino acids are shown in white 
on a black background and amino acids with similar properties are shown in white on a grey back-
ground. (B) Comparison between a Rab6- likeamino acid  sequence (XR853481) from Dog and human 
Rab6B, showing divergence between the N-terminal segments. Alignments were generated  using 
GeneDoc software. Hs: Human, Mm: Mouse, Dr: Zebrafish and Xt: Xenopus. 
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is a splice variant or paralogue. An alignment of this Rab6B like sequence with 
human Rab6B is also shown (Fig. 1B). 
From a phylogenetic-tree plot of human/mouse Rab6B in comparison to Rab6A 
orthologs (Fig. 1C) we conclude that the Rab6B gene has most likely arisen as a 
product of a gene duplication event that must have happened with the Rab6A 
gene, before segregation of fish and amphibian lineages.
Determining relative Rab6B protein levels in mouse brain 
Previous studies on the expression pattern of the Rab6B protein revealed high ex-
pression in human brain tissue and in the brain-derived neuronal cell line SK-N-SH 
(Opdam et al., 2000). We now studied distribution of Rab6B across different brain 
regions and determined relative protein levels in the cerebellum, cortex, hippo-
campus and olfactory bulb of mouse, using Western blot analysis with the purified 
anti-Rab6B antibody. As negative and positive controls, extracts of HeLa cells 
expressing Myc-tagged Rab6A or Myc-tagged Rab6B and a lysate of a whole mouse 
brain were used. On a per- microgram-of protein basis, the levels of Rab6B 
protein in the different parts of the mouse brain were similar, with the excep-
tion of the brain stem, where the relative amount of Rab6B protein was less (Fig. 
2A, upper panel). From these observations, we conclude that Rab6B is expressed 
equally throughout the brain.
Immunohistochemical analysis of mouse brain
In order to analyze the cell-type distribution, we repeated previous preliminary 
analyses on small human brain biopsies (Opdam et al., 2000). We now stained 
various mouse brain areas with our affinity-purified anti-Rab6B antibody that 
lacked any cross-reactivity to Rab6A or Rab6A’. This experiment confirmed 
further that Rab6B protein is predominantly expressed in neuronal cells. In the 
cortex, pyramidal neurons and pericytes around blood vessels stained positive for 
Figure 1: (continued)
(C), Phylogenetic tree of Rab6 
sequences, showing evolutionary 
distances between different mam-
malian Rab6 members.
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 Figure 2: Rab6B protein in mouse brain
(A) Western blot analysis of different regions from mouse brain with anti-Rab6B antibodies (upper 
panel) and anti-btubulin antibody E7 as a loading control (lower panel). Difference in molecular 
weight between endogenous Rab6B in brain and the Rab6 from cell lysates can be attributed to the 
Myc-tag. Molecular mass markers (kDa) are indicated on the left.
(B-E) Immunohistochemical analysis of mouse brain with anti-Rab6B antibody. Positive staining is 
observed in neurons present in the cerebellum (panel B, arrowheads), pericytes surrounding blood 
vessels (panel C, arrowhead). Furthermore staining is observed in neurons present in the hylus of 
the hippocampus (panel D, arrowheads; DG: dentate gyrus) and in Purkinje cells of the cerebellum 
(panel E, arrowheads; ML: molecular layer, GC: granule cell layer).
Figure 3: Expression and localization of Rab6B in peripheral tissue
(A) Proteins in mouse tissue extracts were analyzed with Western blot analysis using highly specific 
Rab6B antibodies. Note, that specific bands only appear in lysates from brain  and testis, and that 
Rab6B specific proteins migrated to different positions in the gel. Molecular mass markers (kDa) are 
indicated on the left. 
(B-C) Tissue sections of testis were analyzed with immunohistochemistry using anti-Rab6B antibody. 
Positive staining can be observed in Leydig cells (panel B and C, arrowhead, ST: seminiferous tubule).
Rab6B (Figs. 2B and 2C). In the hippocampus, staining was uniquely confined to 
neurons (Fig. 2D), and in the cerebellum Rab6B protein was mainly observed in 
the Purkinje cells (Fig. 2E).
Rab6B protein in peripheral tissues
In the past we showed with Northern blot analysis that specific Rab6B transcripts 
are also present in peripheral tissues, albeit at a much lower level when com-
pared to brain tissue (Opdam et al., 2000). We now surveyed different periph-
eral mouse tissues including pancreas, heart, lung, intestine, kidney and testis 
by probing with the anti-Rab6B specific antibody.  On our tissue blot, we only 
detected a specific signal in the lane loaded with brain and testis lysate, and in 
the lanes loaded with Myc-tagged Rab6B as positive control. When compared the 
band observed in the lane loaded with testis lysate runs at a MW that is some-
what higher than that of the Rab6B protein in brain (similar to that of the Myc-
tagged control; Fig. 3A). Subsequent immunohistochemical analysis of testis tis-
sue revealed specific staining of the testosterone producing Leydig cells (Fig. 3B).
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Figure 4: Localization studies of Rab6B in SK-N-SH cells with CLSM and immuno- EM.
Confocal laser scanning microscopy and immunoelectron microscopy analysis of stable EGFP-Rab6B 
expressing SK-N-SH cells. EGFP-Rab6B location was visualized by direct recording of EGFP fluores-
cence in the CLSM, or with anti-GFP antibody and protein A complexed to 10 nm gold particles in the 
case of immuno-EM. EGFP-Rab6B localizes at the Golgi (A) and at vesicular structures in the SK-N-SH 
neurite as shown in panel B (enlargement of the neurite depicted in panel A). Vesicular structures 
are indicated with arrowheads.
Immunoelectronmicroscopy reveals EGFP-Rab6B localization at Golgi cisternea as shown in panel C 
and D, where the square in panel C represents the enlargement depicted in panel D. N indicates the 
nucleus and Golgi localized EGFP-Rab6B is indicated with arrowheads. Barr indicates 0,5 mm.
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Ultrastructural analysis of EGFP-Rab6B-expressing SK-N-SH cells
For the ultrastructural analysis of Rab6B partitioning we used the human neuro-
blastoma cell line SK-N-SH (Opdam et al., 2000). Unfortunately, our experiments 
to visualize Rab6B at the ultrastructual level with immuno-electronmicroscopy 
analysis using the anti-Rab6B antibody, showed only very weak staining. We 
therefore switched to SK-N-SH cells stably expressing N-terminally EGFP-tagged 
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Rab6B. When studied with confocal laser scanning microscopy transfected SK-
N-SH showed specific Golgi localization of EGFP-Rab6B, comparable to endog-
enous Rab6B (Fig. 4A). The EGFP-tagging also allowed us to see Rab6B present 
at vesicular structures in neurites (Fig. 4B). Subsequent processing of cells for 
electron microscopy (EM) and visualization of EGFP-Rab6B with anti-GFP antibody 
with high avidity, helped to confirm that the main bulk of the protein was local-
ized to the Golgi cisternae (see Fig. 4D and enlarged picture in Fig. 4E, indicated 
with arrows).
Rab6B colocalizes with tsVSVG-EYFP-containing vesicles in HeLa cells 30 
minutes after release from the ER
Vesicular structures in neurites arise through transport from the Golgi. This 
knowledge, and the observation that Rab6B is present on these vesicles prompted 
us to investigate a possible function of Rab6B in the post-Golgi anterograde 
pathway. Therefore, we compared behavior of the ts045VSVG-EYFP in the pres-
ence or absence of transfected Myc-tagged Rab6B. Reporter ts045VSVG-EYFP is a 
mutant protein (Presley et al., 1997), which is widely used as trafficking marker 
to follow ER-Golgi and Golgi-to-plasma membrane transit. For this assay we used 
HeLa cells as timing of the tsVSVG transport in these cells is well characterized. 
Furthermore these cells have established ER to Golgi activity and their morphol-
ogy makes them ideal for localization studies. Cells expressing ts045VSVG-EYFP, 
when grown at 40ºC, accumulate this protein in the ER as can be seen in Fig. 
5A-C. After a shift towards 32ºC the tsVSVG-EYFP is released from the ER and 
transported to the Golgi. 
 In contrast to our expectation based on the presumed role of Rab6B, 
transit of tsVSVG-EYFP through the ER-Golgi-plasma membrane pathway occurred 
equally well in cells with and without over-expressed Myc-Rab6B. The main bulk 
of tsVSVG-EYFP protein was in the Golgi 15 minutes after the temperature shift 
to 32ºC (Fig. 5D-F). After 30 minutes at 32ºC a large amount of the tsVSVG-EYFP 
still resided in the Golgi, however, a significant portion of the protein was now 
also in vesicles, en route to the plasma membrane. Interestingly, a large number 
of these tsVSVG-EYFP-containing vesicles also contained Myc-Rab6B as indicated 
by co-staining (arrowheads in Fig. 5G-I). Finally, after 60 minutes at 32ºC, part 
of the tsVSVG-EYFP protein pool had reached the plasma membrane. At this time 
point vesicles containing both tsVSVG-EYFP and Myc-Rab6B could still be observed 
(Fig. 5J-L). As the time course of progression of tsVSVG-EYFP through this route 
was seemingly not altered in presence of extra Myc-Rab6B, we also tested the 
possible effects of GTPase activity of the Myc-tagged protein. Surprisingly, these 
mutants again did not affect the distribution profile of tsVSVG-EYFP (data not 
shown).
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Characterization of Myc-Rab6B and tsVSVG-EYFP positive structures
To establish the nature of the vesicles that are doubly positive for Myc-Rab6B 
and tsVSVG-EYFP we stained transfected HeLa cells after O/N accumulation of 
tsVSVG-EYFP at 40ºC and 30 minutes release at 32ºC with anti-Myc antibody and 
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a selection of different antibodies directed against markers of the secretory 
pathway. In this way we ruled out that the Rab6 positive tsVSVG-EYFP structures 
represent ER-exit sites as they do not colocalize with the ER-exit site markers 
Sec13 (Fig. 6A-D) and Sec24 (data not shown), both components of the COPII 
coat protein complex. Likewise, staining with the anti-ERGIC-53 antibody (Fig. 
6E-H) or anti-bCOP antibody (Fig. 6I-L) also ruled out the possibility that the 
Myc-Rab6B/tsVSVG-EYFP containing vesicles are transport intermediates between 
ER and Golgi, as again no colocalization was observed. Based on our observation 
that colocalization of Myc-Rab6B and tsVSVG-EYFP was still existing after an 30 to 
60 minutes interval at 32ºC we then hypothesized that these structures are TGN 
or post-Golgi transport vesicles. Subsequent staining with anti-TGN38 antibody 
revealed no colocalization with Myc-Rab6B and tsVSVG-EYFP (Fig. 6M-P), indicat-
ing that these structures are post-Golgi transport carriers.
Live cell imaging of paEGFP-Rab6B in SK-N-SH cells  
Finally, we prepared SK-N-SH cells stably expressing the paEGFP-Rab6B protein 
to study the dynamics of this protein in live cells. Strikingly, these experiments 
revealed a bi-directional transport capacity  of Rab6B positive structures in SK-
N-SH neurites. First, anterograde movement was observed after activation of the 
Golgi localized pool of paEGFP-Rab6B. Vesicles moved from this compartment 
into a neurite as shown in movie Fig. 7. Retrograde transport of (other) vesicles 
occurred also, however, and occurs presumably simultaneously. We were able 
to visualize this process after activation of paGFP-Rab6B present at the tip of a 
neurite.  In the movie shown in Figure 8, a long-range retrograde movement of 
paGFP-Rab6B was observed from the tip of the neurite all the way towards the 
cell body. From all our data we conclude that Rab6B-marked vesicles must be 
post-TGN carriers involved in both anterograde and retrograde transport.
<Figure 5: Colocalization of tsVSVG-EYFP and Rab6B at vesicular structures 30 minutes after 
release from the ER. 
HeLa cells expressing Myc-Rab6B and tsVSVG-EYFP were grown 16 hours at 40OC to accumulate ts-
VSVG-EYFP in the ER. After shifting these cells to 32ºC to release tsVSVG-EYFP from the ER cells were 
fixed and stained with anti-Myc antibody 9E10 to visualize Myc-Rab6. Cells grown at only 40OC show 
a normal localization of Rab6 at the Golgi (A) and the expected reticular ER pattern for tsVSVG-EYFP 
(B). Merged images are shown in panel C. After 15 minutes incubation at 32ºC the main bulk of the 
tsVSVG-EYFP, like Myc-Rab6, can be found at the Golgi (panel D-F). Incubation for 30 minutes at 32OC 
revealed, beside the Golgi localization, a vesicular staining pattern for tsVSVG-EYFP. These vesicles 
colocalize with Myc-Rab6B (panel G and H were colocalization of Rab6 and tsVSVG-EYFP is indicated 
with arrowheads).  Enlargements of this part of the cell are depicted in the insets.  60 minutes after 
release from the ER a subset of tsVSVG-EYFP can still be found colocalizing with Rab6 (panel J-L 
indicated with arrowheads). Note that part of the tsVSVG-EYFP protein pool at this time has reached 
the plasma membrane.
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Figure 6: Characterization of Rab6B positive tsVSVG-EYFP containing vesicles.
HeLa cells expressing Myc-Rab6B and tsVSVG-EYFP were grown for 16 hours at 40OC. After being 
transferred to 32ºC for 30 minutes cells were fixed and stained with anti-Myc antibody 9E10 to visu-
alize Myc-Rab6 and several markers for the secretory pathway: ER exit sites with anti-Sec13 antibody 
panel (A–C), ER-Golgi intermediate compartments with anti-ERGIC53 antibody (E-G) and anti-bcop 
antibody (I-K), TGN compartment with anti-TGN38 antibody (M-O). Merged images are shown in 
panels D,H,L and P, respectively. In these panels tsVSVG-EYFP and Myc-Rab6B positive structures are 
indicated with arrowheads. Structures staining only for one of the markers used are indicated with 
arrows.
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The cell-type-specifically  expressed small GTPase Rab6B is localized at post-TGN transport carriers 
Figure 7: Anterograde movement of paGFP-Rab6B in SK-N-SH cells.
Stable paGFP-Rab6B expressing SK-N-SH cells were imaged after activation of paGFP at the Golgi 
(indicated with an arrow).  A total of 100 images were acquired from live cells with three second 
intervals of wich a selection is shown (time interval 165” to 219”). Activation of Golgi localized 
paEGFP-Rab6B reveals anterograde movementof vesicles from the Golgi towards a neurite (indicated 
with arrowheads).
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Discussion 
Rab6B in other species
To date more than 60 different Rab proteins, including isoforms, have been 
recognized. Some of these isoforms have a tissue- or cell-type specific function. 
A good example is Rab33. Whereas Rab33A is ubiquitously expressed Rab33B is 
restricted to brain and cells from the immune system (Zheng et al., 1998). The 
same holds for Rab6B, which is highly expressed in brain, whereas both Rab6A 
and Rab6A’ are ubiquitously expressed. With the ongoing sequencing of genomes 
from different species more and more data becomes available on protein ortho-
logues. However, using BLAST searches we only identified a few Rab6B sequences 
other than human. A multiple alignment of the different Rab6B sequences re-
vealed high similarity among the different species. Especially the 100% identity 
between human and mouse Rab6B is interesting as this most likely hints towards 
an important role in higher vertebrates. 
 Phylogenetic analysis of the different Rab6B sequences suggests that 
Rab6B separated from the Rab6 gene at a relatively late time point. How this 
relates to the assumption that the Rab6A’ gene is the ancestral gene remains 
unknown (Echard et al., 2000). Therefore another possibility is that Rab6B is the 
result of a Rab6A’ gene duplication in which the duplicated gene  converged to a 
form having more Rab6A-like properties.
Rab6B protein expression in brain and testis
We found that Rab6B is present in neurons in the hippocampus, cerebrum, 
hypothalamus and Purkinje cells. These data are now also underlined by in-situ 
hybridizations where similar expression patterns (with exception for the Purkinje 
cells) were observed (see the recently established website from the Allen insti-
tute for brain science: www.brain-map.org). Western blot analysis of peripheral 
tissue with our Rab6B antibody only detected Rab6B protein, although faint, in 
testis. The molecular weight of the band observed in testis lysate runs slightly 
higher when compared to brain Rab6B. An explanation for this apparently aber-
rant molecular weight could be tissue specific posttranslational modification or 
splicing. It is not uncommon to find tissue specific alternative splicing resulting 
in a longer isoforms. An example is the differential splicing of Rab28 where the 
larger isoforms are predominantly found in testis (Brauers et al., 1996). Subse-
quent immunohistochemical analysis of testis sections revealed the presence of 
Rab6B in Leydig cells, the testosterone producing cells of the testis. These cells 
although arising from vascular progenitors acquire neuronal and glial like prop-
erties (Davidoff et al., 2004). Another indication for Rab6B expression in testis 
came with the identification of Vps52 as a Rab6 effector, which is part of the 
GARP/VFT complex (Liewen et al., 2004). In their study they used Rab6B cloned 
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Figure 8: Retrograde movement of paGFP-Rab6B in SK-N-SH cells.
Stable paGFP-Rab6B expressing live SK-N-SH cells were imaged after activation of paGFP-Rab6B at 
the tip of a neurite (indicated with an arrow). A total of 60 images were acquired with three second 
intervals of wich a selection (time interval 75” to 126”) is shown. The retrograde movement of a 
vesicle from the neurite towards the cell body is indicated with arrowheads.
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from a testis cDNA library. 
 Interestingly the MGI consortium (mouse genome informatics, Eppig et 
al., 2004; Hill et al., 2005) has disrupted the gene encoding for Rab6B via retro-
viral insertion between exons 1 and 2, resulting in a mouse lacking Rab6B tran-
script and Rab6B protein. (www.informatics.jax.org/external/ko/lexicon/2141.
html). The homozygous mice show growth retardation and neurological and im-
munological defects. Motor deficits can be explained by absence of Rab6B in Pur-
kinje cells as these are involved in motor coordination. Preliminary transfection 
studies with EGFP-Rab6B in neurons (Toonen et al., personnel communication) re-
vealed its presence at Semaphorin3A (SemA3) containing vesicles. These type of 
neuronal secretory vesicles are important in axonal guidance during development 
and also may play cucial roles in mature neurons (de Wit et al., 2006). Interest-
ingly fertility of male mice is also affected underlining a role for Rab6B in testis. 
Further studies are needed to define the role of Rab6B in membrane transport.
Colocalization of Rab6B with tsVSVG-EYFP
EGFP-Rab6B was found to be present on vesicles in neurites of SK-N-SH cells. As 
these appear to be post-Golgi structures we tried to define a role for Rab6B in 
the secretory pathway. Indeed we found colocalization of Rab6B with tsVSVG-
EYFP in a post-Golgi compartment. However this localization and putative role 
is not specific for Rab6B. It has been proposed that the highly homologous Rab6A 
and Rab6A’ isoforms also may have a regulatory role in the secretory pathway. 
The Rab6A’ homologue in yeast, Ypt6, has been shown to effect early secretion 
(Li et al., 1996). In mammalian pancreatic acinar cells Rab6A has been found on 
zymogen granules, specialized organelles for digestive enzyme storage and regu-
lated secretion (Chen et al., 2006). Retrieval of native Golgi resident proteins 
back to this compartment as has also been shown for Ytp6 (Luo et al., 2003). 
Furthermore Rab6A is also found in a complex with p62 and TGN38/41 in budding 
of exocytotic vesicles from the Golgi (Jones et al., 1993). Very recently it was 
shown that indeed Rab6A resides on secretory vesicles that fuse with the plasma 
membrane (Grigoriev et al., 2007).  With the above described observations it is 
of no surprise that additional experiments revealed also the presence of Rab6A 
and Rab6A’ at these post-TGN structures. This however does not mean all iso-
forms need to play similar roles. We speculate that they play overlapping roles 
at post-Golgi transport carriers were Rab6B may be enriched at the secretory 
vesicles whereas Rab6A/A’ is more restricted at endocytotic vesicles (Del-Nery et 
al., 2006).
Live cell imaging of (pa)EGFP-Rab6B
Attempts to visualize endogenous Rab6B positive structures in neurites with im-
muno-EM were not successful. To gain therefore more insights at these structures 
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we performed live cell imaging and found Rab6B on bi-directional moving struc-
tures. It is known that Rab6B is able to interact with Bicaudal-D1 (chapter 4) and 
DYNLRB1 (chapter 5), thereby indirectly and directly linked towards the dynein 
motor protein complex explaining the retrograde movement of these vesicles, 
Anterograde movement is regulated by members of the kinesin family of mo-
tor proteins. Like Rab6A, Rab6B is able to interact with Rabkinesin-6 (Echard et 
al., 1998; Opdam et al., 2000). Although implicated to play a role during mitosis 
(Fontijn et al., 2001), in postmitotic neurons this protein could be involved in 
facilitating the anterograde movement of Rab6B structures in SK-N-SH neurites. 
The sudden shift in direction of these structures can be explained by the fact 
that both types of motor proteins reside at the same structure (Ma et al., 2002). 
 In conclusion, we have shown that the Rab6B protein is present in 
neurons of the brain and cells in the testis. Rab6B is, in addition to the Golgi, 
present at vesicular structures in neurites of SK-N-SH cells. We found that these 
are post-TGN vesicles containing tsVSVG-EYFP. It is therefore likely that Rab6B 
is involved in the transport of specialized cargo or in the retrievel of specific 
proteins to the Golgi of these cells. Recent proteomic analysis revealed that, in 
contrast to Rab6A and Rab6A’, Rab6B is present on synaptic vesicles (Takamori et 
al., 2006), where it may, in conjunction with other small GTPases of the Rab-
family, regulate synaptic vesicle dynamics. Further research is however necessary 
to confirm this hypothesis.
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Abstract
Rab6B is a member of the Golgi-localized Rab6 subfamily of small GTPases. Rab6B 
is highly expressed in brain cells and the brain-derived SK-N-SH cell line. Live-cell 
imaging in SK-N-SH cells has revealed that Rab6B is present on vesicles capable 
of anterograde and retrograde transport in neurites. This could imply that Rab6B 
has a function in the endocytotic pathway(s) in these cells, similar to the role 
of Rab6A’ in HeLa cells. To explore this possibility in more detail, we analyzed 
whether the fate of Rab6B is coupled to endocytosis. Co-localization analysis 
demonstrated that Rab6B is not associated with the vesicle-machinery involved in 
the internalization of the transferrin receptor nor with the fluid phase pathway. 
However, Rab6B did co-localize with vesicles involved in the endocytotic trans-
port of GPI-anchored proteins, suggesting a possible role in trafficking of this 
special class of membrane-bound proteins.
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Introduction
Endocytosis is the process where extracellular compounds or plasma membrane 
localized proteins such as receptors are internalized by the cell (Alberts et al., 
1994). Today at least three different types of endocytosis are recognized, i.e. the 
well characterized clathrin dependent endocytosis, caveolae mediated endocy-
tosis and a pathway both independent of clathrin and caveolae which seems to 
be involved in the uptake of lipid-rafts (for review: Kirkham and Parton, 2005). 
Commonly internalized molecules appear first in early endosomes, at later stages 
in the process they can be found in late endosomes and in lysosomes, where the 
internalized compounds are finally degraded. Instead of being degraded, inter-
nalized receptors can also be reinserted into the plasma membrane via fusion 
with recycling endosomes. Furthermore, lysosomal degradation is also avoided 
if internalized compounds are transported from late endosomes to the Golgi and 
brought back into the endoplasmic reticulum (ER). Like most intracellular traf-
ficking events also endocytotic membrane transport is regulated by members of 
the Rab family of small GTPases. For example Rab4 and Rab5 are known regu-
lators of the early endocytotic pathway, whereas Rab11 functions at recycling 
endosomes. Furthermore Rab7 and Rab9 control lysosomal related transport (for 
review: Zerial and McBride et al., 2000). Another Rab protein, Rab6, is known 
to regulate a specific step in the endocytotic pathway. To date three isoforms of 
Rab6 are known, designated Rab6A (Goud et al., 1990), Rab6A’ (a protein gener-
ated by alternative splicing of a homologous but distinct exon within the Rab6 
gene; Echard et al., 2002) and Rab6B (a brain specific isoform; Opdam et al., 
2000). Rab6A seems to play a role in the maintenance of the Golgi (Del-Nery et 
al., 2006). For Rab6A’ a role was demonstrated in the COP-I-independent retro-
grade transport from late endosomes via the Golgi to the endoplasmic reticulum 
(ER). This pathway is marked by the destiny of the internalized B-fragment of 
Shiga-toxin (Girod et al., 1999; White et al., 1999; Mallard et al., 2002; Del Nery 
et al., 2006). Next to a role in membrane trafficking Rab6A’ also plays a role 
in mitosis, in the transition from metaphase to anaphase by inactivation of the 
Mad2-spindle checkpoint (Miserey-Lenkei et al., 2006). 
 The role of the brain specific isoform Rab6B remains still ill defined. 
Initial studies revealed high expression of this small GTPase in brain and the brain 
derived SK-N-SH cell line (Opdam et al., 2000). In these cells Rab6B is localized 
on vesicles throughout the cell, but – unlike the other Rab6 isoforms - is also 
specifically found at the ER Golgi intermediate compartment (ERGIC) (Opdam et 
al., 2000) In addition, recent studies with live cell imaging revealed that Rab6B 
associates with vesicles showing bi-directional movements in neurites of SK-N-SH 
cells (chapter 2, this thesis). As retrograde movement could be associated with 
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internalization of molecules that originate at the synapse, we set out to study 
the possible role for Rab6B in any of the different endocytotic processes.  
 Our study revealed no association of Rab6B with receptor or fluid phase-
mediated endocytosis, but specific colocalization of Rab6B with internalized 
glycosylphosphatidylinositol (GPI) anchored proteins. This observation may hint 
towards a role for Rab6B in the trafficking of neuronal GPI-anchored proteins.
Materials and methods
Expression plasmid construction 
To study a possible role for Rab6 in endocytosis we made use of fluorescently 
labeled Rab6A’ and Rab6B. For this the full length open reading frames of Rab6B 
and Rab6A’ were ligated in the BamHI and XhoI restriction sites of the eukaryotic 
expression vector pEGFP-C1 (Clontech).
Cell culture and transfection
HeLa cells (ATCC CCL-2) or Neuro-2A (ATCC CCL-131) were grown in Dulbecco’s 
Modified Eagles Medium (DMEM) supplemented with 10% fetal calf serum (FCS) 
and 1% pyruvate/glutamate. HeLa and Neuro-2A cells were transfected with a 
construct encoding EGFP-Rab6B using Lipofectamine Plus reagent (Invitrogen, 
Life Technologies) according to the manufacturers specifications). Stable trans-
fectants were selected with culture medium containing additional 500 mg/ml 
neomycine. 
Uptake experiments
HeLa cells were grown on glass coverslips until a confluency of 75%. These cells 
were used as the timing of transferrin uptake is well established. Furthermore 
the morphology of these cells makes them ideal for localization studies. One 
hour before uptake of transferrin the culture medium was replaced for DMEM 
without serum. Next the serum free medium was replaced with ice-cold medium 
containing 5 µg/ml transferrin conjugated to Alexa-546 (Molecular Probes). The 
transferrin was allowed to bind to cells for one hour at 4ºC after which unbound 
transferrin was washed away with ice-cold medium. Next medium was replaced 
with medium of 37ºC and the cells were allowed to internalize the transferrin for 
different time points. After uptake cells were fixed with 1% paraformaldehyde in 
0.1M phosphate buffer for 30 minutes at room temperature, washed twice with 
PBS followed by a rinse with milli-Q before being dehydrated for 5 minutes in 
100% methanol. Cells were finally mounted on glass slides by inversion over Mowi-
ol (Sigma) containing 2.5% sodium azide and examined using a Biorad MRC1024 
confocal laser scanning microscope.
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For Alexa-ASSP uptake experiments HeLa cell culture medium was replaced with 
medium containing 500 ng/ml Alexa-567 conjugated ASSP (a kind gift from Dr. 
Visou-vanderGoot). The toxin was allowed to bind to the cells and to be internal-
ized for 2 hours at 37ºC, after which the cells were fixed as described above and 
examined using a confocal laser-scanning microscope (Zeiss LSM510Meta). 
BSA-gold uptake and immunoelectron microscopy 
For the bovine serum albumine (BSA) -gold experiment Neuro-2a cells were used 
as these are well known for their ability to take up BSA-gold and subsequent 
processing for immuno-EM. One hour before the uptake experiment culture 
medium of the Neuro-2A cells was replaced with serum free culture medium of 
37ºC. Next cells were incubated with bovine serum albumin complexed to 5 nm 
gold (BSA-gold) in serum free medium for several different time points. After 
uptake the cells were fixed in 1% paraformaldehyde in 0.1 M PHEM buffer (60 mM 
PIPES, 25 mM HEPES, 10 mM EGTA, 2 mM MgCl2, pH 6.9). Before sectioning cells 
were scraped from the plate and pelleted in 10% gelatin and post fixed in 1% PFA 
for 24 hours. Cryosectioning was done as described before (Fransen et al., 1985; 
Schweizer et al., 1988). Sections were incubated with anti-GFP antibody (1:5000; 
Cuppen et al., 1999) followed by protein A complexed to 10 nm or 15 nm gold. 
Electron microscopy was performed using a Jeol 1010 electron microscope oper-
ating at 80 kV.
Results and Discussion
Rab6B does not colocalize with receptor-mediated or fluid phase endocytosed 
markers
To discriminate between the many possible roles of Rab6B in endocytosis, we 
designed a GFP-tagged version of the protein and used this to transfect HeLa 
cells in order to analyze whether this small GTPase co-localizes with markers for 
the different forms of endocytosis. First we looked at receptor-mediated endo-
cytosis, and compared Rab6B location to the distribution pattern during internal-
ization and subsequent trafficking of the transferrin receptor. No co-localization 
between the internalized receptor and Rab6B was observed after 0 minutes (Fig. 
1A-C), 10 minutes (Fig. 1D-F) or 30 minutes (Fig. 1G-I). After 60 minutes of inter-
nalization the receptor was present in a perinuclear compartment, corresponding 
to late endosomes or lysosomes (Fig. 1J-L), but co-localization with Rab6B was 
still not apparent (Fig. 1A-L). This experiment was also performed using EGFP-
Rab6A’ with similar results (data not shown). We therefore conclude that both 
proteins are not involved in receptor-mediated endocytosis.
Receptor-mediated endocytosis has already been well characterized and is known 
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to involve the action of Rabs such as Rab4, Rab5 for the early steps of endocyto-
sis (van der Sluijs et al., 1991; Bucci et al., 1992) and Rab7 and Rab11 for either 
transport to late endosomes/lysosomes or recycling endosomes respectively 
(Feng et al., 1995; Meresse et al., 1995; Green et al., 1997; Schlierf et al., 2000). 
Also Rab21 and Rab22 are localized to these structures (Simpson et al., 2004; 
Kauppi et al., 2002). Most studies conducted thus far involved experiments using 
the transferrin receptor. Furthermore, it was shown that transferrin is not trans-
ported from late endosomes to the Golgi, the step regulated by Rab6A’ (Del-Nery 
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Figure 1: Expression of Rab6B does not affect transferrin uptake and routing. 
HeLa cells stably expressing EGFP-Rab6B were allowed to bind and internalize Alexa-564 conjugated 
transferrin for 0 minutes (panel A-B), 10 minutes (panel E-F), 30 minutes (panel I-J) and 60 min-
utes (panel M-N), showing the trafficking of internalized transferrin to a perinuclear compartment. 
Merged images are shown in panel C,G,K and O, more detailed merged images in panel D, H, L, P 
respectively. No effect on transferrin uptake or colocalization with EGFP-Rab6B was observed at any 
time point during the experiment. 
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et al., 2006). From our observations, we therefore conclude that, like Rab6A’, 
Rab6B is also not involved in receptor mediated endocytosis nor in the transport 
from late endosomes to the Golgi.
 To check whether Rab6B could be involved in other pathways of endocy-
tosis, notably fluid phase endocytosis, we performed uptake experiments with 5 
nm gold particles labeled BSA followed by immuno-EM. Neuro-2A cells expressing 
EGFP-Rab6B were allowed to take up BSA-gold for 10 minutes and 60 minutes be-
fore being processed for immuno-EM. At both time points after uptake, endocy-
tosed BSA-gold appeared in the cells as large clusters (Fig 2A and Fig, 2B respec-
tively). However no co-localization of Rab6B and gold labeled BSA was observed 
at both time points (Fig. 2A and 2B). Simultaneously performed experiments 
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Figure 2: Rab6B does not colocalize with fluid phase markers.
Neuro-2A cells expressing EGFP-Rab6B were allowed to take up BSA labeled with 5 nm gold particles. 
After 10 (A) and 60 minutes (B) large clusters of endocytosed BSA-gold can be observed (indicated 
with arrows). No significant colocalization with EGFP-Rab6B (labeled with 10 nm gold particles and 
indicated with arrowheads) is observed. Enlargements of the BSA labeled gold containing vesicles are 
shown in the insets. Barr indicates 0,5 mm.
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using PTP-SL, an endosomal localized protein tyrosine phosphatase, showed clear 
colocalization (Dilaver et al., 2003). Taken together, we conclude that the local-
ization and fate of receptor and fluid phase markers do not coincide with ectopic 
Rab6B expression.
Rab6B isoform colocalizes with Alexa-ASSP in structures in close proximity to 
the Golgi 
Next to receptor-mediated and fluid phase endocytosis, a third, transferrin and 
fluid phase independent, pathway is present involving the internalization of 
GPI-anchored proteins, a class of proteins known to be enriched in detergent 
resistant membranes. We set out to elucidate a possible role for Rab6B in the 
trafficking of these proteins. The rationale behind this step was given by com-
bining several observations. Other groups have reported that Rab6A’ affects 
Shiga-toxin transport in HeLa cells (Mallard et al., 2002, Del-Nery et al., 2006), 
but the physiological relevance  for this interference was not completely eluci-
dated. Because we also know that (i) the receptor for this toxin, globotriaosyl-
ceramide or Gb3 receptor (Keusch et al., 1995), is present in detergent resistant 
membranes (DRMs) (Falguereis et al., 2001; Smith et al., 2006), (ii) that DRMs 
are highly enriched in GPI-anchored proteins,  and (iii) that internalized GPI-
anchored proteins are sometimes transported to the Golgi (Nichols et al., 2001, 
2002), we reasoned that Rab6A’ and Rab6B might both be involved in this dis-
tinctly endocytotic pathway. To explore this possibility experimentally we made 
use of the bacterial toxin aerolysin conjugated to Alexa-567 (Alexa-ASSP), a toxin 
that binds to the GPI-moiety of GPI-anchored proteins (Fivaz et al., 2002). HeLa 
cells expressing EGFP-Rab6B or EGFP-Rab6A’ were allowed to bind and inter-
nalize Alexa-ASSP continuously for two hours before being fixed. In these cells 
colocalization was observed for EGFP-Rab6B (Fig. 3A-C) and EGFP-Rab6A’ (Fig. 
3D-F) with Alexa-ASSP in structures in close proximity of the Golgi. However, in 
contrast to the observation made by Nichols and co-workers (Nichols et al., 2001, 
2002), in our HeLa cells GPI-anchored proteins were never transported to the 
Golgi. Most likely the compartment where co-localisation between Rab6A’, Rab6B 
and Alexa-ASSP is observed, corresponds to a specific set of late endosomes (not 
characterized by internalized transferrin) or the trans-Golgi network (TGN). 
To complicate matters, it seems that the destination of Alexa-ASSP is cell type 
specific (Sharma et al., 2002). Therefore, given the aim of this study to analyze 
the cell-type- specific role of Rab6B, future experiments with SK-N-SH should 
be performed. The colocalization of Rab6B with Alexa-ASSP makes it interesting 
to speculate about a role for this small GTPase in regulating trafficking of neu-
ron-specific GPI-anchored proteins or, more general, in DRM dynamics. Several 
GPI-anchored proteins are expressed in brain. A well-known example is the prion 
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protein, which is present in lipid rafts (Taylor et al., 2006). Furthermore, recent 
studies on DRMs in the synapses of rat brain showed that they contain SNARE 
complexes and Munc18, proteins playing a role in vesicle fusion. These DRMs also 
contained synaptophysin (Gil et al., 2005; Gil et al., 2006). Interestingly, Rab6p 
was found to be associated with synaptophysin-containing structures (Tixier-Vidal 
et al., 1993). Future studies should address whether Rab6B functions in DRM traf-
ficking in neuronal cells or not.
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Figure 3: Rab6B and Rab6A’ colocalize with Alexa-ASSP containing structures at close proximity to 
the Golgi.
HeLa cells expressing EGFP-Rab6B and –Rab6A’ were allowed to bind and internalize Alexa-ASSP con-
tinuously for two hours before being fixed. Both Rab6B (A) and Rab6A’ (D) colocalized with Alexa-567 
conjugated aerolysin (Alexa-ASSP) (panel B and E respectively) in structures at close proximity to 
the Golgi as indicated with arrowheads. Merged images are shown in panel C and F. Images at higher 
magnification are shown as insets in the different panels.
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Abstract
The Rab6 subfamily of small GTPases consists of three different isoforms: Rab6A, 
Rab6A’ and Rab6B. Both Rab6A and Rab6A’ are ubiquitously expressed whereas 
Rab6B is predominantly expressed in brain. Recent studies have shown that 
Rab6A’ is the isoform regulating the retrograde transport from late endosomes to 
via the Golgi to the ER and in the transition from anaphase to metaphase during 
mitosis. Since the role of Rab6B is still ill defined, we set out to characterize its 
intracellular environment and dynamic behavior. In a Y-2H search for novel Rab6 
interacting proteins we identified Bicaudal-D1, a large coiled-coil protein known 
to bind to the dynein/dynactin complex and previously shown to be a binding 
partner for Rab6A/Rab6A’. Co-immunoprecipitation studies and pull down assays 
confirmed that Bicaudal-D1 also interacts with Rab6B in its active form. Using 
confocal laser scanning microscopy it was established that Rab6B and Bicaudal-D1 
colocalize at the Golgi and vesicles that align along microtubules. Furthermore, 
both proteins colocalized with dynein in neurites of SK-N-SH cells. Live cell imag-
ing revealed bi-directional movement of EGFP-Rab6B structures in SK-N-SH neu-
rites. We conclude from our data that the brain specific Rab6B via Bicaudal-D1 is 
linked to the dynein/dynactin complex, suggesting a regulatory role for Rab6B in 
the retrograde transport of cargo in neuronal cells.
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Introduction
Rab proteins form the largest branch of the monomeric Ras superfamily of small 
GTPases and are key regulators of intracellular membrane traffic. To date more 
than 60 Rab family members, including isoforms, are recognized (Stenmark and 
Olkkonon 2001). Rab proteins constantly cycle between a GTP bound active and 
GDP bound inactive state and exert their function by interacting with a wide 
range of Rab effector proteins.  These protein complexes can regulate differ-
ent membrane trafficking events such as formation of vesicles at the donor 
membrane, movement and subsequent tethering and fusion with the acceptor 
membrane (Zerial and McBride 2001). Several Rab proteins are known to regulate 
vesicle movement along microtubules or actin filaments (Hammer and Wu 2002). 
One example of Rab regulated microtubule-based transport is the movement of 
lysosomes along microtubules by the Rab7-RILP complex (Jordens et al., 2001). 
Another Rab protein implicated in playing a role in microtubule-based transport 
is Rab6 (Matanis et al., 2002; Young et al., 2005; Jordens et al., 2005). 
 In the past three different isoforms of this protein were identified: Rab6A 
(Goud et al., 1990), Rab6A’ generated by alternative splicing of a homologues 
but distinct exon within the Rab6 gene (Echard et al., 2000), and a brain spe-
cific isoform, Rab6B (Opdam et al., 2000a). Initially it was thought that Rab6A 
was the isoforms regulating a COP-I independent Golgi to endoplasmic reticulum 
(ER) retrograde transport (Martinez et al., 1997; Girod et al., 1999; White et al., 
1999) with an additional role for Rab6A’ in a specific endosome to Golgi transport 
process involving the routing of internalized Shiga toxin (Mallard et al., 2002). 
These latter findings have recently been challenged, proposing Rab6A’ as the iso-
form regulating the entire retrograde pathway from late endosomes to ER. Rab6A 
seems dispensable for this pathway (Del Nery et al., 2006) and most likely exerts 
its functions mainly during mitosis. Rab6A’ has also been implicated to play role 
in mitosis by inactivating the Mad2-spindle checkpoint during the transition from 
metaphase to anaphase (Miserey-Lenkei et al., 2006).  
 For the other Rab6 member, Rab6B, relatively little is known and there-
fore is the main focus of this study. Studies from the past have shown that Rab6B 
binds to all, at that time known, Rab6A binding proteins such as Rabkinesin-6 
(Rab6-KIFL), a Golgi localized kinesin like protein (Echard et al., 1998) and GAP-
CenA, a centrosome associated GTPase activating protein specific for Rab6 (Cuif 
et al., 1999). Detailed Northern blot analysis showed that Rab6B has its highest 
expression in brain and is also prominently expressed in brain-derived cell lines 
like SK-N-SH (Opdam et al., 2000a). In these cells Rab6B is localized to the Golgi, 
at ER-membranes and also at the ER Golgi intermediate compartment (ERGIC) 
(Opdam et al., 2000a). While, in HeLa cells, overexpression of the 
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GTPase-deficient Rab6A mutant induces a redistribution of Golgi localized pro-
teins into the ER preliminary results show that overexpression of the GTPase-defi-
cient Rab6B does not. Its biochemical properties, specific cell and tissue type ex-
pression pattern and its intracellular localization at the ERGIC suggest a specific 
role for Rab6B in neuronal cells. To provide us with more clues about the function 
of Rab6B we performed a yeast-two-hybrid screen, using the GTPase deficient 
mutant as bait, in order to search for novel interacting proteins and reveal more 
clues about the cellular environment in which Rab6B is active. 
 Here we describe the identification of Bicaudal-D1, a large coiled-coil 
protein known to bind to the p50dynamitin component of the dynactin-complex 
(Hoogenraad et al., 2001) as a binding partner for Rab6B, in addition to Rab6A 
(Matanis et al., 2002). This interaction was verified with co-immunoprecipita-
tion and pull down experiments. Colocalization is observed between Rab6B and 
Bicaudal-D1 at the Golgi and additionally at vesicular structures that align along 
microtubules and are found in neurites of SK-N-SH cells. These Rab6B Bicaudal-D1 
vesicles colocalize also with dynein. Live cell imaging in SK-N-SH cells expressing 
EGFP-Rab6B revealed retrograde movement of these structures. 
 Although the functional relationship between Rab6B and Bicaudal-D1 has 
not been fully addressed yet, we conclude that the Rab6B Bicaudal-D1 interac-
tion regulates retrograde membrane transport in neurites of neuronal cells. The 
additional localization of Rab6B at the ERGIC suggests a specific regulatory role 
for this small GTPase at this compartment in neuronal cells. 
Material and methods
Yeast-two-hybrid interaction trap
For Y-2H screening we used the interaction trap system as described (Gyuris et 
al., 1993). GTPase deficient Rab6B Q72L (Rab6B-GTP) bait was introduced in the 
BamH1/XhoI cloning site of the pMW101 vector by standard subcloning proce-
dures. As prey a human fetal brain cDNA library was used (kindly provided by Dr. 
Roger Brent and colleagues, Massachusetts General Hospital, Boston, MA). For 
two hybrid interactions assays plasmids were introduced in yeast strain EGY48 
(Mata trp1 ura1 his3 LEU2::pLexAop6-LEU2) containing the plasmid pSH18-34, 
which includes the reporter lacZ gene, and tested for an interaction as detected 
by growth and blue coloring on minimal agar plates lacking histidine, tryptophan, 
uracil and leucine, containing 2% galactose, 1% raffinose and 80 mg/ml X-gal, 
buffered at pH 7.0. To confirm positive clones, the insert containing pJG4-5 plas-
mid DNA from positive clones was isolated, reintroduced into the yeast strain, 
and screened in a second round for growth and blue coloring.
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Immunoprecipitation and immunoblotting
COS-1 cells (ATCC CRL-1650) were grown in Dulbecco’s modified Eagles medium 
(DMEM; Gibco) supplemented with 10% fetal calf serum (FCS) and 1% pyruvate/
glutamate on 10-cm dishes. The cells were washed with Optimem (Gibco) and 
submerged with 5 ml transfection medium (4.7 ml Optimem, 150 ml 2 mg/ml 
DEAE-dextran chloride (Sigma), 5 ml 100 mM chloroquine) containing 2.5 mg of 
the pSG8-His plasmid vector DNA encoding full length Myc-tagged WT Rab6A, 
Rab6A’, Rab6B or an empty pSG8-His as negative control.  In addition transfection 
was performed with  GFP-tagged Rab4, Rab5, Rab6A’, Rab6B, Rab22B (Opdam et 
al., 2000b) or GFP alone and 2.5 mg Bicaudal-D1 in pEGFP-N2 in which the GFP 
was replaced by a triple HA-tag or GFP tagged N-terminal or C-terminal part of 
Bicaudal-D1 (Matanis et al., 2002). After an incubation of 3 hours the transfection 
medium was removed, cells were incubated for 3 min. in 5 ml 10% dimethylsulf-
oxide (DMSO) in phosphate buffered saline (PBS), washed, and further cultivated 
in DMEM. Twenty-four hours later cells were washed twice with PBS and lysed on 
the plate with 1 ml lysisbuffer (100 mM Na2HPO4 pH 8.0, 1% [v/v] Triton X-100, 
0.2% bovine serum albumin (BSA)) and protease inhibitor cocktail (Roche Diag-
nostics, GmbH, Mannheim, Germany) and put on ice for one hour. The lysate 
was centrifuged 15 min at 10,000g at 4ºC after which 500 ml of the supernatant 
was subjected to immunoprecipitation with a polyclonal antibody against Rab6B 
(Opdam et al., 2000a), GFP (Cuppen et al., 1999) or Bicaudal-D1 #2296 (Matanis 
et al., 2002), non-covalently coupled to 20 ml protein-A Sepharose beads (Amer-
sham Biosciences AB, Uppsala, Sweden). Protein-A beads with captured protein 
were washed six times with high salt buffer (100 mM Tris-HCl pH 7.4, 1.2 M KCl 
and 1%  [v/v] Triton X-100) and twice with PBS. Then beads were taken up in 
20 ml 2x sample buffer (100 mM Tris-HCl pH 6.8, 200 mM dithiotreitol, 4% SDS, 
0.2% bromophenol blue, 20% glycerol) and released protein was subjected to 
electrophoresis on a 10% polyacrylamidegel. Resolved proteins were transferred 
onto nitrocellulose-membrane (Amersham biosciences) by Western blotting. 
After blocking with 5% non-fat dry milk in 10 mM Tris-HCl pH 8.0, 150 mM NaCl 
and 0.05% [v/v] Tween-20 (TBST), the blots were incubated with either anti-HA 
antibody 12CA5 (diluted 1:500; (Wilson et al., 1984)) or anti-Myc antibody 9E10 
(diluted 1:100; (Kari et al., 1986)), anti-GFP antibody B2 (diluted 1:5000; Santa 
Cruz) or anti-Rab6 antibody (diluted 1:5000) followed by secondary horse radish 
peroxidase-conjugated Affinipure Goat anti-mouse or anti-rabbit IgG antibody 
(diluted 1:20.000; Pierce). Incubations and subsequent washes were carried out 
in TBST at room temperature followed by a final rinse with TBS. Immunoreactive 
bands were visualized using freshly prepared chemiluminescent substrate (100 
mM Tris-HCl pH 8.5, 1.25 mM r-coumaric acid, 0,2 mM luminol and 0.009% H2O2) 
and signals were revealed by exposure to Kodak X-omat autoradiography films.  
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Isolation of GST-fusion proteins
For the isolation of GST or GST-Rab6A, GST-Rab6A’ and GST-Rab6B fusion pro-
teins, 200 ml of Escherichia coli DH5a cultures expressing pGEX-Rab6A, -6A’ or 
-6B were grown until an OD600 of about 0.7.  Cultures where then maintained for 
three hours at 30OC in the presence of 100 mM isopropyl β-D-thiogalactopyrano-
side (IPTG) to induce the expression of the GST-fusion proteins. After induction 
the cultures were centrifuged and the pellets resuspended in PBS supplemented 
with a mixture of protease inhibitors, 50 mM GTP, 0.1% Tween 20, 1 mM DTT and 
incubated for 30 min. at 4ºC in the presence of 1 mg/ml lysozyme to release 
bacterial proteins. After sonification and centrifugation GST fusion proteins were 
isolated by adding 140 ml glutathione sepharose 4B beads (Amersham Biosciences 
AB, Uppsala, Sweden) and incubation under rotation for 2 hours at 4ºC. After 
washing the beads twice the fusion protein was eluted with elution buffer con-
taining 50 mM HEPES pH 7.5, 150 mM NaCl, 1 mM MgCl2, 10 mM GTP and 15 mM 
reduced glutathione. The amount of GST fusion proteins was determined with the 
Bradford method (Bradford, 1976).
Pull down experiments
Pull down experiments with GTPgS, a nonhydrolysable variant of GTP, or GDP 
loaded GST-Rab6 were done as described previously (Moniet at al., 2002). A 
total of 10 mg of GST-Rab6 fusion proteins were incubated in the presence of 20 
ml glutathione sepharose 4B beads in loading buffer (25 mM Tris pH 7.5, 10 mM 
EDTA, 5 mM MgCl2) for 1 hour at 4ºC under rotation. Next the GST-Rab6 bound to 
the glutathione sepharose beads were loaded with GTPgS or GDP in loading buf-
fer supplemented with 1mM of GTPgS or 1 mM of GDP for one hour at 37OC. After 
centrifugation the buffer was removed and replaced by interaction buffer (25 mM 
Tris pH 7.5, 10 mM MgCl2, 500 mM NaCl, 0.1% [v/v] Triton X-100) again supple-
mented with 1 mM GDP or 1 mM GTPgS to which 30 ml cell lysate of BHK-21 cells 
transfected with HA-tagged Bicaudal-D1 was added and incubated for 90 min. at 
room temperature under rotation. After the incubation the beads were washed 
4 times with interaction buffer without nucleotides and processed for Western 
blotting.  For GST pull down experiments BHK-21 cells were transfected with 
HA-Bicaudal-D1 encoding construct using Lipofectamine (Invitrogen Life Technolo-
gies) according to the manufacturer’s specifications. Subsequent cell extracts 
were made by lysing the PBS-washed cells in lysis buffer (10 mM Tris-HCl pH 7.4, 
150 mM NaCl, 1 mM MgCl2, 1 mM CaCl2, 0.2% [v/v] Triton X-100, protease inhibitor 
cocktail).
Rab6 binding assay with purified proteins
For binding assays ~5 mg GST, GST-Rab6A or GST-Rab6B was immobilized on 25 
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ml glutathione Sepharose 4B beads and washed three times with buffer NE100 
(20 mM HEPES pH 7.5, 100 mM NaCl, 10 mM EDTA, 0.1% [v/v] Triton X-100), two 
times with buffer NL100 (20 mM HEPES pH 7.5, 100 mM NaCl, 5 mM MgCl2, 0.1% 
[v/v] Triton X-100) and finally two times with 500 ml buffer NL100 GTPgS (20 mM 
HEPES pH 7.5, 100 mM NaCl, 5 mM MgCl2, 0.1% [v/v] Triton X-100, 50 mM GTPgS) 
as described by (Fuchs et al., 2005). For the binding reaction loaded beads were 
resuspended in 200 ml NL100 GTPgS with approximately 4 mg His-Bicaudal-D1-C 
and incubated on a roller for 2 hours at 4ºC. After incubation beads were pel-
leted by centrifugation and unbound protein was removed by washing four times 
with 1 ml NL100 GTPgS. Bound protein was eluted directly in 40 ml 1x SDS sample 
buffer, analyzed on 12% SDS-PAGE gel and visualized on Western blot using anti-
His antibody (QIAGEN). 
Anti-Rab6B antibody purification
To purify the anti Rab6B antibody described by Opdam and coworkers (Opdam et 
al., 2000a) a total of 50 ml of serum containing antibodies raised against GST-
Rab6B was incubated O/N at 4ºC in the presence of excess amounts of GST-Rab6A 
and GST-Rab6A’ fusion proteins bound to glutathione sepharose-4B beads in a 
total volume of 500 ml PBS with 1% BSA to bind Rab6A and Rab6A’ cross reactive 
antibodies. After the incubation the beads were spun down and the remaining 
supernatant, containing Rab6B specific antibodies, was tested for specificity on 
Western blot before use in immunofluorescence assays.
Immunofluorescence assay
HeLa cells (WT or stably expressing EGFP-Rab6B) or SK-N-SH cells were grown un-
til 75% confluency in DMEM supplemented with 10% FCS, 1% pyruvate/glutamate 
in 24-wells plates on glass coverslips and transiently transfected with HA-Bicau-
dal-D1, pEYFP Rab6 WT, GTPase deficient Rab6 Q72L (Rab6-GTP) or constitu-
tive GDP-bound Rab6 T27N (Rab6-GDP) isoforms encoding constructs in case of 
the HeLa cells or pEGFP-Rab6B WT, Rab6B-GTP, Rab6B-GDP or pEYFP-Rab6B and 
pECFP-Rab6A in case of the SK-N-SH cells with the use of Lipofectamine-Plus re-
agent. After 24 h the cells were washed with PBS, fixed for 30 min. in 1% parafor-
maldehyde in 0.1 M phosphate buffer and permeabilized with 0.1% saponin/20mM 
glycine in PBS (PBSG). Some of the cells were treated with 10 mg/ml Nocodazole 
(Sigma) for 3 hours prior to washing and fixation. Cells were incubated with anti-
HA antibody 12CA5 (1:125 dilution), b-tubulin E7 (1:5 dilution; DHSB, university 
of Iowa, Iowa City) dynein intermediate chain IC74 (1:100 dilution; Chemicon), 
ERGIC-53 G1/93 (1:100 dilution; (Schindler et al., 1993)) and polyclonal antibody 
against Bicaudal-D1 #2296 (1:300 dilution (Matanis et al., 2002)) or purified anti-
Rab6B antibody (1:10 dilution). Specific labeling was detected by incubation with 
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Alexa-conjugated secondary goat anti-mouse or goat anti-rabbit IgG antibodies 
(dilution 1:500; Jackson ImmunoResearch Laboratories Inc. West Grove, PA, USA) 
for 1 hour at room temperature. Finally the glass coverslips were rinsed in PBSG/
saponin, water, dehydrated for 5 min. with 100% methanol and mounted on glass 
slides by inversion over Mowiol (Sigma) containing 2.5% sodium azide. Cells were 
examined using a confocal laser-scanning microscope (Biorad MRC1024).
Live cell imaging
SK-N-SH cells expressing EGFP-Rab6B were plated on 35 mm diameter glass bot-
tom Wilco-dishes (Wilco wells B.V. Amsterdam, the Netherlands). Live cell confo-
cal microscopy was performed on Zeiss LSM510Meta equipped with a type S CO2 
incubator and a temperature controlled stage.
Results
Rab6B interacts with Bicaudal-D1
To search for specific binding partners of Rab6B the constitutive GTP-bound form 
of all three Rab6 isoforms (Rab6-GTP) were used to screen a human fetal brain 
cDNA library in a yeast-two-hybrid interaction trap experiment. In relation to 
Rab6A and Rab6A’, no specific Rab6B interactors were found (see supplemental 
table 1 for details). However, we identified Bicaudal-D1 as a novel interactor 
for Rab6B. The binding of Bicaudal-D1 to Rab6A has previously been described 
by Matanis and co-workers (Matanis et al., 2002). To further characterize the 
nature of the Rab6B Bicaudal-D1 interaction, co-immunoprecipitation studies 
were performed with lysates from transfected COS-1 cells expressing all three 
Myc-tagged wildtype (WT) Rab6 isoforms and HA-tagged Bicaudal-D1. As a nega-
tive control empty vectors were used showing no a-specific binding to the beads 
(data not shown). These experiments revealed that all Rab6 isoforms including 
Rab6B are able to co-immunoprecipitate Bicaudal-D1 (Fig. 1A). Reciprocally, im-
munoprecipitation with the anti-Bicaudal-D1 antibody #2296 resulted in the co-
immunoprecipitation of all three Rab6 isoforms (Fig. 1B).  The efficiency of the 
immunoprecipitation with anti-Rab6 and anti-Bicaudal-D1 antibodies is shown in 
the middle panels of Fig. 1A and Fig. 1B respectively. The lower panels show the 
input of Bicaudal-D1 and Rab6. 
 To check whether the interaction between Bicaudal-D1 is specific for the 
Rab6 isoforms we immunoprecipitated GFP-tagged Rab4, Rab5, Rab6A’, Rab6B 
and Rab22B or GFP alone with anti-GFP antibody and analyzed whether HA-Bi-
caudal-D1 was co-immunoprecipitated.  In this experiment only GFP-Rab6A’ and 
GFP-Rab6B were able to co-immunoprecipitate HA-Bicaudal-D1 (Fig. 1C) indicat-
ing that the interaction of Bicaudal-D1 is specific for Rab6 isoforms. 
Rab proteins specify motorized vesicle transport
72
Rab6B directly interacts with the C-terminal part of Bicaudal-D1
To investigate which part of the Bicaudal-D1 protein is responsible for the inter-
action with Rab6B, co-immunoprecipitation experiments with Myc-Rab6B and the 
GFP-tagged N-terminal or C-terminal part of Bicaudal-D1 were performed. The 
results show that the C-terminal part, and not the N-terminal part of GFP-Bi-
caudal-D1 co-immunoprecipitates with Myc-Rab6B (Fig. 1D, upper panel). Subse-
quent pull down assays with purified GST-Rab6A, GST-Rab6B and His-Bicaudal-D1-
C proteins showed that interaction between Bicaudal-D1 and Rab6B is direct (Fig. 
1E, middle panel).
Bicaudal-D1 preferentially binds to Rab6B in the GTP bound form
To further characterize the Rab6B Bicaudal-D1 interaction we investigated 
whether binding is determined by GTP-loading of Rab6B. Therefore, we assessed 
binding relative to Rab6A and Rab6A’ in pull down experiments with the use of 
equal amounts of Rab6A, Rab6A’ or Rab6B GST-fusion proteins coupled to gluta-
thione sepharose-4B beads and loaded with either GTPgS or GDP. As expected the 
GTPgS loaded GST-Rab6B was far more efficient in pulling down Bicaudal-D1 than 
GDP loaded Rab6B. Interestingly for Rab6A a comparable binding was observed 
whereas binding to Rab6A’ appeared independent of GTP loading (Fig. 1F). Based 
on this finding we conclude that Bicaudal-D1 binding prefers the Rab6B protein to 
be in the GTP-bound state.
Ectopic Rab6B colocalizes with Bicaudal-D1 at the Golgi and vesicular struc-
tures that align along microtubules
To study whether Rab6B Bicaudal-D1 can colocalize in Hela cells, we co-ex-
pressed EGFP-Rab6B and HA-tagged Bicaudal-D1 in HeLa cells.  Cells that stably 
expressed EGFP-Rab6B (mild over-expression) were therefore transiently trans-
fected with HA-tagged Bicaudal-D1 encoding plasmid and protein location was 
revealed with anti-HA antibody 12CA5 and direct recording of GFP fluorescence 
with confocal laser scanning microscopy. Ectopic Rab6B colocalizes with Bicaudal-
D1 at the Golgi and at vesicular structures (arrows Fig. 2A-C). Subsequent stain-
ing with the anti-b-tubulin antibody E7 to stain the microtubule network revealed 
that these vesicular structures align along microtubules (Fig. 2D-H, indicated by 
arrows). 
Overexpressed Rab6B-GTP and Bicaudal-D1 accumulates at the cell periphery
Since the Y-2H was performed with the constitutive GTP-bound forms we also 
studied the effect of overexpression the EYFP-Rab6-GTP mutants and Bicaudal-
D1 in HeLa cells. In a large number of cells we observed colocalization between 
EYFP-Rab6A-GTP or EYFP-Rab6B-GTP and Bicaudal-D1 at the cell periphery (Fig. 
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<Figure 1: Rab6 isoforms interact with Bicaudal-D1.
Cell lysates of COS-1 cells transfected with Myc-tagged Rab6A, Rab6A’, Rab6B and HA-tagged 
Bicaudal-D1 were subjected to immunoprecipitations using protein sepharose-A beads loaded with 
anti-Rab6 antibody or anti-Bicaudal-D1 antibody #2296. Co-immunoprecipitated proteins were visual-
ized by Western blotting using anti-HA antibody 12CA5 (A) or anti-Myc antibody 9E10 (B) to detect 
co-immunoprecipitated Bicaudal-D1 or Rab6 respectively. In the middle panels the efficiency of the 
immunoprecipitation with Rab6 (A) and Bicaudal-D1 (B) is shown. In the lower panels the input (5% 
of total lysate) of Bicaudal-D1 (A) and Rab6 (B) is depicted. Molecular mass markers (kD) are shown 
on the left. The difference in molecular weight between Myc-Rab6A/A’ and Myc-Rab6B can be attrib-
uted to a different spacer region between the Myc tag and the Rab6 start codon. 
Rab6 Bicaudal-D1 interaction is specific for Rab6 (C). A number of different GFP-tagged Rab proteins 
were immunoprecipitated with anti-GFP antibody from COS-1 cell lysates. Co-immunoprecipitation 
of Bicaudal-D1 was only found with GFP-Rab6A’ and GFP-Rab6B (C). The efficiency of the immunopre-
cipitation and the inputs (5% of total lysate) are shown in the second and two lower panels respec-
tively.  Molecular mass markers are shown on the left.
Cell lysates of COS-1 cells expressing Myc-tagged Rab6B and full length GFP-Bicaudal-D1, GFP-Bicau-
dal-C, GFP-Bicaudal-N or GFP alone were subjected to immunoprecipitation with anti-Myc antibody 
9E10. Co-immunoprecipitated proteins were visualized with anti-GFP antibody (D, upper panel). 
Efficiency of the immunoprecipitation and input (5% of total lysate) of the different GFP tagged pro-
teins is shown in the middle and lower panel respectively. Asterix indicates an additional band often 
observed after GFP-Bicaudal-D1 expression.
Direct interaction between Bicaudal-D1-C and Rab6. Purified GST-Rab6A, GST-Rab6B or GST alone 
was used in a pull down assay with purified His-tagged Bicaudal-D1-C (E). The amount of GST fusion 
protein is shown in the upper panel by the coomassie staining of the SDS-PAGE gel. The amount of 
Bicaudal-D1-C retained by GST-Rab6 is shown in the middle panel by immunoblot and input of His-
Bicaudal-D1 (5% of total) in the lower panel. Molecular mass markers (kDa) are indicated on the left.
Rab6B preferentially binds to Bicaudal-D1 in the GTP-bound state (F). Cell lysates of BHK-21 cells 
transfected with HA-tagged Bicaudal-D1 were incubated in the presence of glutathione sepharose 4B 
with equal amounts of bound GST-Rab6A, GST-Rab6A’, GST-Rab6B or GST alone and loaded with ei-
ther GTPgS, a nonhydrolysable variant of GTP, or GDP. Retained proteins were visualized by Western 
blotting using anti-HA antibody 12CA5.
3A-C and 3D-F for Rab6A and Rab6B respectively). Interestingly this peripheral 
accumulation was not observed in cell overexpressing EYFP-Rab6A’-GTP (data 
not shown). As this accumulation was also observed in HeLa cells overexpressing 
only EYFP-Rab6A-GTP or EYFP-Rab6B-GTP, we conclude that this accumulation is 
independent of the Bicaudal-D1 interaction.
Localization of endogenous Rab6B and Bicaudal-D1 in SK-N-SH cells
To study the localization of endogenous Rab6B compared to Bicaudal-D1 we 
switched to SK-N-SH cells, a neuroblastoma cell line of human origin that ex-
A role for the Rab6B Bicaudal-D1 interaction in retrograde transport in neuronal cells
 75
Figure 2: Ectopic Rab6B and Bicaudal-D1 colocalize at the Golgi and at vesicular structures along 
microtubules. 
HeLa cells stably expressing Rab6B-GFP were transfected with HA-tagged Bicaudal-D1, and stained 
with anti-HA antibody 12CA5 to visualize Bicaudal-D1 (A-C) or in addition with anti-b-tubulin an-
tibody E7 to stain the microtubule network (D-H) and analyzed with confocal laser scanning mi-
croscopy. Colocalization of Bicaudal-D1 (A) and Rab6B (B) is observed at the Golgi and at vesicular 
structures. Merged images are shown in C. The Rab6B Bicaudal-D1 positive structures align along 
microtubules (G, H). Merged image is shown in G. Alignment along microtubules is shown in more 
detail in H.
presses high levels of endogenous Rab6B. We started with purifying Rab6B 
antibodies (Opdam et al., 2000a) by incubating them in the presence of access 
amounts of GST-Rab6A and GST-Rab6A’ to lose the cross-reactive antibodies. To 
confirm that no cross reacting antibodies were left, we tested the purified frac-
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Figure 3:  Accumulation of Bicaudal-D1 and GTP-bound Rab6A and Rab6B at the cell periphery.
HeLa cells were transiently transfected with HA-tagged Bicaudal-D1 (A and D) and GTP-bound 
EYFP Rab6A (B) or GTP-bound EYFP-Rab6B (E) and stained with anti-HA antibody 12CA5 to visualize 
Bicaudal-D1. Merged images are shown in panel C and F. Peripheral accumulations of GTP-Rab6A or 
GTP-Rab6B and Bicaudal-D1 are indicated by arrows.
tion with Western blotting using cell lysates of COS-1 cells expressing Myc-tagged 
Rab6A, Rab6A’ or Rab6B. Compared to the non-purified anti-Rab6B (Fig. 4A, left 
panel) the purified antibody only recognizes Rab6B protein (Fig. 4A, right panel).
 SK-N-SH stained with anti-Rab6B antibody showed a prominent staining 
of the Golgi (Fig. 4B). Although visible using the non-purified anti-Rab6B anti-
body, we were unable to detect the punctuate pattern in the neurites with the 
purified Rab6B antibody as reported by Opdam and co-workers (Opdam et al., 
2000a). The difference may be that we now used affinity-purified the antibody. 
This purified Rab6B antibody may have a too low affinity to detect endogenous 
Rab6B by immunofluorescence. Endogenous Bicaudal-D1 also localizes to the 
Golgi and is detected as a punctuate pattern in neurites as indicated by arrow-
heads in Fig. 4E (magnified in the inset).  SK-N-SH cells overexpressing HA-tagged 
Bicaudal-D1 show the same distribution as the endogenous protein (Fig. 4C) and 
did not change the distribution of endogenous Rab6B compared to non-trans-
fected cells. In SK-N-SH cells, GFP-Rab6B is mainly localized to the Golgi but also 
present in the neurites colocalizing there with endogenous Bicaudal-D1 (Fig. 4F 
and magnified in the inset). Localization studies addressing the colocalization of 
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endogenous Rab6B and Bicaudal-D1 failed due to loss of affinity of the anti-Rab6B 
antibody after biotinylation. However, based on the individual distribution pat-
terns of endogenous Rab6B (Fig. 4B) and Bicaudal-D1 (Fig. 4E) it is clear that they 
both are localized in the Golgi and in vesicles. 
Characterization of Rab6B positive structures in SK-N-SH cells
One function of Bicaudal-D1 is to recruit the dynein complex to different organ-
elles (Matanis et al., 2002). We therefore checked whether dynein is also present 
on the Rab6B Bicaudal-D1 positive structures in the SK-N-SH neurites, where they 
are most easily visible and reflect structures engaged in active transport. When 
we double stained SK-N-SH cells expressing EGFP-Rab6B with anti-Bicaudal-D1 
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and anti-dynein antibody we observed that most EGFP-Rab6B positive structures 
in SK-N-SH cell extensions were also positive for Bicaudal-D1 and dynein (Fig. 5A-
D, indicated by arrows). This finding suggests that the Rab6B Bicaudal-D1 positive 
structures in neurites are capable of being retrograde transported along micro-
tubules. Subsequent live cell imaging of EGFP-Rab6B in neurites of SK-N-SH cells 
revealed that EGFP-Rab6B positive structures indeed move in both anterograde 
and retrograde directions in neurites (See supplemental movie S1). 
 From previous studies (Opdam et al., 2000a) it is known that, in contrast 
to Rab6A and Rab6A’, Rab6B colocalizes in SK-N-SH cells also with ERGIC-53, a 
protein that resides in the ER Golgi intermediate compartment. To see whether 
the pool of Rab6B present at the ERGIC also colocalizes with Bicaudal-D1 we 
double stained SK-N-SH cells expressing EGFP-Rab6B with anti-ERGIC-53 and 
anti-Bicaudal-D1 antibody. Again colocalization between EGFP-Rab6B and Bicau-
dal-D1 was observed in neurites (Fig. 5E-H, arrowhead). However ERGIC-53 was 
only found colocalizing with Rab6B in the cell body at relative close proximity of 
the Golgi (Fig. 5E-H, arrow). These ERGIC-53 and Rab6B positive structures never 
contained any Bicaudal-D1. It seems therefore that two pools of Rab6B in SK-N-
SH cells exist, one not associated with Bicaudal-D1, present at the ERGIC, and 
one associated with Bicaudal-D1 present at the Golgi and vesicles in the neurites 
together with Rab6A.
Localization of Bicaudal-D1 to the Golgi and in SK-N-SH cell extensions is de-
pendent on Rab6B 
Finally we investigated the effect of overexpression of Rab6B-GTP or Rab6B-GDP 
on endogenous Bicaudal-D1 localization in SK-N-SH cells. Localization of EGFP-
Rab6B-GTP resembles the wildtype form as it is present at the Golgi and punc-
tuate structures in the neurites indicated by arrows, where it colocalizes with 
endogenous Bicaudal-D1 (Fig. 6A,B).
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<Figure 4: Localization of endogenous Rab6B and Bicaudal-D1 in SK-N-SH cells. 
Anti-Rab6B antibody purification. For studying endogenous Rab6B in SK-N-SH cells affinity purified 
anti-Rab6B antibody was used. To verify its specificity cell extracts of COS-1 cells transfected with 
Myc tagged Rab6A, Rab6A’, Rab6B or mock transfected were blotted and incubated with the non pu-
rified anti-Rab6B antibody (A, left) or with affinity purified anti-Rab6B antibody (A, right). Molecular 
mass markers (kD) are shown on the left.
SK-N-SH cells transfected with HA-tagged Bicaudal-D1, stained with anti-HA 12CA5 antibody to visu-
alize Bicaudal-D1 and purified anti-Rab6B antibody to stain endogenous Rab6B are shown in panel B 
and C. Merged images are shown in panel D. 
SK-N-SH transiently transfected with WT EGFP-Rab6B, stained with anti-Bicaudal-D1 antibody #2296 
and analyzed with confocal laser scanning microscopy are shown in panel E and F. Colocalization of 
EGFP-Rab6B and Bicaudal-D1 in neurites is indicated by arrowheads. Merged images are shown in 
panel G.
Figure 5:  Identification of Rab6B and Bicaudal-D1 positive structures.
SK-N-SH cells were transiently transfected with WT EGFP-Rab6B (B,F) and stained with anti-dynein 
antibody (A) anti-Bicaudal-D1 antibody #2296 (C,G) or anti-ERGIC53 antibody (E). Merged images are 
shown in panel D and H respectively. Colocalization for a subset of Rab6B, dynein and Bicaudal-D1 
vesicles are indicated by arrows. 
Rab6B and ERGIC53 positive but Bicaudal-D1 negative structures are found near the cell body indi-
cated by the arrow in panel E, F and H (magnified in the left inset in panel H), whereas Rab6B and 
Bicaudal-D1 positive but ERGIC-53 negative structures in the neurites are indicated by the arrowhead 
in panel F, G and H (magnified in the right inset in panel H).
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Figure 6: Expression of Rab6B-GDP affects the localization of endogenous Bicaudal-D1 in neurites.
SK-N-SH cells were transfected with EGFP-Rab6B-GTP (B) EGFP-Rab6B-GDP (D) encoding plasmids and 
stained for endogenous Bicaudal-D1 with anti-Bicaudal-D1 antibody #2296 (A and C). Localization of 
Bicaudal-D1 in SK-N-SH cells overexpressing GTP-Rab6B resembles the pattern found in cells overex-
pressing WT Rab6B i.e. colocalizing at the Golgi and along neurites. 
SK-N-SH cells overexpressing Rab6B-GDP (D indicated by the asterisks) show a less prominent staining 
of Bicaudal-D1 at the Golgi. In neurites  Bicaudal-D1 localization is also less prominent (inset in panel 
C and D indicated with the arrowhead) when compared to untransfected cells where Bicaudal-D1 is 
still present in the neurites (inset in panel C, indicated with the arrow).
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In cells expressing EGFP-Rab6B-GDP, indicated by an asterisk in Fig. 6 panel C and 
D, the localization of Bicaudal-D1 at the Golgi is less prominent compared to cells 
not expressing EGFP-Rab6B-GDP. Also in neurites the localization of Bicaudal-
D1 is affected by overexpression of EGFP-Rab6B-GDP. There the localization of 
Bicaudal-D1 in neurites of cells expressing EGFP-Rab6B-GDP is less prominent as 
indicated by the arrowhead in Fig.6 inset panel C and D compared to a neighbor-
ing cell not expressing EGFP-Rab6B-GDP indicated with an arrow in Fig. 6 inset 
panel C. Instead the Bicaudal-D1 protein is more evenly distributed throughout 
the cytosol. We therefore conclude that Rab6B is involved in the localization of 
Bicaudal-D1 at the Golgi and vesicles in neurites.
 81
Discussion
In the past three Rab6 isoforms were identified: Rab6A, Rab6A’ and Rab6B (Goud 
et al., 1990; Echard et al., 2000; Opdam et al., 2000a). Both Rab6A and Rab6A’ 
are ubiquitously expressed and are generated via alternative splicing of a dupli-
cated exon within the Rab6A gene (Echard et al., 2000). Rab6B is encoded by a 
different gene, has 93% similarity with Rab6A, and shows a tissue and cell-type 
specific expression pattern in brain. Strikingly, despite these differences between 
Rab6A and Rab6B, all known Rab6A effector proteins are also able to bind Rab6B. 
To learn more about the functional difference between Rab6A and Rab6B we 
searched for novel Rab6B interacting proteins. In the work described here we 
identified in a Y-2H screen the human homolog of the Drosophila coiled-coil pro-
tein Bicaudal-D1 (Suter et al., 1989). This protein turned out not to be a specific 
partner for Rab6B as its interaction with Rab6A and to a lesser extend also with 
Rab6A’ had been described previously (Matanis et al., 2002).
 In mammalian cells two homologs of Bicaudal-D are present, Bicaudal-D1 
(at least four forms by alternative splicing) and Bicaudal-D2 (Baens and Marynen 
1997). Previous studies have shown that in mammalian cells Bicaudal-D2 but also 
Bicaudal-D1 associates with the dynein-dynactin complex and is able to induce 
minus end directed transport of organelles (Hoogenraad et al., 2001;  Hoogen-
raad et al., 2003). The dynein-dynactin protein complex is the major minus-end 
directed microtubule associated motor protein complex (for review (Karki and 
Holzbaur 1999)). In addition it was also established that Rab6 binds directly to 
p150glued, a component of the dynactin protein complex (Short et al., 2002). 
Taken together these data implicate an important role for Rab6 in the regulation 
of dynein-mediated processes. The fact that Rab6B is cell type specific expressed 
and probably regulates a different pathway from that of Rab6A/A’ prompted us 
to look in more detail at the interaction between Rab6B and Bicaudal-D1 in neu-
ronal cells. 
 To confirm the yeast-two-hybrid data co-immunoprecipitation experi-
ments were performed. On the basis of the co-immunoprecipitations with the 
anti-Rab6 antibody one could assume that Rab6B binds stronger to Bicaudal-D1 
compared to the other isoforms. This is however not supported by the data of 
the reciprocal immunoprecipitation and the pull down experiments with GTPgS 
or GDP loaded Rab6. Interesting there was no difference in the amount of Bicau-
dal-D1 pulled down by GTPgS or GDP loaded Rab6A’. This is not uncommon as also 
differences in binding of the different Rab6 isoforms to Rab6IP1 were observed 
(Monier et al., 2002). 
 In our localization studies in SK-N-SH cells we made the following ob-
servations. First, when these cells were transfected with EGFP tagged Rab6B 
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fluorescence was observed, as expected, at the Golgi but also in vesicles in 
neurites that are characteristic for SK-N-SH cells. At these EGFP-Rab6B positive 
patches, also endogenous Bicaudal-D1 was detected with the Bicaudal-D1 specific 
antibody. The staining pattern observed for Bicaudal-D1 is not influenced by the 
presence of overexpressed EGFP-Rab6B. SK-N-SH overexpressing HA-tagged Bicau-
dal-D1 again shows the same staining pattern as observed for endogenous Bicau-
dal-D1. SK-N-SH cells transfected with EGFP tagged Rab6B and stained for en-
dogenous Bicaudal-D1 and in addition stained for dynein with an antibody against 
its intermediate chain shows co-localization in these cell extensions for some of 
these structures. Subsequent live cell imaging revealed movement of EGFP-Rab6B 
structures in both anterograde and retrograde directions. The bi-directional 
nature of these structures can be explained by the presence of both plus, per-
haps Rabkinesin-6 (Opdam et al., 2000a) and minus end directed dynein/dynactin 
motors at the same time on these vesicles (Ma et al., 2002). The cargo of these 
Rab6B vesicles remains unknown, however in a recent study Rab6B was found in a 
purified synaptic vesicle preparation (Takamori et al., 2006). 
 Rab6B also partially localizes to the Golgi ER intermediate compart-
ment (ERGIC) in SK-N-SH cells, but no co-localization was observed for Rab6B 
and Bicaudal-D1 at the ERGIC. This is in agreement with Matanis who also did not 
observe Bicaudal-D1 at the ERGIC in HeLa cells (Matanis et al., 2002). Live cell 
imaging experiments using SK-N-SH cells expressing EYFP-Rab6B and ECFP-Rab6A 
revealed the presence of both Rab6 isoforms on vesicles in the neurites (data not 
shown). This may suggest that Rab6A and Rab6B function side by side at these 
vesicles. However Del Nery and co-workers (Del Nery et al., 2006) have shown 
that, although Rab6A was shown to function in retrograde transport in other cell 
types, this function is largely dispensable and that Rab6A most likely exerts its 
function during mitosis (Miserey-Lenkei et al., 2006). The same can hold for neu-
ronal cells. Only at the ERGIC specific localization of Rab6B was found, although 
not with Bicaudal-D1. It seems therefore that Rab6B fulfills a dual role, one in 
ERGIC associated COP-I or COP-II related traffic and another COP independent 
dynein associated pathway involving Bicaudal-D1 and vesicles moving in and out 
neurites. 
 We observed that a large number of cells that co-express the GTP-bound 
forms of Rab6A and Rab6B together with HA-Bicaudal show an accumulation of 
both proteins at the cell periphery in accordance to the observations by Mata-
nis (Matanis et al., 2002) when they overexpressed only the C-terminal part of 
Bicaudal-D1. However accumulation of Rab6A or Rab6B is also observed in a large 
number of cells only expressing Rab6A-GTP or Rab6B-GTP and seems therefore in-
dependent of the overexpression of Bicaudal-D1. This indicates that accumulation 
of GTP-bound Rab6A or Rab6B is induced by another process then the accumula-
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tion observed in cells overexpressing C-terminal Bicaudal-D1. In these structures 
also no Rabkinesin-6 was found (data not shown), ruling out any involvement of 
this supposed motor protein. Interestingly these peripheral accumulations are not 
observed in the case of GTP-Rab6A’.
 Our data suggest that Rab6B is involved in the recruitment of Bicaudal-D1 
to Rab6B positive structures. Cells overexpressing Rab6B-GDP showed less stain-
ing for Bicaudal-D1 at the Golgi. In addition cells overexpressing the GDP-bound 
form of Rab6B lack the characteristic Bicaudal-D1 structures in the cell exten-
sions. Overexpression of Rab6B-GTP had no observable effect on the staining pat-
tern of Bicaudal-D1, as it resembles the pattern compared to cells overexpressing 
WT Rab6B. 
 It still remains unclear what the exact nature of the Rab6B Bicaudal-D1 
interaction is. However in neurites it functions in regulating dynein mediated ret-
rograde movement, maybe in combination with Rab6A and/or Rab6A’, a process 
very important for the viability of these cells (Hafezparast et al., 2003; Levy et 
al., 2006). In addition, it might be that Rab6B regulates a neuronal cell specific, 
Bicaudal-D1 independent role at the ERGIC. 
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Rab6A Q72L Rab6A’ Q72L Rab6B Q72L
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1
7
1
0
0
1
1
0
1
1
1
5
0
0
0
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Abstract
The small GTPase Rab6 is a key regulator in the retrograde transfer from endo-
somes via the Golgi to the ER. Three isoforms of Rab6 have been identified, the 
ubiquitously expressed Rab6A and Rab6A’, and the brain-specific Rab6B. Recent 
studies have shown that Rab6A’ is the major isoform regulating this retrograde 
transport. Cytoplasmic dynein is the main motor protein complex for this trans-
port. Dynein consists of two heavy chains, two intermediate chains, four light 
intermediate chains and several light chains, called roadblock/LC7 proteins or 
DYNLRB proteins. In mammalian cells two light chain isoforms have been identi-
fied, DYNLRB1 and DYNLRB2. We here show with yeast-two-hybrid, co-immuno-
precipitation and pull down studies that DYNLRB1 specifically interacts with all 
three Rab6 isoforms and colocalizes at the Golgi. This is the first example of a 
direct interaction between Rab6 isoforms and the dynein complex. Pull down 
experiments showed further preferred association of DYNLRB1 with GTP-bound 
Rab6A and interestingly GDP-bound Rab6A’ and Rab6B. In addition DYNLRB1 was 
found in the Golgi apparatus where it co-localizes with EYFP-Rab6 isoforms. 
DYNLRB has been postulated as a modulator of the intrinsic GTPase activity of 
GTP-binding proteins. However in vitro we were not able to obtain experimental 
support for this effect on Rab6 GTPase activity. 
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Introduction
Rab proteins are small GTPases that are key regulators of intracellular membrane 
traffic and control this activity by constant cycling between a membrane associ-
ated GTP-bound active and cytosolic GDP bound inactive state. Today more than 
60 Rab family members, including isoforms, are known (Stenmark and Olkkonen 
2001). Rab proteins exert their function by binding to a variety of effector pro-
teins (Zerial and McBride 2001), bringing in specificity in the control of distinctly 
different membrane trafficking events, including fission, tethering, and subse-
quent fusion of membranes. Another major event in membrane trafficking regu-
lated by Rab proteins is the transport along the actin or microtubule cytoskeleton 
(for reviews see (Hammer 3rd and Wu 2002; Jordens et al., 2005). 
 Rab6 is one of the few Rab proteins known to be involved in direct regu-
lation of microtubule-based transport as it interacts with kinesins, i.e. Rabki-
nesin-6 (Echard et al., 1998) or with the dynein/dynactin complex via p150glued 
(Short et al., 2002) and Bicaudal-D (Hoogenraad et al., 2001; Matanis et al., 
2002; Wanschers et al., 2007). In the past, three different isoforms of the Rab6 
protein were identified. These include Rab6A (Goud et al., 1990), Rab6A’ gener-
ated by alternative splicing of a homologous but distinct exon within the Rab6 
gene (Echard et al., 2000), and Rab6B, a brain specific isoform (Opdam et al., 
2000a). Until recently, both Rab6A and Rab6A’ were thought to play a role in a 
COPI independent Golgi-to-ER or trans-Golgi-to ER retrograde transport (Girod et 
al., 1999; White et al., 1999; Young et al., 2005) with an additional function for 
Rab6A’ in specific endosome to Golgi transport characterized by the transport of 
internalised Shiga toxin B-fragment (Mallard et al., 2002). Recent studies showed 
however that Rab6A is dispensable for Golgi to ER transport and that Rab6A’ is 
instrumental in regulating this specific transport step (Del Nery et al., 2006). Fur-
thermore, Rab6A’ has also been implicated in the transition from metaphase to 
anaphase during mitosis (Miserey-Lenkei et al., 2006). In the past we have shown 
that Rab6A’ is the only isoform which does not interact with rabkinesin-6 (Echard 
et al., 2000). Since microtubules are important in both anterograde and retro-
grade transport a role for its interaction with dyneins can be anticipated (Young 
et al., 2005). 
 Dyneins are large multi-subunit protein complexes. From a structural 
and functional point of view can be divided into two major classes, axonemal 
dyneins involved in cilliary and flagellar movement, and cytoplasmic dyneins that 
function in minus-end directed transport along microtubules. In this latter role 
dyneins are involved in cell migration, cell division, maintaining the integrity of 
the Golgi apparatus and vesicular transport (for review: Karki and Holzbaur, 1999; 
King, 2000; Pfister et al., 2006; Höök and Valee 2006). The cytoplasmic dynein 
Rab6 family proteins interact with the dynein light chain protein DYNLRB1
 91
protein complex consists of two heavy chains where ATP hydrolysis takes place 
to generate the actual motor activity.  The heavy chains are associated with two 
intermediate chains (IC). These ICs provide a direct binding to dynactin, a large 
multisubunit protein complex known to mediate the binding of several cargoes 
to - and to facilitate the processivity of - cytoplasmic dynein along microtubules 
(King and Schroer, 2000; Lane et al., 2001; ). Cytoplasmic dynein furthermore 
consists of four light intermediate chains (LIC) and several light chains (LC). The 
LC group consists of several small, unrelated proteins such as the LC7/roadblock, 
LC8 and the Tctex1/rp3 protein family. These latter proteins function in the di-
rect binding of cargo to the dynein motor protein complex (Tai et al., 1999). 
 The LC7/roadblock protein family, now also designated as DYNLRB pro-
teins (Pfister et al., 2005), was first identified in Drosophila in a search for axonal 
transport mutants (Bowman et al., 1999). In mammalian cells, two isoforms, 
DYNLRB1 and DYNLRB2, are present. Both are capable of forming homo- and 
heterodimers (Nikulina et al., 2004) that bind directly to the ICs (Susalka et al., 
2002). Based on its secondary structure DYNLRB shows similarity with the bacte-
rial MglB protein from Mycococcus xanthus and therefore it has been proposed 
that DYNLRB can help to modulate the GTPase activity of small GTPases (Koonin 
and Aravind 2000). 
 In a search for novel Rab6 interacting proteins we identified DYNLRB1 as 
a Rab6 interacting protein via a yeast-two-hybrid interaction trap. This interac-
tion was verified with GST-pull down assays and co-immunoprecipitations studies, 
revealing that DYNLRB1 interacts directly with all three Rab6 isoforms. Interest-
ingly, DYNLRB1 binds preferentially to GTP bound Rab6A and GDP bound Rab6A’ 
and Rab6B. Expression studies using VSV-tagged DYNLRB1 and EYFP tagged Rab6 
isoforms revealed that VSV-DYNLRB1 was recruited from the cytosol to the Golgi. 
Based on structural studies it was proposed that members of the DYNLRB protein 
family are able to affect the intrinsic GTPase activity of small GTPases. This pro-
posed effect of DYNLRB1 on the intrinsic GTPase activity of Rab6 was, however, 
not detected in our experimental set up. Rather, based on the Rab6-DYNLRB1 
interaction identified here, we propose that direct binding of the Rab6-DYNLRB1 
ensemble to the dynein complex could function in stabilizing further binding of 
other interacting proteins such as p150glued or Bicaudal-D1. In this manner Rab6 
could serve to form a multiprotein assembly with specific functional specificity in 
retrograde transport. 
Material and methods
Yeast two-hybrid interaction trap
For the Y-2H screening we used the LexA system as described (Gyuris et al., 
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1993). Constitutive active Rab6 (Rab6-GTP), introduced in the BamH1/XhoI clon-
ing site of the pMW101 vector, was used as bait. As prey source a human foetal 
brain cDNA library was used (kindly provided by Dr. Roger Brent and colleagues, 
Massachusetts General Hospital, Boston, MA). For two hybrid interactions as-
says plasmids were introduced in yeast strain EGY48 (Mata trp1 ura1 his3 LEU2::
pLexAop6-LEU2) containing the plasmid pSH18-34, which includes the reporter 
lacZ gene. Bait-prey interactions were detected by growth and blue colouring on 
minimal agar plates lacking histidine, tryptophan, uracil and leucine, contain-
ing 2% galactose, 1% raffinose and 80 mg/ml X-gal, buffered at pH 7.0. To confirm 
positive interactions, the insert containing pJG4-5 plasmid DNA from positive 
clones was isolated, reintroduced into the yeast strain, and the screening for 
growth and blue coloring was repeated.
Expression plasmid construction
The complete cDNA encoding DYNLRB1 was PCR amplified from the pJG4-5 vector 
used in the two-hybrid-screen with specific primers. One set of primers (forward 
5’-CGGGATCCATGGCAGAGGTGGAGGAGAC-3’) and (reversed 5’-CGGGATCCGAGA-
GTGGCTTATTCGGTTGG-3’) introduced both a BamH1 site (underlined) upstream 
and downstream of the cDNA sequence to facilitate subsequent cloning into the 
pSG8-VSV, pEYFP-C1 (Clontech, Mountain View, CA) and pGEX-6P-2 vector (GE 
Healthcare, Uppsala, Sweden). Likewise, the second set of primers (forward 
5’-CGGGATCCATGGCAGAGGTGGAGGAGAC-3’) and (reversed 5’-CGGGATCCTTCG-
GTTGGATTCTGAATC-3’) was also used to introduce flanking BamH1 sites and to 
delete the stop codon for subsequent cloning of the cDNA insert into the pEGFP-
N3 (Clontech, Mountain View, CA) plasmid vector, in which the startcodon of 
EGFP has been removed (pEGFP-N3-DATG, a kind gift from Dr. Ron Dirks). To 
verify proper DYNLRB1 expression Western blot analysis was performed. We ob-
served an additional band resulting from a second product from a second transla-
tion initiation site. To eliminate this product the methionine at position 31 was 
changed into a lysine. This is a natural amino acid residue, present in the DYN-
LRB2 isoform. Primers used for this cloning step were (forward-primer 5’-CCAT-
CAAGAGCACCCTGGACAACCCCACC-3’) and (reversed-primer 5’-GGTGGGGTTGTC-
CAGGGTGCTCTTGATGG-3’). Mutations were introduced by using the Quickchange 
site directed mutagenesis kit (Stratagene Inc. La Jolla, CA) according to the 
manufacturers specifications. Successful modification of open reading frames was 
checked by sequence analysis. The pGEX4T-1-DYNLRB2 construct was a kind gift 
from Kevin Lo.
Isolation of GST fusion proteins
For the isolation of GST-Rab6A, GST-Rab6A’, GST-Rab6B or GST-DYNLRB1 fu-
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sion proteins Escherichia coli DH5a cultures expressing pGEX-2T-Rab6A, -A’, -6B 
or pGEX-6P-2-DYNLRB1 were grown until an OD600 of 0.7.  Cultures where then 
grown for an additional two hours at 30ºC in the presence of 100 mM isopropyl 
β-D-thiogalactopyranoside (IPTG) to induce the expression of the GST-fusion pro-
teins. After induction, the cultures were centrifuged and the pellets resuspended 
in phosphate buffered saline (PBS) supplemented with a mixture of protease 
inhibitors, 50 mM GTP, 0.1% [v/v] Tween-20, 1 mM DTT and incubated for 30 min. 
at 4ºC in the presence of 1 mg/ml lysozyme. The suspension was then subjected 
to sonification followed by centrifugation. The supernatant containing the GST 
fusion proteins was incubated with 140 ml glutathion sepharose 4B beads (GE 
Healthcare, Uppsala, Sweden) under rotation for 2 hours at 4ºC. After washing 
the beads twice, the fusion proteins were eluted with buffer containing 50 mM 
HEPES pH 7.5, 150 mM NaCl, 1 mM MgCl2, 10 mM GTP and 15 mM reduced glutathi-
one. Next the DYNLRB1 was cleaved from the GST by incubating the GST-DYNLRB1 
protein O/N at 4OC in the presence of the Prescission protease (GE Healthcare, 
Uppsala, Sweden) in cleavage buffer (50 mM Tris pH 7.0, 150 mM NaCl, 1 mM 
EDTA and 1 mM DTT). Purified recombinant Rab6 protein for use in pull down ex-
periments was obtained by incubating GST-Rab6 bound to glutathione sepharose 
4B beads O/N in PBS with 0.1% [v/v] Triton X-100 containing 10 units of thrombin 
protease (GE Healthcare, Uppsala, Sweden). The amount of recombinant protein 
was calibrated against a standard BSA concentration range using to the Bradford 
method (Bradford, 1976). 
Pull down experiments with GST-DYNLRB fusion proteins
After purification and elution, 10 mg of the GST-DYNLRB fusion proteins were 
re-coupled to 25 ml of glutathione sepharose 4B beads and incubated O/N under 
rotation in the presence of approximately 5 μg of purified recombinant Rab6 
protein. After incubation the beads were washed four times with PBS 0.1% [v/v] 
Triton X-100 and twice with PBS before being processed for SDS-PAGE followed by 
Western blotting or staining of the gel with Coommassie Brilliant Blue.
Pull down experiments with GTPgS or GDP loaded GST-Rab6 fusion proteins
GST-Rab6 was coupled to 20 ml glutathion sepharose 4B beads in loading buffer 
(25 mM Tris pH 7.5, 10 mM EDTA, 5 mM MgCl2) for 1 hour at 4ºC under rotation. 
Beads were then loaded with GTPgS (a nonhydrolysable variant of GTP, Roche, 
Almere the Netherlands), or GDP (Sigma Aldrich, Zwijndrecht, the Netherlands) 
in loading buffer supplemented with 1 mM of GTPgS or 1 mM of GDP for one hour 
at 37ºC. After centrifugation the buffer was removed and replaced by interaction 
buffer (25 mM Tris pH 7.5, 10 mM MgCl2, 250 mM NaCl, 0.1% [v/v] Triton X-100) 
again supplemented with 1 mM GDP or 1 mM GTPgS to which 100 ml cell extract 
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of BHK cells transfected with pEGFP-N3 DYNLRB1. As a control, Bicaudal-D1 was 
expressed from the pEGFP-N2 plasmid vector in which the GFP encoding moi-
ety was replaced with a triple HA-tag encoding segment (Matanis et al., 2002). 
Tagged-protein containing extract was added and incubated for 90 min. at room 
temperature under rotation. After the incubation the beads were washed 4 times 
with interaction buffer without nucleotides and processed for Western blotting. 
The BHK-21 cell extracts were prepared by lysing the cells in buffer containing 
10 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM MgCl2, 1 mM CaCl2, 0.2% [v/v] Triton 
X-100 and protease inhibitor cocktail. 
Immunoprecipitation and immunoblotting
BHK-21 cells were grown in DMEM supplemented with 10% FCS and 1% pyruvate/
glutamate on 10-cm dishes. The cells were transfected with the purified plas-
mid vector of interest, i.e. 2.5 µg of the mammalian expression vector pSG8-His 
encoding VSV tagged Rab6B or Rab22B (Opdam et al., 2000b), or Myc-tagged 
Rab6 isoforms, and 2.5 mg DYNLRB1 in the pEGFP-N3 vector, by use of the Lipo-
fectamine Plus reagent (Invitrogen Life Technologies, Breda, the Netherlands) 
according to the manufacturers specifications. Twenty four hours later cells were 
washed twice with PBS and lysed on the plate with 1 ml lysis buffer (100 mM 
Na2HPO4 pH 8.0, 1% [v/v] Triton X-100, 0.2% BSA and protease inhibitor cocktail 
(Boehringer Mannheim, Germany) for immunoprecipitations or lysed with cell 
extraction buffer (20 mM Tris pH 8.0, 150 mM NaCl, 5 mM EDTA, 1% [v/v] Triton 
X-100, 0.2% BSA and protease inhibitor cocktail) for use in pull down assays and 
put on ice for one hour. The lysates were cleared by centrifugation for 5 min. at 
5000g at 4ºC after which 500 ml of the supernatant was subjected to immunopre-
cipitation with a polyclonal antibody against GFP, with anti-VSV antibody P5D4 
(Kreis et al., 1986) or anti-Myc 9E10 (Kari et al., 1986), non-covalently coupled to 
25 ml protein-A Sepharose beads. After precipitation, the protein-A beads loaded 
with anti-GFP antibody were washed six times with high salt buffer (100 mM Tris-
HCl pH 7.4, 1.2 M KCl and 1% [v/v] Triton X-100) and twice with PBS. Protein-A 
beads loaded with anti-VSV or anti-Myc antibody were washed four times with 
lysis buffer, once with lysis buffer without Triton X-100 and finally twice with 
ten times diluted lysis buffer without Triton X-100. After washing the Protein-A 
beads were taken up in 25 ml 2x sample buffer (100 mM Tris-HCL, pH 6.8, 200 
mM dithiotreitol, 4% SDS, 0.2% bromophenol blue, 20% glycerol and subjected 
to electrophoresis on a 12% or 15% polyacrylamide-SDS gel and transferred onto 
PVDF-membranes by Western blotting. After blocking with 2.5% non-fat dry milk 
in 10 mM Tris-HCl pH 8.0, 150 mM NaCl and 0.05% [v/v] Tween-20 (TBST), the 
blots were incubated with either anti-GFP antibody (diluted 1:5000; Cuppen et 
al., 1999), polyclonal anti-VSV antibody (diluted 1:1000; ITK Diagnostics, Uit-
Rab6 family proteins interact with the dynein light chain protein DYNLRB1
 95
hoorn, the Netherlands), anti-Myc antibody 9E10 (diluted 1:100), or monoclonal 
anti-GFP antibody B2 (diluted 1:5000; Santa Cruz Biotechnology). For the detec-
tion of retained recombinant Rab6 in the pull down assay with purified proteins 
monoclonal anti-Rab6 antibody M01 (diluted 1:300, Abnova, Tapei, Taiwan) was 
used. In case of the pull down experiments with GTPgS or GDP loaded GST-Rab6 
fusion proteins, recovered DYNLRB1-EGFP was visualized with anti-GFP antibody 
B2 and HA-Bicaudal-D1 with anti-HA antibody 12CA5 (dilution 1:500; (Wilson et 
al., 1984), followed by incubations with secondary antibody (horse radish per-
oxidase-conjugated affinipure goat anti-mouse or goat anti-rabbit IgG (diluted 
1:20.000). Incubations and subsequent washes were carried out in TBST at room 
temperature followed by a final rinse with TBS. Immunoreactive bands were vi-
sualized using freshly prepared chemiluminescent substrate (100 mM Tris-HCL pH 
8.5, 1.25 mM r-coumaric acid, 0,2 mM luminol and 0.009% H2O2) and exposure to 
Kodak X-omat autoradiography films.     
Immunofluorescence assay
Neuro2A (N2A) or BHK-21 cells were cultured in a 24-wells plate on glass cover-
slips and transiently transfected with plasmids encoding EYFP-tagged Rab6 WT, 
active, inactive iso-forms or VSV-tagged DYNLRB1 with Lipofectamine-Plus re-
agent. After 24 h the cells were washed with PBS, fixed for 30 min in 1% parafor-
maldehyde in 0.1 M phosphate buffer and permeabilized with 0.1% saponin/20mM 
glycine in PBS (PBSG). Where indicated, prior to fixation and permeabilization, 
N2A cells were incubated for 3 hours with DMEM containing the microtubule 
depolymerising agent Nocodazole (Sigma) (10 µg/ml). Next, N2A cells were incu-
bated with a polyclonal antibody against DYNLRB2  (#CT200 1:10 dilution (Niku-
lina et al., 2004)), BHK-21 cells with monoclonal anti-VSV P5D4 antibody (1:5000 
dilution). Specific labelling was detected by incubation with Alexa-conjugated 
(dilution 1:300; Jackson ImmunoResearch Laboratories, Inc. West Grove, PA, USA) 
goat anti-rabbit IgG for 1 hour at room temperature. Finally, the fixed cell con-
taining glass coverslips were rinsed in PBSG/saponine, water, dehydrated 5 min. 
with 100% methanol and mounted on glass slides by inversion over Mowiol (Sigma) 
containing 2.5% sodium azide. Cells were examined using a confocal laser-scan-
ning microscope (Biorad MRC1024). 
Immunoelectron microscopy
Ultrastructural localisation studies were performed on BHK-21 cells either trans-
fected with a construct encoding VSV-DYNLRB1 or co-transfected with VSV-DYN-
LRB1 and EYFP-Rab6. Cells were fixed with 1% paraformaldehyde in 0,1M PHEM 
buffer (60 mM PIPES, 25 mM HEPES, 10 mM EGTA, 2 mM MgCl2, pH 6.9) for one 
hour at room temperature. Before sectioning cells were pelleted in 10% gelatine 
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and post-fixed in 1% PFA for 24 hours.  Ultra-thin cryosectioning was done as 
described before (Fransen et al., 1985; Schweizer et al., 1988). Sections were 
incubated with anti-VSV antibody P5D4 at a 1:100 dilution followed by protein-A 
complexed with 10 nm colloidal gold particles for single labelling experiments. 
Double labelling was performed with anti-VSV antibody P5D4 and by protein-A 
complexed with 5 nm colloidal gold particles followed by anti-GFP and protein-A 
complexed with 10 nm colloidal gold. Electron microscopy was performed using a 
Jeol 1010 electron microscope at 80 kV.
Silencing of DYNLRB1 expression via small interfering RNAs
A siRNA was designed to target DYNLRB1 at position 253 to 271 (GACTATTTCCT-
GATTGTGA) and cloned into the pSUPER plasmid vector (Oligoengine Seattle, WA, 
USA) (Brummelkamp et al., 2002) containing a neomycin selection cassette. The 
construct was transfected and stable transfectants were selected with Neomycin 
(1000 mg/ml). Knockdown of DYNLRB1 transcript levels were detected with stan-
dard RT-PCR techniques using b-actin as a control. 
 
Rab GTPase activity assay
To assay the Rab6 GTPase activity we used a method similar to the one described 
by Nagelkerken and co-workers (Nagelkerken et al., 2000). Here, prenylated 
Rab6 isoforms were isolated from cell lysates of BHK-21 cells transfected with 
Myc-tagged Rab6 using protein sepharose-A beads loaded with anti-Myc antibody 
9E10. Next, the Rab6A coupled to protein-A sepharose beads was loaded with 
Mg-[g-32P]-GTP in loading buffer (20 mM Tris pH 7.5, 1 mM DTT, 0.5 g/ l BSA and 
0.05% CHAPS) for 90 min. at room temperature.  After loading the beads were 
washed four times with loading buffer containing additional 30 mM MgCl2 to 
stabilize Rab6 in the GTP bound state. Beads were then resuspended in loading 
buffer supplemented with 30 mM MgCl2 containing recombinant DYNLRB or buf-
fer alone as a negative control and incubated at 37ºC. Released 32Pi was isolated 
with the charcoal method (Swarts et al., 1994). At several time points a sample 
of 50 ml was taken and mixed with 6% (v/v) trichloroacetic acid (TCA) containing 
10% (w/v) charcoal. After 10 min. of incubation on ice the TCA/charcoal mixture 
was briefly centrifuged at 10.000xg. To the cleared supernatant, containing the 
released inorganic 32Pi, 4 ml of Optifluor (Canberra Packard, Tilburg, the Neth-
erlands) was added after which the mixture was analysed by liquid scintillation 
counting. The amount of released Pi in time over the period of measurement 
(i.e., counts) was plotted as a percentage of the total counts bound to the beads 
at time point zero. 
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Results
All three Rab6 isoforms interact specifically with DYNLRB1
In a search for specific binding partners for Rab6 isoforms, the GTPase-defective 
forms of all three isoforms were used as baits to screen a fetal human brain cDNA 
library in a yeast-two-hybrid interaction trap experiment. 
 Using Rab6A and Rab6B several novel interactors were identified, among 
which was DYNLRB1 (for Rab6A and Rab6B seven and five DYNLRB1 clones, re-
spectively; see also Wanschers et al., 2007).With Rab6A’ as bait only one positive 
clone of DYNLRB1 was found. DYNLRB1 (also known as HSPC162, Robl1, km23 or 
DNLC2A) is a small protein of about 11 kD belonging to the dynein LC7/roadblock 
light chain protein family. To verify these results and check for the specificity 
of the interaction, co-immunoprecipitation studies were performed with cell 
lysates of BHK-21 cells containing GFP-DYNLRB1 or GFP alone and WT Myc-tagged 
Figure 1: All three Rab6 isoforms show specific and direct interactions with DYNLRB1. > 
Cell lysates containing all three Myc-tagged Rab6 isoforms and GFP-DYNLRB1 or GFP alone as a 
control were subjected to immunoprecipitation with anti-GFP antibody or anti-Myc antibody 9E10. 
Co-immunoprecipitated proteins were visualized on Western blot using anti-Myc 9E10 (A upper panel) 
or anti-GFP (B, upper panel) respectively. The middle panels show the efficiency of the immunopre-
cipitation and the lower panels the inputs. Molecular mass indicators (kD) are shown on the left. All 
three Myc-Rab6 isoforms encoding constructs contain the full length cDNA. The difference in molecu-
lar weight between Myc-Rab6A/-Rab6A’ and -Rab6B can be attributed to a different spacer region 
between the Myc tag and the startcodon.  
To show that the interaction is specific, cell lysates of BHK-21 transfected with constructs either 
encoding VSV-tagged Rab22B or VSV-tagged Rab6B in combination with EGFP-DYNLRB1, or as a nega-
tive control with EGFP, alone were subjected to immunoprecipitations with anti-VSV antibody P5D4. 
Co-immunoprecipitated proteins were visualized with anti-GFP antibody (C, upper panel). Efficiency 
of the immunoprecipitation with anti-VSV antibody and the input of GFP-DYNLRB1 or GFP alone are 
shown in the middle and lower panel respectively. To show that the interaction is specific and direct 
for DYNLRB1, purified recombinant Rab6A and Rab6A’ proteins were subjected to a pull down with 
GST-DYNLRB1, GST-DYNLRB2 or GST alone bound to glutathione 4B beads. Retained Rab6A and Rab6A’ 
were visualized on Western blots with anti-Rab6 antibody (D, two left upper panels). Equal loading 
of glutathione beads with GST fusion proteins was visualized by staining the gel with Coommassie 
Brilliant Blue (CBB) after SDS-PAGE (D, lower panel). Inputs of Rab6A and Rab6A’are depicted in the 
two upper right panels. (E) Comparison of human DYNLRB1, human DYNLRB2 and the predicted rat 
DYNLRB2 sequence (accession number NP_054902, NP_570967 and EDL92633 respectively). Identical 
amino acids are shown in white on a black background and amino acids with similar properties are 
shown in white on a grey background.
Rab proteins specify motorized vesicle transport
98
Rab6A, Rab6A’ and Rab6B. Using anti-GFP antibody this resulted in the co-im-
munoprecipitation of all three Myc tagged Rab6 isoforms with GFP-DYNLRB1, but 
not with GFP alone (Fig. 1A, upper panel). The reciprocal experiment, an immu-
noprecipitation of Myc-Rab6 isoforms using the anti-Myc antibody 9E10, resulted 
in the specific co-immunoprecipitation of GFP-DYNLRB1 (Fig. 1B, upper panel). 
This interaction is specific for Rab6 isoforms, as immunoprecipitation with the 
more distantly related Rab22B isoform did not result in co-immunoprecipitation 
of DYNLRB1 (Fig. 1C upper panel).  
 To further determine the binding specificity of Rab6 and to show that the 
interaction is a direct one, we performed pull-down experiments with GST-DYN-
LRB1 and GST-DYNLRB2 fusion proteins or with GST alone, using purified recom-
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binant Rab6A and Rab6A’ protein. These experiments revealed that only GST-
DYNLRB1 is able to pull down Rab6A and Rab6A’ isoforms (Fig. 1D, upper panels). 
Because of the specificity of monoclonal antibody M01 this experiment was only 
performed for Rab6A and Rab6A’. However, on basis of the co-immunoprecipita-
tion data we can assume Rab6B will interact directly also. Sequence comparison 
between DYNLRB1 and DYNLRB2 is given in Fig 1E. From these experiments we 
conclude that the Rab6 isoforms and DYNLRB1 engage into a specific and direct 
interaction.
DYNLRB1 binds to GTP and GDP loaded conformations of Rab6 isoforms
To investigate whether DYNLRB1 indeed preferentially binds to Rab6 in the 
GTP-bound state or also can bind to the GDP-bound form of the proteins we 
performed pull down experiments in which all three Rab6 isoforms fused to GST 
were bound to glutathione sepharose 4B and loaded with either GTPgS, a non 
hydrolysable variant of GTP, or GDP. As a control GST alone was used. The loaded 
GST fusion proteins were then incubated in the presence of cell extracts of BHK-
21 cells containing EGFP-DYNLRB1. As expected, we found that GST-Rab6A loaded 
with GTPgS was able to pull down EGFP-DYNLRB1 efficiently. In contrast, the GDP 
Figure 2: DYNLRB1 binds to GTP- and GDP-loaded conformations of Rab6 isoforms. 
Cell lysates of BHK-21 cells expressing EGFP-DYNLRB1 or, as a control, HA-Bicaudal-D1 were sub-
jected to pull down experiments with equal amounts of GST-Rab6A, GST-Rab6A’, GST-Rab6B or as a 
control GST alone loaded with either GTPgS, a nonhydrolysable variant of GTP, or GDP. Bound GFP-
DYNLRB1 was visualized on Western blot using an anti-GFP antibody (upper panel). These data show 
that DYNLRB1 binds to both GDP and GTP loaded Rab6 isoforms, but the preferred interactions are 
with GTP loaded Rab6A and GDP loaded Rab6A’ and Rab6B.. HA-Bicaudal-D1 was used as a control for 
nucleotide loading and its pull down is shown in the lower panel.
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loaded GST-Rab6A was not detectably bound (Fig. 2 upper panel). Remarkably, 
GTPgS loaded GST-Rab6A’ and GST-Rab6B were very inefficient in  pulling down 
EGFP-DYNLRB1, in contrast to both GDP-loaded GST-Rab6A’ and GST-Rab6B  (Fig. 
2 upper panel). As a control for GT/DP loading and pull down efficiency HA-
tagged Bicaudal-D1 was used (Fig. 2 lower panel), which is an established Rab6 
interactor, known to preferentially bind to GTP-loaded Rab6A, Rab6A’ (Matanis et 
al., 2002) and Rab6B (Wanschers et al., 2007). Indeed, we could reproduce the 
more efficient pull down of HA-Bicaudal-D1 with GTPgS loaded Rab6 compared to 
GDP-loaded Rab6 isoforms.
 Combined, our data show that all Rab6 isoforms interact directly with 
DYNLRB1 as WT protein and as GDP or GTP loaded proteins, but the preferred 
interactions are with GTP loaded Rab6A and GDP loaded Rab6A’ and Rab6B.
Rab6 isoforms colocalize with endogenous DYNLRB at the Golgi apparatus in 
Neuro-2A cells 
To study the subcellular localisation of DYNLBR1 in relation to the different Rab6 
isoforms, Neuro-2A cells were transfected with pEYFP-Rab6A, Rab6A’ or pEGFP-
Rab6B and stained for endogenous DYNLRB with the CT200 antibody (Nikulina 
et al., 2004). In untransfected cells DYNLRB localizes to the Golgi (Fig. 3A). 
Using CLSM extensive colocalisation of all three Rab6 isofoms and DYNLRB was 
observed at the Golgi apparatus (shown for Rab6A’ in Fig. 3A-C). When the cells 
were treated with the microtubule depolymerising agent Nocodazole, causing 
fragmentation of the Golgi apparatus, a large portion of the Rab6 positive Golgi 
fragments also contained DYNLRB (Fig. 3D-F). 
DYNLRB1 co-localizes with EYFP-tagged Rab6 isoforms to the Golgi in 
BHK-21 cells
To study a possible effect on Rab6 isoform localisation by overexpression of 
DYNLRB1 we co-transfected BHK-21 cells with EYFP-tagged Rab6 isoforms and 
VSV- tagged DYNLRB1 followed by staining with the anti-VSV antibody P5D4. Cells 
transfected with VSV-DYNLRB1 alone show a “mixed” cytosolic and filamentous 
staining (Fig. 4A). In contrast, in cells co-transfected with VSV-DYNLRB1 and 
Rab6 isoforms, VSV-DYNLRB1 partitioned uniquely to the Golgi and colocalized 
with all three Rab6 isoforms (see EYFP-Rab6A and EYFP-Rab6A’ in Fig. 4B-D and 
4E-G, respectively). The Golgi localization of VSV-DYNLRB1 in co-transfection 
studies was further confirmed by staining for the Golgi marker Giantin (data not 
shown). The pattern obtained resembled the localization of endogenous pro-
tein (Fig. 3A-C). Furthermore, co-localisation of both proteins occurred also at 
vesicular structures located in close proximity of the Golgi (Fig. 4B-D, indicated 
with arrowheads in the insets). The identity of these vesicles remains unknown. 
Rab6 family proteins interact with the dynein light chain protein DYNLRB1
 101
Recruitment of DYNLRB1 is specific for Rab6 isoforms, as VSV-DYNLRB1 was not 
recruited by co-expression with EYFP-tagged Rab22B, which also localises to the 
Golgi apparatus (Fig 4H-J, indicated with an arrowhead). Overexpression of single 
VSV-DYNLRB1 did not result in an altered or disturbed localization of components 
of the dynein/dynactin complex as judged by the distribution of the dynein inter-
mediate chain IC74 or Bicaudal-D1 (data not shown). 
Figure 4: Expressed EYFP-Rab6 isoforms co-localize with VSV-DYNLRB1 in the Golgi. >
BHK-21 cells were transfected with a construct encoding VSV-DYNLRB1 (A) or in addition with EYFP-
Rab6A (B-D), EYFP-Rab6A’ (E-G) or EYFP-Rab22B (H-J) and stained with anti-VSV antibody P5D4 to 
visualize VSV-DYNLRB and analysed. Merged images are show in panels D, G and J. In contrast to 
single transfected cells, in double transfected cells VSV-DYNLRB1.  DYNLRB1 was found on Rab6 
positive structures (Golgi) and vesicular structures (indicated with arrowheads in the insets in panel 
B-D). VSV-DYNLRB1 does not co-localize with Rab22 positive structures,  indicated with arrowheads 
in panel H-J.
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Figure 3: Endogenous DYNLRB1 colocalizes with Rab6 isoforms at the Golgi. 
Neuro2A cells incubated with anti-DYNLRB antibody CT200 (A) and expressing a construct encoding 
EYFP-Rab6A’ (B) were analysed with CLSM. The merged image is shown in panel C. The cells marked 
with arrowheads show localization of endogenous DYNLRB1 in untransfected cells.
After a 3h treatment with the microtubule depolymerising agent Nocodazole, which results in the 
fragmentation of the Golgi, DYNLRB (D) was still found co-localizing with EYFP-Rab6A’ (E). Merged 
image is shown in panel F.
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 We also tried to assess the role of DYNLRB1 in Rab6 regulated processes 
and localization in vivo, by a knock down approach. Expression of a vector based 
siRNA construct did result in the decrease of DYNLRB1 transcripts as determined 
with RT-PCR, however no apparent effects on Rab6 and Bicaudal-D1 localization 
or Golgi morphology were observed (data not shown).
 
Ultrastructural localization of VSV-DYNLRB1
The VSV-DYNLRB1 localization was further verified at the ultrastructural level by 
Figure 5: Localisation and recruitment of VSV-DYNLRB1 at the Golgi at the ultrastructual level 
BHK-21 cells were transfected with VSV-DYNLRB1 (A) or in addition with EYFP-Rab6A (B). Next these 
cells were subjected to immunoelectron microscopy. VSV-DYNLRB1 localizes mainly at Golgi mem-
branes (panel A) but in addition can be found on other membranes and cytosol. In cells co-expressing 
EYFP-Rab6B (10 nm gold, arrows) and VSV-DYNLRB1 (5 nm gold, arrowheads) colocalization can be 
observed in the Golgi. Bar indicates 0.2 mM.
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performing immunoelectron microscopy using anti-VSV antibody on VSV-DYNLRB1 
expressing BHK-21 cells. As shown in Fig. 5A, gold labelling was indeed found at 
intracellular membranes, such as Golgi (Fig.5A). Importantly, we observed that in 
the presence of EYFP-Rab6A colocalization occurs with VSV-DYNLRB1 at the Golgi 
(Fig. 5B). Furthermore, the number of VSV-DYNLRB1-bound gold particles pres-
ent at the Golgi membranes was clearly higher as compared to single transfected 
cells. These findings show that single expressed VSV-DYNLRB1 can also associate 
with other membranes, further confirming the light microscopy data (Fig. 3).
Localisation of DYNLRB1 in cells expressing Rab6-GTP or Rab6-GDP 
To study the localisation of DYNLRB1 in the presence of either active or inactive 
Figure 6: Localization of VSV-
DYNLRB1 in cells expressing 
constitutive active or inactive 
Rab6 isoforms. 
BHK-21 cells were co-transfect-
ed with VSV-DYNLRB1 (panel 
A, C, E) and constitutive active 
EYFP-Rab6A Q72L (B), EYFP-
Rab6A’ Q72L (D) or constitutive 
inactive EYFP-Rab6A T27N (F) 
encoding constructs. DYNLRB1 
was visualized with anti-VSV 
antibody P5D4 and cells were 
analyzed with CLSM.
Using constitutive active 
EYFP-Rab6A or EYFP-Rab6A’ 
mutants (Rab6 Q72L) recruit-
ment of VSV-DYNLRB1 to Rab6 
structures also occurs (A-D), 
whereas in the presence of 
constitutive inactive EYFP-Rab6 
isoforms (here Rab6 T27N) 
VSV-DYNLRB1 remains like the 
inactive Rab6 predominantly 
cytosolic (E). A number of cells 
expressing EYFP-Rab6 T27N 
show it to be localized to the 
Golgi (F). 
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Rab6 isoforms, BHK-21 cells were transfected with VSV-DYNLRB1 and EYFP-Rab6 
Q72L (constitutive active conformation) or EYFP-Rab6 T27N (inactive confor-
mation). Both Rab6A and Rab6A’ Q72L are able to recruit DYNLRB1 (Fig. 6A-B 
and Fig. 6C-D respectively). In the presence of inactive Rab6 DYNLRB1 remains 
cytosolic (Fig. 6E). Note that in cells expressing Rab6 T27N a portion of the Rab6 
protein is localized to the Golgi (Fig. 6F)  
DYNLRB does not modulate the intrinsic GTPase activity of Rab6
Members of the Roadblock/LC7 family are part of a large group of structurally re-
lated proteins implicated in the regulation of small GTPases (Koonin and Aravind 
2000). As we identified DYNLRB1 as a binding partner for Rab6 isoforms we were 
curious whether DYNLRB1 was able to modulate the intrinsic GTPase activity of 
Rab6 isoforms. To test this hypothetical function we performed a GTPase activity 
assay in which the hydrolysis of radioactively labelled GTP bound to Rab6 iso-
forms was determined in the presence or absence of recombinant DYNLRB1. The 
amount of released inorganic phosphate (Pi), assessed by liquid scintillation, was 
considered a reliable measure for the intrinsic GTPase activity of Rab6 isoforms. 
In contrast to our expectation, we found that the rate of GTP hydrolysis did not 
significantly differ in the presence or absence of DYNLRB1, as is shown for Rab6A 
in Fig 7. As a control for our experimental set-up we also loaded Rab6A Q72L with 
Figure 7: DYNLRB1 does not modulate 
the intrinsic GTPase activity of Rab6A. 
Determination of Pi release from [g-32P]-
GTP loaded (in this case) Myc-Rab6A 
coupled to anti-Myc antibody loaded pro-
tein-A sepharose beads in the presence 
or absence of recombinant DYNLRB1. 
No significant alteration of the intrinsic 
GTPase activity of Rab6 isoforms was 
observed in the presence of DYNLRB1. 
As a control for the experimental set-up 
also the Pi release of GTPase deficient 
Rab6A Q72L loaded with [g-32P]-GTP 
was determined. As expected the GTP 
hydrolysis is significantly less compared 
to WT Rab6.
[g-32P]-GTP and determined the amount of released Pi from this mutant. 
As expected the rate of hydrolysis of [g-32P]-GTP appeared impaired, compared to 
the intrinsic activity of WT Rab6. Thus, the assay used has proper sensitivity, but 
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a modulating role of DYNLRB1 was not established (Fig. 7).
Discussion
Interaction of DYNLRB1 with Rab6
In a search for novel binding partners for the different Rab6 isoforms we identi-
fied DYNLRB1 as a novel Rab6 interacting protein. DYNLRB1 forms an integral part 
of the dynein motor protein complex, implicating a role for the Rab6-DYNLRB1 
interaction in minus end directed microtubular transport. The association report-
ed here is the first example of a direct interaction between Rab6 and the dynein 
complex.  
 Our co-immunoprecipitation and pull down studies verified that the 
interaction is direct. Interesting is the observation that only DYNLRB1 - and 
not DYNLRB2 (which shares 85% sequence identity with DYNLRB1) - was able 
to pull down purified Rab6. Although the recombinant DYNLRB2 protein used 
in this experiment is derived from rat, the differences between human and rat 
DYNLRB2 are minimal (98% sequence similarity). We therefore think that the 
effect observed reflects the difference in function between these two DYNLRB 
isoforms, and should not be attributed to species-specific properties of DYNLRB1 
and DYNLRB2. Although both isoforms participate in the formation of the mature 
cytoplasmic dynein complex (Pfister et al., 2006), DYNLRB2 is proposed to be 
the main isoform in axonemal dynein as it is highly expressed in testis where it is 
found in the flagella of developing sperm cells (Nikulina et al., 2004). DYNLRB1 
and DYNLRB2 can form homo- and heterodimers (Nikulina et al., 2004). We do 
presently not known whether this dimerization plays a role in Rab6 binding, or 
whether Rab6 isoforms exclusively bind to the DYNLRB1 homodimer. In fact one 
may argue that the now identified interaction between the Rab6 isoforms and 
DYNLRB1 is not reflecting all possibilities of association into the dynein complex, 
as it is known that Rab6A also interacts with p150glued (Short et al., 2002) and 
Bicaudal-D1 (Hoogenraad et al., 2001; Matanis et al., 2002), other components 
of the dynactin complex. Interactions with these partners thus could strengthen 
the integration in the protein assembly. This newly disclosed property of Rab6 is 
therefore the second example of direct interaction of a Rab protein with the dy-
nein complex, next to the earlier described interaction of Rab4 with the dynein 
intermediate light chain 1 (Bielli et al., 2001).   
Nucleotide dependent differential binding of DYNLRB1 to Rab6A 
Although we show that Rab6 isoforms can interact with DYNLRB1 in all conforma-
tions, we observed to our surprise that preferred binding of DYNLRB1 to Rab6A 
and Rab6A’ or Rab6B depended on the nucleotide-bound state, in an isoform-spe-
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cific manner. It is not uncommon to find differences in the efficiency of different 
Rab6 isoforms to pull down their binding partners. Monier and co-workers for ex-
ample, showed different efficiencies of the three Rab6 isoforms in pulling down 
Rab6IP2 (Monier et al., 2002). However, Rab6IP2 always preferentially bound to 
Rab6 isoforms in their GTP-bound conformation. Examples of differences in bind-
ing of effector proteins depending on the nucleotide-bound state are also known. 
In one case g1-adaptin, a protein serving in the recycling of membranes from the 
early endosome, was shown to interact directly with Rab4 and Rab5, but specific 
interaction occurred with Rab5 in the GTP-bound state and with Rab4 in the GDP-
bound conformation (Deneka and van der Sluijs, personal communication).  Yet, 
to our knowledge control of discriminative binding of an effector protein by GTP 
or GDP-loading of closely related isoforms as found here for Rab6A, Rab6A’ and 
Rab6B has never been observed before. This finding underscores the earlier ob-
served differential roles of Rab6A and Rab6A’ in membrane transport and mitosis 
(Echard et al., 1998; Del Nery et al., 2006; Miserey-Lenkei et al., 2006). It also 
illustrates the many levels and combinatorial possibilities of regulation of small 
GTPase functions. Exactly, how our observations relate to functioning of Rab6B 
remains unknown.   
Recruitment of VSV-DYNLRB1 to EYFP-Rab6 isoforms
Strikingly, we observed that overexpressed VSV-DYNLRB1 adapts a cytosolic re-
ticular-like localization in singly transfected cells. Only in the presence of pEYFP-
Rab6 isoforms VSV-DYNLRB1 acquired its Golgi localization, i.e. the location 
anticipated on basis of the distribution of the endogenous protein in N2A cells. 
When the localization of single transfected VSV-DYNLRB1 was studied with im-
munoelectron microscopy it became clear that the main part of the VSV-DYNLRB1 
pool is actually localized at Golgi membranes, a feature not detected with light 
microscopy, because this specific location was obscured by presence of a “cloud” 
of cytosolic protein. We can thus most easily explain our findings by assuming 
that endogenous Rab6 does not provide enough binding opportunities to accom-
modate all VSV-DYNLRB1 molecules, resulting in a pool of ‘non-Golgi’ DYNLRB1. 
Only in the presence of extra transfected EYFP-Rab6 sufficiant novel binding sites 
become available to recruit all molecules in this pool.  
No effect of DYNLRB1 on the GTPase activity of Rab6 isoforms
DYNLRB1 is structurally related to MglB proteins, which are implicated in modu-
lating the GTPase activity of small GTPases (Koonin and Aravind 2000). Based on 
this relation, and also because DYNLRB1 does not show sequence similarity with 
GTPase activating proteins (GAPs), we hypothesized that DYNLRB1-Rab6 interac-
tion may not only be structurally relevant, but that this association might have a 
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negative, GTPase antagonizing, role. In our experimental approaches – where we 
used in vitro assays with purified protein - we were, however, not able to reveal 
this putative activity. Perhaps we must attribute this failure to lack of additional 
protein components, which need to associate in a multiprotein assembly but sim-
ply were not present in our test preparation, and/or to an improper configuration 
of the recombinant DYNLRB1. However, a recent study has demonstrated that 
the intrinsic GTPase activity of Rab6 is very low (Bergbrede at al., 2005). There-
fore, one may question the need for a mechanism inhibiting the GTPase activity 
of Rab6. Based on our combined findings presented here we would like to stress 
that DYNLRB1 binding to Rab6 could also very well serve merely a functional role 
in microtubule based transport of vesicles, which is interesting in its own right 
as it may serve to stabilize the binding of the Rab6 effectors Bicaudal-D (Matanis 
et al., 2002) and p150glued (Short et al., 2001) and bring all proteins together into 
the dynein complex.  
 In conclusion, our data show for the first time a direct interaction of 
Rab6 isoforms with the dynein complex via the dynein light chain DYNLRB1. This 
interaction most likely functions during membrane transport. A role for this inter-
action can also be anticipated during mitosis as both Rab6A, Rab6A’ and dynein 
function in this process (Miserey-Lenkei et al., 2006). More experiments are nec-
essary to further elucidate the exact biological significance of the Rab6 DYNLRB1 
interaction.                                                                                                        
            
Acknowledgements
We would like to thank Dr. Ron Dirks from the department of Animal Physiology 
Radboud University Nijmegen for providing us with the pEGFP-DAUG construct, 
Kevin Lo from the department of Cell Biology from the university of Virginia 
for providing us with the pGEX4T-1-DYNLRB2 construct and Wiljan Hendriks for 
critical reading of the manuscript. Work of Stephen King is supported by a grant 
GM51293 from the National Institutes of Health (to SMK). 
References
Bergbrede, T., O. Pylypenko, A. Rak, and K. Alexandrov. 2005. Structure of the extremely slow GTPase 
Rab6A in the GTP bound form at 1.8A resolution. J Struct Biol. 152:235-238.
Bielli, A., P.O. Thornqvist, A.G. Hendrick, R. Finn, K. Fitzgerald, and M.W. McCaffrey. 2001. The small 
GTPase Rab4A interacts with the central region of cytoplasmic dynein light intermediate chain-1. 
Biochem Biophys Res Commun. 281:1141-1153.
Bowman, A.B., R.S. Patel-King, S.E. Benashski, J.M. McCaffery, L.S. Goldstein, and S.M. King. 1999. 
Drosophila roadblock and Chlamydomonas LC7: a conserved family of dynein-associated proteins 
Rab6 family proteins interact with the dynein light chain protein DYNLRB1
 109
involved in axonal transport, flagellar motility, and mitosis. J Cell Biol. 146:165-180.
Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of 
protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
Brummelkamp, T.R., R. Bernards, and R. Agami. 2002. A system for stable expression of short interfer-
ing RNAs in mammalian cells. Science. 296:550-553.
Cuppen, E., M. Wijers, J. Schepens, J. Fransen, B. Wieringa, and W. Hendriks. 1999. A FERM domain 
governs apical confinement of PTP-BL in epithelial cells. J Cell Sci. 112 ( Pt 19):3299-3308.
Del Nery, E., S. Miserey-Lenkei, T. Falguieres, C. Nizak, L. Johannes, F. Perez, and B. Goud. 2006. 
Rab6A and Rab6A’ GTPases play non-overlapping roles in membrane trafficking. Traffic. 7:394-407.
Deneka, M., S. Honig, and P. van der Sluijs. 2002. A Novel Interaction Between Rab4 and g1-adaptin. 
In Cell Biology. University of Utrecht, Utrecht. 136.
Echard, A., F. Jollivet, O. Martinez, J.J. Lacapere, A. Rousselet, I. Janoueix-Lerosey, and B. Goud. 
1998. Interaction of a Golgi-associated kinesin-like protein with Rab6. Science. 279:580-585.
Echard, A., F.J. Opdam, H.J. de Leeuw, F. Jollivet, P. Savelkoul, W. Hendriks, J. Voorberg, B. Goud, 
and J.A. Fransen. 2000. Alternative splicing of the human Rab6A gene generates two close but func-
tionally different isoforms. Mol Biol Cell. 11:3819-3833.
Fransen, J.A., L.A. Ginsel, H.P. Hauri, E. Sterchi, and J. Blok. 1985. Immuno-electronmicroscopical 
localization of a microvillus membrane disaccharidase in the human small-intestinal epithelium with 
monoclonal antibodies. Eur J Cell Biol. 38:6-15.
Girod, A., B. Storrie, J.C. Simpson, L. Johannes, B. Goud, L.M. Roberts, J.M. Lord, T. Nilsson, and R. 
Pepperkok. 1999. Evidence for a COP-I-independent transport route from the Golgi complex to the 
endoplasmic reticulum. Nat Cell Biol. 1:423-430.
Goud, B., A. Zahraoui, A. Tavitian, and J. Saraste. 1990. Small GTP-binding protein associated with 
Golgi cisternae. Nature. 345:553-556.
Gyuris, J., E. Golemis, H. Chertkov, and R. Brent. 1993. Cdi1, a human G1 and S phase protein phos-
phatase that associates with Cdk2. Cell. 75:791-803.
Hammer, J.A., 3rd, and X.S. Wu. 2002. Rabs grab motors: defining the connections between Rab 
GTPases and motor proteins. Curr. Opin. Cell Biol. 14:69-75.
Hoogenraad, C.C., A. Akhmanova, S.A. Howell, B.R. Dortland, C.I. De Zeeuw, R. Willemsen, P. Visser, 
F. Grosveld, and N. Galjart. 2001. Mammalian Golgi-associated Bicaudal-D2 functions in the dynein-
dynactin pathway by interacting with these complexes. Embo J. 20:4041-4054.
Hook, P., and R.B. Vallee. 2006. The dynein family at a glance. J Cell Sci. 119:4369-71.
Jordens, I., M. Marsman, C. Kuijl, and J. Neefjes. 2005. Rab proteins, connecting transport and 
vesicle fusion. Traffic. 6:1070-1077.
Kari, B., N. Lussenhop, R. Goertz, M. Wabuke-Bunoti, R. Radeke, and R. Gehrz. 1986. Characteriza-
tion of monoclonal antibodies reactive to several biochemically distinct human cytomegalovirus glyco-
protein complexes. J. Virol. 60:345-352.
Karki, S., and E.L. Holzbaur. 1999. Cytoplasmic dynein and dynactin in cell division and intracellular 
transport. Curr Opin Cell Biol. 11:45-53.
King, S.J., and T.A. Schroer. 2000. Dynactin increases the processivity of the cytoplasmic dynein mo-
tor. Nat Cell Biol. 2:20-24.
Rab proteins specify motorized vesicle transport
110
King, S.M. 2000. The dynein microtubule motor. Biochim Biophys Acta. 1496:60-75.
Koonin, E.V., and L. Aravind. 2000. Dynein light chains of the Roadblock/LC7 group belong to an an-
cient protein superfamily implicated in NTPase regulation. Curr Biol. 10:R774-R776.
Kreis, T.E. 1986. Microinjected antibodies against the cytoplasmic domain of vesicular stomatitis virus 
glycoprotein block its transport to the cell surface. Embo J. 5:931-941.
Lane, J.D., M.A. Vergnolle, P.G. Woodman, and V.J. Allan. 2001. Apoptotic cleavage of cytoplasmic 
dynein intermediate chain and p150(Glued) stops dynein-dependent membrane motility. J Cell Biol. 
153:1415-1426.
Mallard, F., B.L. Tang, T. Galli, D. Tenza, A. Saint-Pol, X. Yue, C. Antony, W. Hong, B. Goud, and L. 
Johannes. 2002. Early/recycling endosomes-to-TGN transport involves two SNARE complexes and a 
Rab6 isoform. J Cell Biol. 156:653-664.
Matanis, T., A. Akhmanova, P. Wulf, E. Del Nery, T. Weide, T. Stepanova, N. Galjart, F. Grosveld, B. 
Goud, C.I. De Zeeuw, A. Barnekow, and C.C. Hoogenraad. 2002. Bicaudal-D regulates COPI-indepen-
dent Golgi-ER transport by recruiting the dynein-dynactin motor complex. Nat Cell Biol. 4:986-992.
Miserey-Lenkei, S., A. Couedel-Courteille, E. Del Nery, S. Bardin, M. Piel, V. Racine, J.B. Sibarita, F. 
Perez, M. Bornens, and B. Goud. 2006. A role for the Rab6A’ GTPase in the inactivation of the Mad2-
spindle checkpoint. Embo J:1-12.
Monier, S., F. Jollivet, I. Janoueix-Lerosey, L. Johannes, and B. Goud. 2002. Characterization of novel 
Rab6-interacting proteins involved in endosome-to-TGN transport. Traffic. 3:289-297.
Nagelkerken, B., E. Van Anken, M. Van Raak, L. Gerez, K. Mohrmann, N. Van Uden, J. Holthuizen, 
L. Pelkmans, and P. Van Der Sluijs. 2000. Rabaptin4, a novel effector of the small GTPase rab4a, is 
recruited to perinuclear recycling vesicles. Biochem J. 346 Pt 3:593-601.
Nikulina, K., R.S. Patel-King, S. Takebe, K.K. Pfister, and S.M. King. 2004. The Roadblock light chains 
are ubiquitous components of cytoplasmic dynein that form homo- and heterodimers. Cell Motil Cyto-
skeleton. 57:233-245.
Opdam, F.J., A. Echard, H.J. Croes, J.A. van den Hurk, R.A. van de Vorstenbosch, L.A. Ginsel, B. 
Goud, and J.A. Fransen. 2000. The small GTPase Rab6B, a novel Rab6 subfamily member, is cell-type 
specifically expressed and localised to the Golgi apparatus. J Cell Sci. 113:2725-2735.
Opdam, F.J., G. Kamps, H. Croes, H. van Bokhoven, L.A. Ginsel, and J.A. Fransen. 2000. Expression 
of Rab small GTPases in epithelial Caco-2 cells: Rab21 is an apically located GTP-binding protein in 
polarised intestinal epithelial cells. Eur J Cell Biol. 79:308-316.
Pfister, K.K., E.M. Fisher, I.R. Gibbons, T.S. Hays, E.L. Holzbaur, J.R. McIntosh, M.E. Porter, T.A. 
Schroer, K.T. Vaughan, G.B. Witman, S.M. King, and R.B. Vallee. 2005. Cytoplasmic dynein nomencla-
ture. J Cell Biol. 171:411-413.
Pfister, K.K., P.R. Shah, H. Hummerich, A. Russ, J. Cotton, A.A. Annuar, S.M. King, and E.M. Fisher. 
2006. Genetic analysis of the cytoplasmic dynein subunit families. PLoS Genet. 2:e1.
Schweizer, A., J.A. Fransen, T. Bachi, L. Ginsel, and H.P. Hauri. 1988. Identification, by a monoclonal 
antibody, of a 53-kD protein associated with a tubulo-vesicular compartment at the cis-side of the 
Golgi apparatus. J Cell Biol. 107:1643-1653.
Short, B., C. Preisinger, J. Schaletzky, R. Kopajtich, and F.A. Barr. 2002. The Rab6 GTPase regulates 
recruitment of the dynactin complex to Golgi membranes. Curr Biol. 12:1792-1795.
Rab6 family proteins interact with the dynein light chain protein DYNLRB1
 111
Stenmark, H., and V.M. Olkkonen. 2001. The Rab GTPase family. Genome Biol. 2:REVIEWS3007.
Susalka, S.J., K. Nikulina, M.W. Salata, P.S. Vaughan, S.M. King, K.T. Vaughan, and K.K. Pfister. 2002. 
The roadblock light chain binds a novel region of the cytoplasmic Dynein intermediate chain. J Biol 
Chem. 277:32939-32946.
Swarts, H.G., C.H. Klaassen, F.M. Schuurmans Stekhoven, and J.J. De Pont. 1994. Tertiary amines as 
antagonists of both the luminal and cytosolic K(+)-site of gastric H,K-ATPase. Biochim Biophys Acta. 
1189:143-151.
Tai, A.W., J.Z. Chuang, C. Bode, U. Wolfrum, and C.H. Sung. 1999. Rhodopsin’s carboxy-terminal cyto-
plasmic tail acts as a membrane receptor for cytoplasmic dynein by binding to the dynein light chain 
Tctex-1. Cell. 97:877-887.
Tai, A.W., J.Z. Chuang, and C.H. Sung. 1998. Localization of Tctex-1, a cytoplasmic dynein light chain, 
to the Golgi apparatus and evidence for dynein complex heterogeneity. J Biol Chem. 273:19639-
19649.
White, J., L. Johannes, F. Mallard, A. Girod, S. Grill, S. Reinsch, P. Keller, B. Tzschaschel, A. Echard, 
B. Goud, and E.H. Stelzer. 1999. Rab6 coordinates a novel Golgi to ER retrograde transport pathway in 
live cells. J. Cell Biol. 147:743-760.
Wilson, I.A., H.L. Niman, R.A. Houghten, A.R. Cherenson, M.L. Connolly, and R.A. Lerner. 1984. The 
structure of an antigenic determinant in a protein. Cell. 37:767-778.
Zerial, M., and H. McBride. 2001. Rab proteins as membrane organizers. Nat Rev Mol Cell Biol. 2:107-
117.
  
Rab proteins specify motorized vesicle transport
112
Chapter 6
General discussion
 113

Previous work in our lab has focused on the identification of novel Rab proteins 
involved in trafficking in polarized intestinal epithelial cells (Ouwendijk et al., 
1996; Ouwendijk et al., 1998). These studies resulted in the identification of 
several new Rab proteins (Opdam et al., 2000a) including Rab6A’ (Echard et 
al., 2000), Rab6B (Opdam et al., 2000b) and Rab21 (Opdam et al., 2000a). The 
research described in this thesis is a follow-up of this work and was focused on a 
detailed characterization of the Rab6 isoforms with special emphasis on Rab6B. 
Analysis of this last small GTPase revealed a role in vesicular transport in neuro-
nal cells (chapter 2) and a possible role in endocytosis (chapter 3). Furthermore, 
we identified two novel Rab6 interacting proteins (chapter 4 and chapter 5). 
The findings described in these last two chapters underscore the role that Rab6 
isoforms play in dynein-mediated microtubule-based transport. 
Ubiquitous and cell-type-specific expression of Rab isoforms 
Today more than 60 members of the Rab family of small GTPases, including 
isoforms, are recognized in mammalian cells (Stenmark and Olkonen 2000). The 
number of Rab proteins (including isoforms) encoded in the mammalian genome 
is substantially higher that that of other small GTPases involved in membrane 
trafficking, such as members of the Arf and Sar families. Most likely this reflects 
the highly specialized function of Rab proteins. Whereas Arf and Sar play a more 
general role, Rab proteins are involved in regulating distinct membrane traf-
ficking events, which in mammalian cells are manyfold and often serve cell-spe-
cific functions. As an illustration of this point, we can for example mention the 
specialized role of the different Rab3 isoforms. Rab3A is mostly found in neurons 
where it regulates the docking and fusion of synaptic vesicles (Fisher von Mol-
lard et al., 1991). One of the other isoforms, Rab3D, is solely found in adipocytes 
regulating GLUT4 vesicle trafficking (Baldini et al., 1992). Conversely, presence 
of two or more closely related Rab isoforms in one cell most likely aids in the 
fine-tuning of membrane trafficking. Often, these subtle differences are accom-
plished because of slight differences in effector protein binding or GTPase activ-
ity of co-existing Rab isoforms.
 These principles also apply to members of the Rab6 subfamily, consisting 
of two ubiquitously expressed isoforms and a third, cell-type-specific isoform. 
The ubiquitous isoforms are Rab6A (Goud et al., 1990) and Rab6A’ (Echard et al., 
2000), whereas Rab6B (Opdam et al., 2000) is cell type specifically expressed, 
probably in addition to the two other Rab6 isoforms. A detailed characteriza-
tion of Rab6B revealed expression in several neuronal cell types present in the 
cerebellum of the brain. Although Rab6B was initially identified in the intestinal-
derived CaCo-2 cell line, we ourselves were not able to detect Rab6B on West-
ern blot using lysates of normal mouse intestine tissue. Most likely this can be 
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attributed to the fact that the expression level of endogenous Rab6B is really low 
(Opdam et al., 2000).  As neurons and polarized epithelial cells share their polar-
ized nature this might suggest a role for Rab6B in polarized transport. Whether 
this role is universal for all polarized cells is still an open question that is subject 
to further study. 
Localization and dynamics of Rab6B
Rab6B is highly expressed in the brain-derived SK-N-SH neuroblastoma cell line 
(Opdam et al., 2000). We therefore used this cell line to study in more detail 
the intracellular localization and dynamics of this small GTPase. When SK-N-
SH cells stably expressing EGFP-Rab6B were studied with live-cell imaging, we 
found  - next to the Golgi localization - Rab6B to be present as dots in neurites of 
these cells. In these long and thin protrusions the EGFP-Rab6B decorated struc-
tures moved bi-directionally, e.g. showed retrograde and anterograde move-
ment. The finding that the transport of these vesicles was relatively fast, large 
distances were covered and similar tracks were used repeatedly, points towards 
the involvement of microtubule-based transport. Based on Rab6B’s presence in 
SK-N-SH neurites the question arises whether in fully developed neurons Rab6B 
is localized on vesicles present in axons, dendrites or both. SK-N-SH cells are not 
polarized cells yet and will not form axons. This makes it impossible to determine 
whether Rab6B is enriched in either one or both structures. Past studies have 
shown a Rab6 isoform (Rab6p) to be present on synaptophysin containing vesicles 
in developing neurons (Tixier-Vidal et al., 1993). Whether Rab6p is identical to 
Rab6B needs yet to be established. Furthermore, recent studies have shown that 
Rab6B (and not Rab6A or Rab6A’) is present at the presynaptic zone and at syn-
aptic vesicles (Morciano et al., 2005; Takamori et al., 2006). This last observation 
could indeed be an indication that Rab6B is involved in axonal-based transport of 
these post-Golgi structures. The retrograde-transported vesicles may also resem-
ble endosomes transporting their content (neurotrophic signals for example) from 
the distal part of the neurite towards the cell body (Howe and Mobley 2005), a 
process which is very important for cell survival and plasticity. The second pos-
sibility, e.g. presence of Rab6B at endocytosed structures, becomes more likely if 
we take into account our findings described in chapter 3 where we showed that 
Rab6B colocalizes with internalised GPI-anchored proteins.
 Next to the localisation of Rab6B at endosomes containing GPI-anchored 
proteins we found this small GTPase to be also present at vesicles containing 
tsVSVG-EYFP, a well-established marker tool in studying trafficking from ER via 
the Golgi to the plasma membrane. Colocalization was found approximately 30 
minutes after release from the ER, so the vesicles most likely represent struc-
tures that are on their way to the plasma membrane. As we did not observe 
Rab proteins specify motorized vesicle transport
116
colocalization with TGN markers, these vesicles can be considered a post-TGN 
compartment with a role in transport towards the plasma membrane or synapses. 
Approximately 60 minutes after ER release a large portion of the tsVSVG-EYFP 
marker appeared on the plasma membrane, however now without Rab6B. Similar 
observations were made by Grigoriev and co-workers (Grigoriev et al., 2007) who 
proposed a role for Rab6 in organizing exocytosis. Furthermore, experiments in 
Drosophila have shown that Rab6 and its effector Bicaudal-D are crucial in the 
correct delivery of secretory cargo (Januschke et al., 2007). Experiments in neu-
rons revealed further the presence of Rab6B at Semaphorin3A (Sema3A) contain-
ing vesicles (Toonen et al., personnel communication) further underlining a role 
for Rab6 in the secretion of molecules.
 The observed absence of Rab6B at the plasmemembrane can be attribut-
ed to the dispersal of Rab6 over the plasma membrane after the Rab6 decorated 
secretory vesicles have fused with it (Grigoriev et al., 2007). However, another 
process that could take place is the rapid removal of Rab6B from tsVSVG-EYFP 
containing vesicles. This removal can be attributed to Rab conversion, a process 
in which one Rab family member is rapidly replaced by another family member. 
This process is also recognized as organelle maturation (Deretic 2005). A particu-
larly well-studied example of Rab exchange occurs during endosome biogenesis 
where during transition from early to late endosome Rab5 is replaced with Rab7. 
This process requires the class c VPS/HOPS complex, an established Rab7 GEF and 
Rab5 interactor (Rink et al., 2005). As a basis for further progress in our stud-
ies it would therefore be interesting to identify such dual effector proteins for 
Rab6, and in particular for Rab6B. Just recently, already two such proteins have 
been identified: Rab6IP1 and Giantin. Rab6IP1 is also able to interact with Rab11 
(Miserey-Lenkei et al., 2007), whereas Giantin interacts also with Rab1 (Rosing et 
al., 2007). In order to identify other dual specific Rab effector proteins one may 
therefore have to focus on effectors capable of interacting with multiple Rabs, 
preferably those which are present at the TGN and late endosomes, such as Rab7 
and Rab8. For Rab6B one possible strategy for the identification of dual specific 
interactors could be to focus on neuron-specific Rabs being enriched at synaptic 
vesicles, such as Rab3. This remains work for future studies. 
Rab6 in dynein-mediated transport
Aiding in the characterization of Rab proteins is the elucidation of their intracel-
lular environment by identifying novel Rab6 effector proteins.  To accomplish this 
task, we made use of a yeast-two hybrid screen using the GTP-bound Rab6 iso-
forms as bait. This resulted in the identification of several novel Rab6 interacting 
proteins. Interestingly, two of these novel Rab6 binding proteins, Bicaudal-D1 and 
DYNLRB1 (described in chapter 4 and 5 respectively), are known to be associated 
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with the dynein complex. 
 The first-ever link of Rab proteins with the microtubule cytoskeleton was 
described for Rab6A, with the identification of Rabkinesin-6, a plus end directed 
microtubule motor (Echard et al., 1998). Soon other Rab proteins were also 
shown to be involved in microtubule-based transport such as Rab4 and Rab5 (for 
review: Jordens et al., 2005). With the identification of Bicaudal-D1 (Matanis et 
al., 2002) and p150glued (Short et al., 2002) as Rab6A binding proteins an impor-
tant role in dynein-mediated transport became obvious. In the past it was shown 
that next to Rab6A also Rab6B interacts with Rabkinesin-6 (Opdam et al., 2000). 
We show here that this small GTPase also can interact with the dynein motor 
protein, either indirectly via Bicaudal-D1 (chapter 4) or directly via DYNLRB1 
(chapter 5). With the identification of Bicaudal-D1 and -D2 (Hoogenraad et al., 
2001; Matanis et al., 2002; chapter 4), p150glued (Short et al., 2002) and DYNLRB1 
(chapter 5) as Rab6B - but also Rab6A and Rab6A’ - effector proteins the role of  
Rab6 in dynein-mediated transport was confirmed. The question remains, how-
ever, which type of trafficking is regulated by the Rab6-dynein complex. Based on 
the microtubule orientation in non-polarized cells we propose that Rab6/dynein-
mediated transport probably mediates the retrograde transport from late endo-
somes to the TGN. The complex may also serve in and subsequent TGN to Golgi 
and retrograde intra Golgi transport, the pathway regulated by Rab6A’ (Del-Nery 
et al., 2006). Rab6 regulated Golgi to ER needs the action of a kinesin. Whether 
this could be Rabkinesin-6 remains open for speculation as discussed below. The 
microtubule organization in polarized epithelial cells (for review see Müsch 2004) 
and neurons differs from that in non-polarized cells. In the axon of neuronal 
cells the plus end of microtubules are oriented towards the synapse. In dendrites 
however the microtubules are organized in an anti-parallel fashion making it pos-
sible that vesicle movement in neurites away from the cell body are mediated by 
dynein, whereas movement towards the cell body is due to the action of kinesins 
(Fig. 3B).
 The interaction of Rab6B with both plus and minus end directed motors 
provides a good explanation for the observed anterograde and retrograde move-
ment of Rab6B containing structures in SK-N-SH cells. Both plus end and minus 
end directed motors can reside on one vesicle simultaneously (Ma et al., 2002). 
For the control of anterograde movement of Rab6B vesicles the first-identi-
fied motor, rabkinesin-6, remains a good candidate, but its actual involvement 
remains uncertain for several reasons. In interphase cells the concentration of 
rabkinesin-6 is below detection level, and the protein is only expressed at very 
high levels in mitotic cells, where it can be found localized to the midbody. 
These observations hint more towards a role for this kinesin in cell division (Fon-
tijn et al., 2001) in conjunction with, in this case Rab6A. It is therefore possible 
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that the anteroretrograde movement observed for transport of Rab6B vesicles in 
interphase cells is due to the action of other motor proteins. 
Other Rab6 effector proteins
Rab6 does not only interact with the above-described proteins. In the past 
several other Rab6 interactors were identified. Some of these and their possible 
roles will be discussed here. 
 The Mint3 adaptor protein interacts with Rab6 by its phosphotyrosine-
binding domain. This same domain also mediates binding to ameloid precursor 
protein (APP) (Teber et al., 2005). An effect of Rab6 on APP trafficking and pro-
cessing was described several years earlier (McConlogue et al., 1996). This pro-
cessing is dependent on the amount of Rab6 present at the membrane, which in 
turn is regulated by PKC and presenillin (PS) activity (Scheper et al., 2003). This 
latter study reported the importance of presenillin for Rab6 membrane binding, 
but findings presented were solely based on biochemical experiments. Prelimi-
nary experiments done at our lab with cells derived from PS1 and PS2 (Herreman 
et al., 1999) single and double knockout mice however did not show a disturbed 
Golgi localization of Rab6 (Rab6B). 
 Also the GARP (Golgi associated retrograde protein complex), also known 
as Vps fifty three (VFT), interacts with Rab6B. The complex formed functions in 
the retrieval of endosomal contents to the TGN. In mammalian cells GARP con-
sists of three proteins: Vps52, 53 and 54. The tethering protein Vps52 is a known 
Rab6 effector protein. Vps52 is also associated with the SNARE Synataxin10 
(Liewen et al., 2004). This indicates a role for Rab6 in the tethering and maybe 
fusion of this complex to the Golgi. Interestingly, the Rab6 isoform used in this 
study was Rab6B cloned from a testis cDNA library. The ability of Rab6B to bind to 
this complex reveals the ability to play a role in the endosomal pathway thereby 
underlining our studies in chapter 3, where we showed colocalization of Rab6B 
with internalized alexa-ASSP. 
 The presence of Rab6 in the GARP-complex could also imply a regulatory 
role in membrane fusion. Of note, a function for Rab6 in membrane fusion has 
already been proposed a few years ago with the finding that N-ethylmaleimide-
sensitive fusion protein (NSF) is able to interact with Rab6. When in complex with 
Rab6 the ATPase activity of NSF increases two-fold. This effect was also observed 
for Rab3 and Rab4 (Han et al., 2000). ATPase activity is necessary for membrane 
fusion and thus catalyzed by these small GTPases. The protein that catalyzes 
the ATPase activity of NSF is complexed with Rab6. Interestingly, so far the only 
protein able to bind to Rab6 and having a proposed role in modulating NTPase 
activity is DYNLRB1 (Koonin and Aravind 2000). A tempting idea is that DYNLRB1, 
which showed in our setup no GTPase modulating activity towards Rab6, could in 
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fact modulate the ATPase activity of NSF when complexed to Rab6. 
 A number of Rab6 effectors are large coiled-coil proteins. Some of these 
proteins are recruited to the Golgi complex by small GTPases that are referred to 
as Golgins (Barr et al., 2003; Short et al., 2005). To this class of proteins belong 
the earlier mentioned Bicaudal-D1, D-2 and TMF1/ARA60, both effectors of Rab6 
(Matanis et al., 2002; this thesis; Fridmann-Sirkis et al., 2004). Whereas Bicaudal-
D could act in tethering the dynein complex to Rab6 positive structures, there 
seems to be no direct link to TMF1/ARA60 in Rab6 regulated trafficking. This 
complex seems to function in maintaining the Golgi structure as knockdown of 
this protein resulted in an altered Golgi morphology. 
 Although not classified as a Golgin, another large coiled-coil protein, 
Rab6IP2,  was found to interact with Rab6 (Monier et al., 2002). This protein is 
also known as ELKS-Rab6 interacting-CAST family or ERC. For ERC, two splice 
isoforms have been identified, known as ERC1a for the larger protein, and ERC1b 
for the shorter variant. Both ERC1a and ERC1b can interact with Rab6 but differ 
in tissue distribution and binding to the Rim (Rab3 interacting molecule) protein. 
ERC1a is only found in peripheral tissues whereas ERC1b expression is restricted 
to brain. Of the two splice isoforms only ERC1b is able to interact with Rim, 
which contains a PDZ-domain. Rim proteins have a presynaptic function, probably 
regulating neurotransmitter release. A possible role for Rab6IP2 or ERC could be 
to aid in the assembly of active zone containing vesicles in neuronal cells (Wang 
et al., 2002). Rab6IP2 was found to interact very efficiently with Rab6B (Monier 
et al., 2002), again suggesting an important role for the Rab6B ERC1b complex in 
neuronal cells and/or their synapses. 
 From the above it is clear that Rab6 can interact with a multitude of dif-
ferent effector and associating proteins. A summary of Rab6-interacting proteins 
is given in table 1. This raises the question how many partners can be associated 
with Rab6 at the same time. As it has been shown that multiple parts of the Rab 
protein contribute to partner protein binding, it is very likely that Rab6 is able to 
bind more than one partner protein. Whether this binding can occur simultane-
ously, and in what combinations this binding occurs, remains open for specula-
tion. Some partner proteins are cell type specifically expressed, therefore ex-
cluding the formation of some Rab6 effector protein complexes. Also, like Rab6, 
partner proteins are not evenly distributed throughout the cell. That makes it 
possible that at late endosomes high concentrations of one Rab6 effector are 
present whereas at the TGN others are present in large amounts. It is known that 
concentrations of effector proteins play an important role whit respect to binding 
to and forming complexes with Rab (Aivazian et al., 2006). Finally, it is possible 
that some of the partners may bind uniquely to one specific Rab6 isoform. The 
best-known example is the inability of Rab6A’ to interact with Rabkinesin-6. In 
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this light it is a pity that, concerning the identification of novel Rab6 effector 
proteins, the role of isoform differences is often not further specified. Mostly, 
Rab6A is used as bait, and not much attention is paid to the roles of Rab6A’ or 
Rab6B in complexes. Especially in the view of the different roles that Rab6A and 
Rab6A’ play in different aspects of membrane transport and during different 
phases of the cell cycle (Miserei-Lenkey et al., 2006) this is an important omis-
sion in current literature. Finally, a small overview of some Rab6-based protein 
complexes is given in figure 1. 
Table 1: Rab6 interacting proteins. Verified interactions between Rab6 isoforms are indicated with 
‘+’ or ‘-’ in case no interaction was found.  When it is unknown whether a Rab6 isoform is able to 
interact with the indicated protein, a question mark is used.
Rab6 IP 6A 6A’ 6B Putative function Reference
Bicaudal-D1
Bicaudal-D2
DYNLRB1
Mint3
Rab6IP1
Rab6IP2A/B
ERC1A/B
p150glued
GAPCenA
Rabkinesin-6/
MKLP2
TMF/ARA160
hVps52
NSF
OCRL1
Giantin
+
+
+
+
+
+
+
-
+
+
?
+
+
+
+
+
+
?
?
+
+
-
-
?
?
+
?
?
+
?
+
?
?
+
?
-
+
?
+
+
?
?
Tethering?
Tethering?
Light chain of the dynein 
complex
Adaptor protein APP complex
Contains DENN domain
Function in late endosome 
to TGN
Component of the dynein dyn-
actin complex
Centrosome associated previ-
ously thought to be a Rab6  
GTPase activating protein 
Motor protein Involved in 
mitosis?
Golgi morphology
Large coiled-coil protein that 
is part of the VFT complex
N-ethylmaleimide sensitive 
fusion protein
Rab6 targets and activates 
OCLR1at the Golgi  
Large coiled-coil protein wich 
also interacts with Rab1
Matanis et al., 2002, Wanschers 
et al., 2007
Hoogenraad et al., 2002  
Wanschers et al., 2008
Teber et al., 2005
Levivier et al., 2001
Monier et al., 2001
Short et al., 2002
Cuif et al., 1999;
Fuchs et al., 2007
Echard et al., 1998;
Fridmann-Sirkis et al., 2004
Liewen et al., 2005
Han et al., 2000
Hyvola et al., 2006
Rosing et al., 2007
Unexplained observations
A function for Rab6 in mitosis?
In a search for posttranscriptional modification sites in Rab6 sequences, a poten-
tial site for the attachment of a SUMO (small ubiquitin-related modifier) group 
was found. This so-called sumoylation motif  (y-K-x-E, whereby y is a hydro-
phobic residue and x any other residue) is present in the C-terminal part of the 
Rab6A and Rab6A’ sequence and shown in Fig. 2. As this site is located at the 
General discussion
 121
Figure 1: Schematic overview of some Rab6 effector protein complex localisation in interphase 
cells.
A schematic overview of some Rab6 protein complexes and their localization in relation to each 
other, the MTOC (microtubule organizing center), Golgi, ER and microtubules. Golgi associated retro-
grade protein complex (GARP); ES, endosome; NSF, N-ethylmaleimide-sensitive fusion protein 
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extreme C-terminal part of the protein, it is likely that, due to steric hindrance, 
no SUMO-group can be placed on membrane-anchored Rab6. This situation could 
be different for non-anchored Rab6. Underlining this hypothesis is the identifica-
tion of Ubc9, the E2-ligase for SUMO (Desterro et al., 1997) in our yeast-two-hy-
brid experiment. Unfortunately initial co-immunoprecipitation studies with Ubc9 
and Rab6 were not successful and we were unable to detect SUMO-modified Rab6 
in cell lysates. A future, more detailed study may reveal whether Rab6 indeed 
can be modified by sumoylation. Posttranscriptional modification of proteins by 
the addition of a SUMO group is an important way of regulating several important 
cellular events, one of them being mitosis (Montpetit et al., 2006). Interest-
ingly both Rab6A and Rab6A’ are implicated to play a role during this process 
(Miserey-Lenkei et al., 2006). Rab6A’ has been proposed to function in mitosis 
by inactivating the spindle checkpoint by removing Mad2 from the kinetochore 
via its effector p150glued complexed to dynein/dynactin. This role became clear 
when after overexpression of Rab6A’ T27N or silencing Rab6A’ translation via 
siRNAs a high number of binucleated cells were observed (Miserey-Lenkei at al., 
2006). Although the role of Rab6A has not been fully addressed, also this isoform 
seems to have a role in cell division. Further support for this role comes from the 
observation that the Rab6 effector protein Rabkinesin-6 and the GTPase activat-
ing protein for Rab6, GAPCenA, are also important in this process (Miserey-Lenkei 
et al., 2006). Perhaps a role for Rab6, as a Golgi localized Rab protein, can be 
anticipated in the distribution of membranes during cell division. At the onset of 
mitosis, the Golgi is fragmented and its membranes must be evenly distributed 
over the two daughter cells (Nizak et al., 2004). 
ETLK-motif
Studies on Golgi localized large coiled-coil proteins identified a single tyrosine 
residue in the C-terminal part of these proteins important for their localiza-
Figure 2: Multiple alignment of Rab6 isoform sequences showing a potential sumoylation site.
The potential sumoylation site in Rab6A and Rab6A’ and the corresponding site in Rab6B are boxed 
grey. Sumoylation site was predicted with the SUMOplot™ program revealing 94% probability.
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tion, referred to as the GRIP-domain. Initially it was thought that Golgi localiza-
tion was mediated by Rab6 via this domain (Barr 1999). Later studies however 
showed this motif also to be present in other Golgi localized proteins that are not 
known to bind to Rab6 (Barr et al., 2003; Short et al., 2005). In our attempt to 
find similarities between Rab6 binding proteins we performed a multiple align-
ment of the following Rab6 binding proteins: human Bicaudal-D1, Bicaudal-D2, 
DYNLRB1, DYNLRB2, GAPCenA, chicken p150glued, mouse Rabkinesin-6. All these 
proteins contained a similar small stretch of four amino acids, the ETLK-motif. In 
a search for other proteins with this same motif we found CENP-E, a centrosome 
associated protein, which contains this motif even twice. In figure 3 a multiple 
alignment of the regions containing the ETLK-motif of the corresponding proteins 
is shown. Although the ETLK-motif is found in a large number of Rab6 interacting 
proteins it is probably not mediating binding to Rab6. In Rabkinesin-6 for example 
the ETLK-motif is present in a domain not important for Rab6 binding (Echard et 
al., 1998). Furthermore the ETLK-motif is also present in DYNLRB2, which does 
not interact with Rab6 isoforms (chapter 5). Conspicuously, the motif is present 
twice in CENP-E, a centrosome associated motor like protein. So far however this 
protein has not been reported to be a Rab6 interactor. What these proteins have 
in common is either their involvement in microtubule-based transport or their 
centrosomal localization in case of CENP-E and GAPCenA. In light of the centro-
somal association of some of these proteins it is interesting to know that recent 
studies also revealed Bicaudal-D1 to be localized at this structure (Fumoto et al., 
2006). Taken combined, these observations suggest that the ETLK-motif may per-
haps play a role in (microtubule) tubulin binding, either during vesicle transport 
or cell division. Again, future studies should address this hypothesis.
Figure 3: Multiple alignment of several Rab6 binding proteins revealing ETLK-motif
Multiple alignment of the Rab6 binding proteins human Bicaudal-D1 and -D2 (HsBicd1, HsBicd2), 
human DYNLRB1 and DYNLRB2, chicken p150glued, mouse Rabkinesin-6, human GAPCenA, and two 
stretches of human CENP-E. The ETLK-motif is boxed black and grey as identical amino acids are 
shown in white on a black background and amino acids with similar properties are shown in white on 
a grey background.
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Future prospects
It is evident that we are still a long way from understanding the exact role of 
Rab6B. Especially the questions (i) what are the exact role(s) that this isoform 
plays in the transport in neuronal cells, and (ii) what types of vesicles and cargo 
are involved in its action, remain largely unanswered. An approach to learn more 
about the role of Rab6B in these cells would be to silence expression of Rab6B by 
blocking its translation with siRNAs. This technique has been proven to be very 
useful in determining the role of Rab6A and Rab6A’ (Miserey-Lenkei et al., 2006). 
However, these experiments are quite challenging as the other two Rab6 iso-
forms could take over the role of Rab6B. So the possibility exists that no clearcut 
effects will be observed. In identifying the role of Rab6B, the use of ‘knockout 
mouse models’, and cell lines derived thereof could also be helpful. Other clues 
could be revealed if we would be able to identify additional Rab6  - and especial-
ly Rab6B - interacting proteins. Modern approaches by which this can be achieved 
is by performing co-immunoprecipitation or pull down assays with whole lysates 
from different Rab6B containing tissues, in combination with use of mass-spec-
trometry. Rab conversion is a particular interesting topic for such a future study, 
as already became evident from tsVSVG-EYFP experiments (chapter 2). 
 Finally, our current knowledge about Rab6B regulated transport in neuro-
nal cells is summarized in figure 4. In neuronal cells Rab6B is localized to synaptic 
(Takamori et al., 2006) and Sema3A (Toonen et al., personnel communication) 
containing vesicles. Long range bi-directional movement of these vesicles is gov-
erned by the microtubule cytoskeleton, either via Bicaudal-D1 complexed to the 
dynein/dynactin protein (Matanis et al., 2002; this thesis, Chapter 4) or in com-
plex with Kinesin-1 (Grigoriev et al., 2007). From the above it is clear that Rab6B 
may be an important regulator of vesicle transport in neuronal cells. Therefore, 
to elucidate further the role of Rab6B, future studies should be emphasized on 
these type of cells.   
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Figure 4: Schematic overview of Rab6B localization in neuronal cells
Localisation and trafficking of Rab6B containing motor protein complexes in axons of neuronal cells. 
Rab6B is present in the dynein/dynactin complex and in complex with Kinesin.
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List of abbreviations
ATP    adenosine triphosphate
Arf    ADP ribosylation factor
BHK-21    baby hamster kidney cells
BSA     bovine serum albumin
cDNA     copy or complementary DNA
COP    coat protein
CLSM    confocal laser scanning microscopy
DEAE    diethylamino ethanol
DNA    desoxiribonucleic acid
DRM    detergent resistent membrane
DTT     dithiotrheitol
EDTA    ethylenediamine tetraacetic acid
EGFP     enhanced green fluorescent protein
EM    electron microscopy
ER    endoplasmic reticulum
ERGIC    ER Golgi intermediate compartment
EYFP     enhanced yellow fluorescent protein
FCS     fetal calf serum
GAP    GTPase activating protein
GFP    green fluorescent protein
GDI    GDP dissociation inhibitor
GDP     Guanosine diphosphate
GEF    Guanine exchange factor
GPI    Glycosylphosphatidylinositol
GST    Glutathione S-transferase
GTP     Guanosine triphosphate
HA    hemagglutinin
HeLa     Henrietta Lacks
HEPES     (4-(2-hydroxyethyl)-1-piperazineethanesulfonic  
    acid )
kD     kilodalton
MTOC    Microtubule Organizing Centre
NSF    N-ethylmaleimide sensitive factor
O/N     overnight
OD    optical density
ORF    open reading frame
PAGE     polyacrylamide gel electrophoresis
PBS     phosphate buffered saline
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PCR    polymerase chain reaction
Rab   Ras-related in brain
REP   Rab escort protein
RNA   ribonucleic acid
rt   room temperature
RT-PCR   reverse transcriptase-PCR
SDS    sodium dodecyl sulphate
SNARE                        Soluble N-ethylmaleimide sensitive factor attachment 
   protein receptor
t-SNARE  target SNARE
TGN   Trans Golgi Network
tsVSV    temperature sensitive vesicular stomatitis virus
v-SNARE  vesicle SNARE
YFP   yellow fluorescent protein
WT    wild type
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Summary
The eukaryotic cell is highly compartmentalized. Especially the endocytotic/se-
cretory pathway is an elaborate system of vesicles and organelles,  composed of 
early and late endosomes, lysosomes, secretory vesicles, the endoplasmic reticu-
lum and the Golgi compartment. Between these different membrane surrounded 
structures communication can take place in the form of vesicular transport. Not 
to end in chaos this vesicular transport has to be regulated, in a spatial and tem-
poral manner. Proteins responsible for this regulation are small GTPases belong-
ing to the Rab-family. Rab small GTPases constantly cycle between an ‘active’ 
GTP-bound and inactive GDP-bound state. In their GTP-bound conformation Rab 
proteins can engage in complex formation with so called effector proteins. It is 
at this level that the control of membrane transport is exerted.
 Next to providing the cell with structural integrity the cytoskeleton also 
plays an important role in supporting vesicular transport. The main components 
of the cytoskeleton are actin filaments and microtubules. Movement along the 
actin fibers is mediated by motor proteins belonging to the unconventional 
Myosins (Myosin-I, V, VI, VII). Along microtubules other classes of motor proteins 
can move. These are the plus end directed kinesins and the minus end directed 
dyneins. The transport role of Rab-effectors complexes is coupled to both classes 
of mictotubular motor proteins. The first clue for this function came with the 
identification of the Rab6 effector Rabkinesin-6, a member of the kinesin fam-
ily of motor proteins. Later Rab6 was also shown to play an important role in 
the regulation of dynein mediated movement along the cytoskeleton with the 
identification of several Dynein/dynactin associated Rab6 effector proteins such 
as Bicaudal-D1, p150glued and DYNLRB1. To learn more about the role that Rab6 
proteins play in dynein mediated transport we set out to characterize the differ-
ent isoforms, with emphasis on Rab6B, in more detail. 
 In chapter 2 we characterized Rab6B in more detail. As this small GTPase 
is highly expressed in the central nervous system we determined the relative lev-
els of this protein in the different regions of the brain. We found no differences 
in the amount of Rab6B protein in different areas or neural cell types. Using im-
munohistochemistry we found Rab6B protein to be present in neurons, pericytes 
and Purkinje cells of the cerebellum. In peripheral tissue we detected Rab6B pro-
tein in the Leydig cells in the mouse testis, but not elsewhere. As Rab6B is highly 
expressed in the SK-N-SH neuroblastoma cell line we used this cell line to study 
the ultrastructural localization of Rab6B. Using this technique we located Rab6B 
at the Golgi cisternea. ‘Live cell imaging’ with photo activatable GFP revealed 
the bidirectional movement of Rab6B positive structures, possibly belonging to 
the post-Golgi compartment. This latter finding was corroborated with a tsVSVG 
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assay, wich localized Rab6B on vesicles moving from the Golgi towards the plasma 
membrane. Our observations suggest a regulatory role for Rab6B in secretion.
Based on the observed bidirectional movement of Rab6B positive structures, 
we examined in chapter 3 a possible role for Rab6B in endocytosis. Although no 
effect was observed in receptor mediated of fluid-phase endocytosis we found 
colocalization of Rab6B with vesicles containing internalized GPI-anchored pro-
teins. GPI-anchored proteins are found enriched in ‘lipid-rafts’ and reside also 
in neuronal cells in the synapse. Based on the above mentioned colocalisation a 
regulatory role for Rab6B in the internalization of these proteins can be antici-
pated, but this should be addressed in future studies. 
 A way to learn more about the role of small GTPases is to characterize 
their molecular environment by identifying novel effector proteins. Therefore 
we performed a yeast-two-hybrid interaction screen using Rab6-GTP isoforms as 
bait. In this way we identified several novel Rab6 binding proteins of which two 
were analyzed in more detail, namely Bicaudal-D1 and DYNLRB1.
It was already known that the large coiled-coil protein Bicaudal-D1 can inter-
act with Rab6A and Rab6A’ and is linked to the dynein/dynactin complex via an 
interaction with p50dynamitin. In chapter 4 we show that also Rab6B can engage in 
direct complex formation with this protein. In SK-N-SH cells both Bicaudal-D1 and 
Rab6B are localized to the Golgi and at vesicular structures in neurites of these 
cells. These structures also contain dynein. In SK-N-SH cells part of the Rab6B 
protein is localized at the ERGIC. This structure is however devoid of Bicaudal-
D1 revealing that there are two pools of Rab6B. One associated with the ERGIC 
and another associated to Bicaudal-D1. Our data suggest an important role for 
the Rab6B-Bicaudal-D1 interaction in the retrograde transport in neuronal cells. 
Future studies should address the cargo of these vesicles.
 In chapter 5 we look in more detail at the interaction of Rab6 with 
DYNLRB1, one of the light chains found in the dynein complex. We show with 
pull-down assays and co-immunoprecipitation studies the direct and specific 
interaction of Rab6 isoforms with this protein. The interaction between Rab6 and 
DYNLRB1 therefore ensures a direct binding of Rab6 to the dynein complex, this 
in contrast to the associaten with Bicaudal-D1, which is indirect. Interesting is 
the observation that DYNLRB1 preferentially binds to GTP-Rab6A and GDP-Rab6B. 
The interaction of DYNLRB1 and Rab6 isoforms was further confirmed by micros-
copy-based studies using tagged proteins. In single VSV-DYNLRB1 expressing cells 
the DYNLRB1 shows a cytosolic, reticular like staining. However, in the presence 
of EYFP-Rab6 VSV-DYNLRB1 is localized to the Golgi. From this we conclude that 
the VSV-DYNLRB1 is recruited to the Golgi by Rab6. DYNLRB1 is structurally re-
lated to proteins implicated in modulating the GTPase activity of small GTPases. 
To test whether DYNLRB1 displays a GTPase modulating activity towards Rab6 we 
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performed a GTPase activity assay. We however were not able to reveal a GTPase 
modulating activity. We therefore propose that the role for the Rab6-DYNLRB1 
interaction in the dynein complex could be structural in nature, and serve to sta-
balize the binding of other Rab6 effector proteins found in the dynein/dynactin 
complex. 
 This thesis adds new knowledge to the understanding of how Rab pro-
teins, with emphasis on Rab6B, can create specificity in vesicular transport. How-
ever we are still a long way from establishing the exact role of Rab6B, and future 
studies should adress its function by use of gene-silencing with small interfering 
RNAs. Furthermore the identification of novel, tissue specific, Rab6B interacting 
proteins by use of pull-down assays followed by mass spectrometry, should be 
considered.
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Samenvatting (summary in Dutch)
De eukaryote cel bestaat uit een groot aantal verschillende membraan-omgeven 
compartimenten die verschillend zijn in samenstelling en functie. Het 
uitgebreide systeem van blaasjes (vesicles) voor de opname van extracellulaire 
componenten (endocytose) en uitscheiding van stoffen (secretie) staat hiervoor 
model. Kenmerkende onderdelen van dit systeem zijn de vroege en late endo-
somen (blaasjes met opgenomen stoffen), lysosomen (verantwoordelijk voor 
de afbraak van opgenomen stoffen), het Golgi-apparaat en endoplasmatisch 
reticulum (beide betrokken bij synthese en transport) en de eigenlijke secretie-
blaasjes. Tussen de verschillende compartimenten van het endocytose/secretie 
systeem vindt op uitgebreide schaal transport van blaasjes (vesicles) plaats. Om 
dit transport niet in totale chaos te laten eindigen is een vorm van regulatie no-
dig, zowel spatieel als temporeel. Verantwoordelijk hiervoor zijn kleine GTPases 
behorende tot de Rab-familie. Deze kleine GTP bindende eiwitten wisselen keer 
op keer tussen een membraan gebonden actieve GTP-gebonden vorm en een 
cytosolische inactieve GDP-gebonden vorm. In hun GTP-gebonden vorm kunnen 
Rab-eiwitten specifieke interacties aangaan met zogeheten effector eiwitten. 
Het zijn deze Rab-effector eiwit complexen, meestal onderdeel van nog grotere 
eiwitcomplexen, die verantwoordelijk zijn voor de regulatie van het vesicle 
transport. 
 Naast het geven van structurele stabiliteit speelt het cytoskelet ook 
een belangrijke rol in vesiculair transport. De belangrijkste onderdelen van het 
cytoskelet zijn de actine filamenten en microtubuli. Langs beide structuren kan 
transport van vesicles plaatsvinden m.b.v. motor eiwitten. De motor-eiwitten die 
van het actine skelet gebruik maken zijn de onconventionele myosines (Myo-
sine-I, V, VI en VII). Voor microtubuli zijn dit de kinesine en dyneïne/dynactine 
motoreiwitten. Vanwege hun belangrijke regulerende rol in vesiculair transport 
is het dan ook niet verrassend dat Rab-eiwitten een rol spelen in het reguleren 
van de laatstgenoemde klassen van motoreiwitten. De eerste aanwijzing hiervoor 
kwam met de identificatie van Rabkinesin-6, een microtubule motor eiwit, als 
Rab6 effector. Later werden ook Rab eiwitten gevonden die dyneïne gemedieerd 
transport reguleren. Vooral Rab6 lijkt hierbij een belangrijke rol te spelen. Dit 
blijkt alleen al uit het feit dat een groot aantal Rab6 effector eiwitten binden 
aan eiwitten uit het dyneïne/dynactin complex. In het onderzoek beschreven in 
dit proefschrift hebben we getracht meer te leren over Rab6 en in het bijzonder 
Rab6B. Een samenvatting van de verkregen resultaten volgt hier beneden. 
 In hoofdstuk 2 hebben we in meer detail naar Rab6B gekeken. Omdat 
Rab6B hoog tot expressie komt in de hersenen hebben we de relatieve hoeveel-
heden Rab6B eiwit in de verschillende hersengebieden bepaald. Hieruit bleek dat 
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er geen grote verschillen zaten tussen de verschillende gebieden. 
Daarnaast is met immunohistochemie gekeken naar de lokalisatie van Rab6B over 
de verschillende hersenstructuren en celtypen. Rab6B komt vooral tot expressie 
in neuronen, pericyten en in de Purkinje cellen van de kleine hersenen. In per-
ifeer weefsel konden we Rab6B alleen aantonen in Leydig cellen van de testis. 
Omdat Rab6B verder hoog tot expressie komt in SK-N-SH neuroblastoma cellen 
hebben we deze cellijn gebruikt om te kijken naar de lokalisatie van Rab6B op 
elektronen microscopisch (EM) niveau. Hier konden we Rab6B alleen zichtbaar 
maken op het Golgi. Tot slot is door middel van ‘live cell imaging’ met ‘foto-ac-
tiveerbaar GFP-Rab6B’ gevonden dat Rab6B zich op vesicles bevindt die zowel 
retrograde als anterograde bewegingen laten zien. Waarschijnlijk vetegenwoordi-
gen en dat deze vesicles een post-Golgi compartiment. Deze laatste waarneming 
werd bevestigd door het volgen van het temperatuur sensitieve VSVG eiwit in de 
secretieroute. Ongeveer 30 min. na verlaten van het ER  bevindt het tsVSVG eiwit 
zich in transport blaasje op weg van het Golgi naar de plasmamembraan. Op deze 
blaasjes is Rab6B aanwezig. Deze resultaten suggereren een rol voor Rab6 in de 
secretie van eiwitten.
 In hoofdstuk 3 is onderzocht of Rab6B een rol speelt in endocytose. Al-
hoewel geen rol voor dit eiwit werd gevonden in receptor gemedieerde of ‘fluid-
phase’ endocytose werd wel co-lokalisatie gevonden met geinternaliseerde GPI-
geankerde eiwitten. Men vermoedt dat deze klasse van eiwitten zich in bepaalde 
domeinen van het plasmamembraan bevinden. Deze domeinen onderscheiden 
zich van de rest van het plasmamembraan door een andere lipide samenstelling 
en worden ook wel ‘lipid-rafts’ genoemd. De aanwezigheid van Rab6B op GPI-ge-
ankerde eiwitten bevattende blaasjes is mogelijk een aanwijzing dat Rab6B een 
rol speelt in het transport en/of de internalisatie van deze klasse van eiwitten, 
die ook in de synapsen van neuronen worden gevonden. Meer onderzoek is nodig 
om hier verdere conclusies aan te verbinden.
Een andere manier om meer te leren over de functie van Rab6, en Rab6B in 
het bijzonder, is het identificeren en karakteriseren van nieuwe Rab6 (Rab6B) 
bindende eiwitten. Een ‘yeast-two-hybrid’ screen met Rab6 leverde een aantal 
potentiële nieuwe interactoren op. Twee van deze nieuwe interactoren koppelen 
Rab6(B) aan het dyneïne/dynactin complex en de karakterisatie van deze twee 
eiwitten wordt beschreven in hoofdstuk 4 en 5. 
 Hoofdstuk 4 gaat over de interactie tussen Rab6B en Bicaudal-D1. Het 
Bicaudal-D1 is een groot ‘coiled-coil’ eiwit dat voor het eerst werd geïdenti-
ficeerd in de fruitvlieg (Drosophila melanogaster) waarbij al een rol in dyneïne 
gemedieerd transport gevonden werd. Van Bicaudal-D1 was al bekend dat het een 
interactie kon aangaan met Rab6A en Rab6A’ en dat het via p50dynamitin verbonden 
is aan het dynactine. Op zijn beurt weer is dit eiwitcomplex weer gebonden aan 
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dyneïne. Wij laten zien dat, naast Rab6A en Rab6A’, ook Rab6B direct interact-
eert met Bicaudal-D1. Verder co-lokaliseren beide eiwitten met elkaar op het 
Golgi-apparaat en worden ze ook gevonden op vesicles in neurieten van SK-N-SH 
cellen. Op deze vesicles zit ook het dyneïne eiwit. Naast het Golgi is Rab6B ook 
gelokaliseerd op het ERGIC. Op dit compartiment is echter nooit Bicaudal-D1 
gevonden, wat er op duidt dat Rab6B in SK-N-SH cellen over twee compartimen-
ten verdeeld is, namelijk het ERGIC en Bicaudal-D1 structuren. ‘Live-cell-imag-
ing’ laat zien dat deze blaasjes vanuit het uiteinde van neuriten naar het cel-
lichaam bewegen. Dit impliceert een belangrijke rol voor de Rab6B Bicaudal-D1 
interactie in het retrograde transport in neuronen. Wat deze blaasjes trans-
porteren is tot op heden nog onbekend en is onderwerp voor verder, toekomstig 
onderzoek.
 In hoofdstuk 5 tot slot wordt de interactie van Rab6 met DYNLRB1 
beschreven. DYNLRB1 is een van de lichte ketens die worden gevonden in het 
dyneïne complex. De interactie tussen dit eiwit en Rab6 zorgt dus voor een di-
recte binding van Rab6 aan het dyneïne complex, anders dan in de interactie met 
Bicaudal-D1. Pull-down en co-immunoprecipitaties laten zien dat de interactie 
tussen Rab6 en DYNLRB1 direct en specifiek is. Dit laatste blijkt uit het gegeven 
dat alleen Rab6 interacteert met DYNLRB1 en dat de tweede DYNLRB isovorm 
(DYNLRB2), bijna identiek aan DYNLRB1, niet in staat is om aan Rab6 te binden. 
Een andere interessante waarneming is het feit dat GTP gebonden Rab6A en 
GDP gebonden Rab6A’ en Rab6B een voorkeur hebben voor DYNLRB1. Dit verschil 
is misschien een verdere aanwijzing voor de verschillende rollen die Rab6A en 
Rab6A’ spelen in de cel. Een andere aanwijzing voor een interactie van Rab6 
met DYNLRB1 komt naar voren uit transfectiestudies gedaan met beide eiwit-
ten. Wanneer alleen DYNLRB1 in een cel tot expressie wordt gebracht zien we 
een cytosolische reticulaire lokalisatie. In aanwezigheid van Rab6 daarentegen is 
DYNLRB1 op het Golgi gelokaliseerd. Hieruit concluderen wij dat DYNLRB1 naar 
het Golgi wordt gerecruiteerd door Rab6. Tot slot is onderzocht of DYNLRB1 de 
GTPase activiteit van Rab6 kan beïnvloeden. Dit naar aanleiding van een artikel 
waarin werd vermeld dat DYNLRB structureel tot een familie van eiwitten be-
hoort, welke in potentie de GTPase activiteit van GTPases kunnen beïnvloeden. 
Wij konden deze hypothese echter niet bevestigen. Wij vermoeden daarom, 
omdat ook andere Rab6 bindende eiwitten in het dyneïne/dynactine complex 
voorkomen, dat de Rab6 DYNLRB1 interactie een stabiliserende rol vervult in het 
dyneïne complex. 
 Al met al is er nog een lange weg te gaan voordat de exacte rol van 
Rab6B bekend is. Toekomstig onderzoek zou er op gericht moeten zijn om de 
expressie van Rab6B d.m.v. ‘small interfering RNA’s’ te verminderen. Ook de 
identificatie van nieuwe Rab6B bindende eiwitten d.m.v. ‘pull-down assays’ uit 
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(hersen)weefsels gevolgd door massaspectrometrie is het overwegen waard. 
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Nu wordt het toch echt wel tijd om een 2e en laatste stage te regelen. De 
studiegids doorbladerend valt mijn oog op confocale lasermicroscopie bij de 
afdeling Celbiologie van het UMC. Mooie fluorescentieplaatjes maken van cellen, 
ja dat lijkt mij wel wat. E-mail gestuurd en een paar maanden later zat ik aan de 
labtafel bij Gönül en was ik bezig met PTP-SL en PTPBR7. Van het één kwam toen 
het ander en ik had toen niet kunnen denken dat ik 7 jaar later nog bij Celbiolo-
gie zou werken. 	
Als eerste wil ik mijn copromotor bedanken. Jack, bedankt voor het begeleiden 
van het onderzoek en voor de vrijheid die je mij hebt gegeven binnen het proj-
ect. Dingen die ik niet snel zal vergeten zijn o.a. het bezoek aan Parijs. Net op 
de dag van de terugreis was er gedreigd met een aanslag met ricine toxine en 
overal liepen dus zwaar bewapende Gendarmes rond, ook op Gare-du-Nord. Toen 
jij daar dus op het station met ‘Shiga-toxine’ in je rugzak rondliep, werd het wel 
even spannend. En ja, je moet wat doen om je promotie veilig te stellen. Eén 
manier is om kaartjes voor het U2-concert in de Arena te regelen voor je copro-
motor. Dit dan ook maar gedaan. Het geluid was bagger, maar de sfeer en plek 
was goed. 
Bé, bedankt voor de begeleiding van het project van wat meer afstand. Verder 
wil ik je nog bedanken voor een extra jaar Celbiologie op het IOP-project en dat 
je ‘mijn naam hebt laten vallen’ bij Martijn.
Rinske, jouw yeast-two-hybrid heeft aan de basis gestaan van hoofdstuk 4 en 
5 en is dus heel belangrijk gebleken. Verder kon ik bij jou altijd terecht voor 
van-alles-en-nog-wat, dit heb ik altijd erg gewaardeerd. Met jou heb ik ook de 
meeste tijd in één U doorgebracht en ik zal het vele geklets in de U niet snel 
vergeten. 
Mietske voor de gezelligheid binnen ‘routing’ en voor het doen van al het EM-
werk. Helaas is onze ‘creatie’ niet op de cover van dat tijdschrift gekomen. 
Trouwens, de teek die jij nog vakkundig hebt verwijderd bewaar ik nog steeds in 
een potje, maar waar ik dat beest opgelopen heb....... 
Huib, voor het altijd klaarstaan wanneer er (weer) eens een probleem was met 
de confocale of welke andere microscoop of computer dan ook. Ook voor de vele 
immunologische kleuringen die je gedaan hebt waarvan er een aantal in hoofd-
stuk 2 staan. Verder nog bedankt voor de Lightroom-software (echt handig om al 
die (vliegtuig)foto’s mee te bewerken).
Gönül, je bent alweer een hele tijd weg, maar ik wil je op deze manier toch nog 
een keer laten weten dat ik veel van jou heb geleerd tijdens mijn stage. 
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Wiljan, jouw suggesties betreffende het DYNLRB1-verhaal hebben er zeker aan 
bijgedragen dat het uiteindelijk gepubliceerd is. Nogmaals bedankt hiervoor. 
Jan K, Femke, Yvet, Susan en Lieke. Jullie zijn toch wel de ‘harde kern’ die 
meestal als laatste overbleef bij kerstborrels, labuitjes, stappen in Nijmegen of 
bij Frans Bauer of Jan Smit ‘in concert’. Jullie waren (vaak samen met Jack, Huib 
en Ad) ook vaak te vinden op de vrijdagmiddagborrels met een biertje en veel 
chips. Mede door jullie heb ik een zeer leuke tijd gehad. Zeker weten dat ik dit 
soort dingen ga missen.
Nu vooral niet de andere celbiologen en ex-celbiologen vergeten: Rick, Walther, 
Frank, Ralph, René, Ad, Helma, Michiel, Marieke, Mariska, Lieke G, Jan S, Ineke, 
Renato, Remco, Magda, Gerda, Irene, Monique, Marloes, Sharita. Zonder jullie 
zou het lang niet zo leuk zijn geweest. Vaak gelachen, vooral tijdens de pauzes, 
wanneer de  krant weer eens grondig (lees grappig) werd geanalyseerd, of tijdens 
de vele gesprekken die helemaal nergens over gingen. Aan de koffietafel werden 
vaak ook meer serieuzere zaken besproken. Soms leek het wel of veel wereld-
problemen in een paar minuten konden worden opgelost. 
Tot slot: Wilma, in mijn herinnering leef je voort als een zeer betrokken iemand. 
Ik zal je nooit vergeten. 
De ‘Buren’ van Moleculaire Dierfysiologie (a.k.a. Moldier): Karen, Jessica, Nick 
en Marcel. Ik ben regelmatig samen met jullie wezen eten ‘op het ziekenhuis’. 
Het eten zelf was niet altijd even lekker, maar voor de rest was het wel gezellig. 
Verder Eric, Martine, Astrid, Jeroen, Gerrit, Jos, Rob, Dorien, Ron, 
François, Bart en Gerard. Jullie ook bedankt voor de goede integratie en sfeer op 
de 6e.
De ‘Tillers’ die een tijd lang op de 6e hebben ‘gebivakkeerd’: Suzanne, 
Alessandra, Ben en Joost. Ook niet vergeten: de de Boertjes: Marieke de V, Alwin, 
Godfried en Peter.
Dan ‘mijn’ studenten:
Rebecca voor het werk met het tsVSV-G eiwit. Jammer dat we geen effect zagen 
van Rab6B op het transport van dit eiwit. Edwin, alhoewel je niet echt bij mij 
stage hebt gelopen, heb je toch een belangrijke bijdrage geleverd aan het onder-
zoek. Veel succes met jouw promotieonderzoek.
De samenwerking met Rotterdam, met Casper en Anna. Jullie antilichamen en 
constructen zijn erg belangrijk geweest voor het onderzoek naar de interactie 
tussen Rab6B en Bicaudal-D1. Vooral de input van jullie kant en dan met name 
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de ‘laatste loodjes’ (de experimenten van Daniël en Max) hebben er voor gezorgd 
dat hoofdstuk 4 gepubliceerd is geworden. Nogmaals, heel erg bedankt hiervoor.
Stephen King, thanks for sharing your DYNLRB antibodies with us and your input 
concerning chapter 5. It was nice meeting you at the ASCB-meeting in San Fran-
cisco. 
Tot slot mijn familie: Pa en Ma bedankt voor het altijd klaarstaan, de ritjes naar 
en het klussen in Nijmegen, en de interesse in het onderzoek. Hetzelfde geldt 
voor Elke en Lotte (leuk dat jullie mijn paranimfen willen zijn) en René en 
Patrick.
Goodgoan,
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Strip: weekje Celbiologie ;-)
Vaak begon de week met (A) het uitzetten van cellen (variërend van HeLa, BHK-21, COS, N2A tot 
SK-N-SH cellen). De volgende dag werden deze cellen getransfecteerd met verschillende DNA-con-
structen (Rab6, tsVSVG, Bicaudal-D1, DYNLRB1, noem maar op).  Op woensdag (C) werden de cellen 
of gelyseerd op de plaat of gebruikt in bijvoorbeeld een tsVSVG-assay (1). 
De lysaten konden worden gebruikt voor (D) een co-immunoprecipitatie. Deze werd de volgende dag 
opgewerkt om vervolgens op (E) gel te worden gezet. Belangrijk, altijd checken of de monsters wel 
de goede kant op gaan! Na de SDS-PAGE blotten en O/N incuberen met antilichamen. Op vrijdag werd 
het pas echt spannend! Blotje ECLen en de film inleggen en ontwikkelen in (F) de DoKa. Daar kon het 
trouwens vrijdag, zo rond de middag, best wel ‘gezellig’ druk zijn. Na het ontwikkelen van de film 
deze goed analyseren (G). Tenminste, als er wat op de film te zien was en deze niet geheel ‘leeg’ 
was gebleven of zwart was geworden (zoals in dit geval). 
Na de tsVSVG-assay op woensdag (1) de Rab eiwitten aankleuren (rood) door middel van (2) een 
immunofluorescentieassay. Het tsVSVG-eiwit is al groen. Tijdens de IFA natuurlijk genoeg tijd om 
andere dingen te doen. De volgende dag (3) de cellen analyseren m.b.v. CLSM. Helaas was er niet 
echt een verschil te zien in het transport van tsVSVG in de aanwezigheid van de verschillende Rab6 
mutanten. Gelukkig was er dan altijd wel iemand in de buurt om het één en ander te relativeren.
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Strip: weekje Celbiologie
